Shiga toxin-producing bacteriophage in Escherichia coli O157:H7 by Hallewell, Jennyka & University of Lethbridge. Faculty of Arts and Science
University of Lethbridge Research Repository
OPUS http://opus.uleth.ca
Theses Arts and Science, Faculty of
2008
Shiga toxin-producing bacteriophage in
Escherichia coli O157:H7
Hallewell, Jennyka
Lethbridge, Alta. : University of Lethbridge, Deptartment of Biochemistry, 2008
http://hdl.handle.net/10133/776
Downloaded from University of Lethbridge Research Repository, OPUS
 SHIGA TOXIN-PRODUCING BACTERIOPHAGE IN 
ESCHERICHIA COLI O157:H7 
 
 
 
JENNYKA HALLEWELL 
B. Sc. Biochemistry, University of Lethbridge, 2005 
 
 
A Thesis  
Submitted to the School of Graduate Studies  
of the University of Lethbridge  
in Partial Fulfillment of the  
Requirements for the Degree 
 
 
 
 
 
MASTER OF SCIENCE 
 
 
 
Department biochemistry  
University of Lethbridge  
LETHBRIDGE, ALBERTA, CANADA  
 
 
© Jennyka Hallewell, 2008 
 
 
 
 
 
ABSTRACT 
Shiga toxin-producing E. coli (STEC) including E. coli O157:H7 are potential 
food and water borne zoonotic bacterial pathogens capable of causing outbreaks of severe 
illness in humans. The virulence of E. coli O157:H7 strains may be related to the type of 
Stx produced and several Stx2 variants have been identified which appear to differ in 
their ability to cause disease.  Two lineages exist within O157 strains where lineage I is 
associated mainly with human and bovine isolates and lineage II is associated mainly 
with bovine isolates. The goal of this study was to identify and characterize a lineage II 
EC970520 Stx2c phage and determine if variations in the phage compared to Stx2 phage 
found within the lineage I strain, EDL933, can result in differences in virulence observed 
between the lineages. This study suggests: 1) that the lineage II strain EC970520 contains 
a highly heterogeneous Stx2c variant phage; 2) that location of integration of the phage 
within the genome of a bacterium may be important for host selection; 3) that EC970520 
Stx2c phage genes are lineage II specific but only a subset of EDL933 phage genes are 
lineage I specific; 4) that differences in the stability of phages within bacteria contribute 
to the evolution of new pathogens; 5) that variation in phage genes can be used to detect 
different strains of E. coli O157:H7 and other STEC; and 6)that the type of phage may 
result in phenotypic differences between lineages and occurrence of human disease.  
Results of this study indicate that lineage II strains may be less virulent than lineage I 
strains due to specific genetic differences and the ability to release phage which is 
important to the evolution of new pathogenic strains. 
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CHAPTER ONE 
1.   Shiga toxin-producing bacteriophage in Escherichia coli O157:H7 
1.1.   Introduction 
Bacteriophage or “phage” are viruses capable of infecting bacterial cells.  There 
are ~4500 different dsDNA phage described that are capable of infecting a variety of 
bacteria.  Comparison of the genomes from these phage shows that a majority of them 
have a common ancestry.  It seems that phage are capable of undergoing a constant 
exchange of genetic elements from a large shared pool and may create recombinant 
phage variants (Hendrix et al., 1999).   
Phage are capable of existing in two states: lysogenic and lytic.  During lysogeny, 
bacteriophage DNA is inserted into the bacterial chromosome and in this inactive state 
the phage DNA is referred to as a prophage.  Upon induction or spontaneous replication 
of the phage or bacterial virus, it will enter a lytic cycle resulting in production of new 
phage progeny using the host’s ribosomes resulting in death of the host, and spread of the 
phage to new bacterial hosts.  During packaging of the phage DNA into phage heads 
prior to release, DNA fragments of the host genome are sometimes packaged instead of 
the phage DNA resulting in phage-mediated gene transfer (Brussow et al., 2004).  
Therefore, phage serve as vectors for dissemination of genes by horizontal transfer which 
can contribute to the evolution of new strains, as well as encode structural components 
associated with bacterial pathogenesis.  The study of these recombinant phage in bacteria 
will aid in understanding the role phage play in the evolution of new pathogenic bacterial 
species.   
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Several emerging pathogenic bacterial strains have recently acquired virulence 
factors which are encoded by phage (Saunders et al., 2001).  These virulence factors, 
such as bacterial toxins are associated with human illness (Miao and Miller, 1999).  
These phage-encoded virulence factors contribute to the fitness of the bacterial host and 
contribute to its pathogenic capabilities (Brussow et al., 2004). 
Typing of bacterial strains has allowed us to trace the sources of infection.  This 
source information is invaluable in preventing the spread of infections in epidemics.  
Characterization of these phage in bacteria is important as it will aid in the identification 
of new pathogens as well as specific clones of well known pathogens responsible for 
epidemics.  By studying phage, we will learn more about their evolution, and how these 
viruses contribute to the virulence of bacteria and allow us to develop methods to identify 
these markers of virulence in well known and newly emerging pathogens.  
 
1.2. Roles of phage in bacterial evolution 
Phage have played an important role in the emergence of pathogenic bacteria. 
Some bacteria may contain specific toxin-encoding phage and/or have multiple fitness 
factor-encoding prophage that coexist in the same bacterial host.  This is referred to as 
polylysogeny.  The configuration and gene content of these phages may account for 
variability in virulence and the emergence of strains responsible for increased disease 
severity and the number of hosts infected (Brussow et al., 2004).  It is thought that most 
pathogenic bacterial species have emerged by acquisition of virulence factors by phage.  
A select few of these include Vibrio cholerae, Staphylococcus aureus, Group A 
Streptococcus (GAS), Salmonella and Escherichia coli O157:H7.  All possess one or 
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more phage and appear to display varying levels of pathogenesis depending on their 
phage content (Table 1.2.1.).  
 
1.2.1.  Bacteriophage in V. cholerae 
V. cholerae causes severe secretory diarrhea and is responsible for epidemic 
cholera.  In V. cholerae, the toxins essential for infection of the bacteria into the host are 
encoded on phage or phage-like elements.  Acquisition of these phage virulence genes 
appears to have been recent; i.e., phage structure is still relatively intact and, GC content 
and codon usage is unique and different from that seen in the host chromosomal DNA 
(Sanchez and Holmgren, 2005).  V. cholerae requires two main regulated factors for 
virulence; i.e., cholerae toxin (CT) and a toxin-coregulated pilus (TCP) (Faraque and 
Mekalanos, 2003). CT is composed of a single toxic A subunit (CTA) which triggers 
rapid chloride and water efflux into the intestinal lumen causing watery diarrhea and a 
circular homopentamer B subunit (CTB) responsible for toxin binding to intestinal cells 
(Sanchez and Holmgren, 2005).  The CT genes (ctxAB) are found on the phage CTXΦ 
which is capable of transferring genes between toxigenic and non-toxigenic strains of 
bacteria (Waldor and Mekalanos, 1996).  CTXΦ uses TCP pili which promote bacterial 
interactions that allow V. cholerae to establish colonies on the intestinal epithelia.  
Interestingly, the TCP gene cluster is flanked by att-like attachment sequences carrying 
integrase and transposase genes which may have been initially involved in horizontal 
transfer of phage genes (Karaolis and Kaper, 1999).  The ability of TCP gene products to  
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Table 1.2.1. Summary of important phage related toxins and co-virulence factors 
associated with select representative bacterial pathogens; i.e., E. coli, V. cholerae, S. 
aureus, Group A strepotococci (GAS) and Salmonella.  
Virulent strains of E. coli and V. cholerae have specific toxins whereas S. aureus, GAS 
and Salmonella contain several toxins and co-virulence factors associated with virulence.  
 
Phage- 
encoded 
proteins 
E. coli  
 O157:H7 
V. 
cholerae 
S.  
Aureus 
 
 
GAS 
 
Salmonella 
 
Toxins 
Shiga toxin 
(Stx)  
Cholera 
toxin (CT)  enterotoxin A 
exotoxins 
SpeA,K,C,L,
M SopE 
    
cytotoxin leukocidins 
(lukS/lukF)  
superantigen 
SSA  
    
exfoliative toxin A 
(ETA)   
      enterotoxin P     
Co- 
virulence 
factors 
Sp1-18, 
multigenic 
regions  Pili  (TCP) 
Satellite and helper 
phages for tst, 
enterotoxins B,C DNAse Spa1 GIFSY-1 
  SpLE1-6   
phospholipase 
Sla GIFSY-2 
      Fels-1 
      Fels-2 
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participate in DNA excision and transfer to other bacteria suggests that this element is 
phage-related although the evidence for this is disputed (Faraque and Mekalanos, 2005).  
 
1.2.2.  Bacteriophage in S. aureus 
S. aureus causes a wide range of diseases in humans from food poisoning and 
skin infections to invasive diseases (Brussow, 2004).  More than 250 staphylococcal 
phage have been described in the literature and many of the virulence factors associated 
with S. Aureus are coded for by a family of phage rather than one particular phage 
(Pantucek et al., 2004).  The enterotoxin A (food poisoning), exfoliative toxin A (scalded 
skin syndrome) and Panton-Valentine leukocidin (PVL) which encodes the cytotoxin 
leukocidins, lukS and lukF which assemble into pore-forming transmembrane complexes 
that can lyse human leukocytes are all carried on phage (Lindsay and Holden, 2004). 
Some strains are also known to carry prophage that encode enterotoxin P, a superantigen 
involved in the symptoms of food poisoning, and staphylokinases, which are suspected of 
being involved in proteolytic destruction of host tissues (Canchaya et al., 2003).  Phage-
mediated transfer of pathogenicity islands by satellite and helper phage may also be 
responsible for the spread of the superantigen family of toxins which cause disease 
conditions such as toxic shock syndrome and encode entertoxins B and C (Lindsay and 
Holden, 2004; Brussow et al., 2004).  
 
1.2.3.  Bacteriophage in Group A Streptococcus (GAS) 
GAS are responsible for many different diseases but are frequently associated 
with invasive infections such as toxic shock syndrome, necrotizing fasciitis and may 
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result in death (Banks et al., 2002).  Genome sequencing of the Group A Streptococcus 
(GAS) pathogen serotypes M1, M3 and M18 has revealed that phage or phage-like 
elements account for the majority of variation in gene content seen in these bacteria and 
may play a vital role in the evolution and diversification of GAS strains; e.g., integrated 
bacteriophage make up as much as 12% of the genome in some pathogenic serotypes 
(Beres et al., 2002).  In M1 serotypes Spa1, which is from a family of DNAses, and the 
pyrogenic exotoxin SpeC are encoded adjacent to one another on the same prophage. 
Other prophage-encoded exotoxins, SpeL and SpeM found in M18, have been known to 
be lethal in rabbits (Brussow et al., 2004).  The highly virulent M3 serotype is associated 
with several phage-encoded genes that contribute to pathogenesis such as exotoxins 
SpeK, SpeA, the superantigen SSA, and phospholipase, Sla.  These proteins found in 
M13 are not encoded in contemporary M1 strains of the bacteria and may have been lost 
from the genome by phage-mediated recombination which has resulted in excision of 
these genes (Beres et al., 2002). 
 
1.2.4.  Bacteriophage in Salmonella 
Salmonella, which encompass a variety of serovars, are bacterial pathogens 
responsible for bacterial gastroenteritis and may result in death.  Salmonella strains have 
different combinations of phage which enhance the pathogen fitness; e.g., GIFSY-1 and 
GIFSY-2 are fully functional lambdoid prophages which are competent to undergo 
excision and viral assembly.  These phage encode several factors thought to contribute to 
systemic infections such as superoxide dismutases which protect bacteria from oxygen 
radicals produced by host macrophages (Brussow et al., 2004).  Besides GIFSY, two 
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other P2-like prophage have been identified (Fels-1 and Fels-2) which contain the genes 
for putative fitness factors such as another superoxide dismutase and a neuraminidase 
whose role in virulence is not clearly defined (Brussow et al., 2004).  Salmonella host 
interactions are largely mediated by type III secretion systems which enable bacterial 
effector proteins to translocate into eukaryotic cells (Bakshi et al., 2000).  The SopE 
protein belongs to a class of toxins that are involved in type III-secreted Rho-GTPase 
function and is encoded by SopEФ, another P2-like bacteriophage.  Bacterial isolates 
found to carry SopEФ are known to belong to epidemic strains (Hopkins and Threlfall, 
2004).  Spontaneous phage induction in Salmonella results in phage-mediated killing of 
sensitive bacteria and lysogenic conversion of survivors; this contributes to the diversity 
and evolution of these pathogenic strains (Bossi et al., 2003). 
 
1.2.5. Bacteriophage in E. coli O157:H7  
E. coli O157:H7 is responsible for severe diarrhea which may result in 
hemorrhagic colitis, hemolytic uremic syndrome and death.  Comparative genomic 
analysis of E. coli O157:H7 strains (EDL-933 and Sakai) to E. coli K-12 MG1655, a non-
pathogenic laboratory strain of these bacteria, determined several regions in E. coli 
O157:H7 which possessed an atypical base composition suggesting that horizontal gene 
transfers had occurred relatively recently from a donor species of foreign origin (Perna et 
al., 2001; Hayashi et al., 2001).  Eighteen multigenic regions in EDL-933 were found to 
be related to bacteriophage (Perna et al., 2001).  In Sakai, 18 prophage (Sp1-18) and 6 
prophage-like elements (SpLE 1-6) were present in the chromosome suggesting that 
bacteriophage have played a key role in generating diversity in E. coli (Ohnishi et al., 
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2002).  In particular, considerable diversity of the main virulence factors, the Shiga toxins 
(Stx, also known as Verocytotoxins or VTs) which are encoded by phage, exists among 
different isolates of the bacteria (Ohnishi et al., 2002).  These Stx phage are thought to 
contribute greatly to the diversity and pathogenicity found within the serotype and other 
E. coli strains and will be the focus of this review.  
 
1.3. Stx bacteriophage 
Shiga toxins (Stx) are a family of bacterial heterodimeric protein toxins that are 
involved in human and animal disease and have multiple damaging effects on eukaryotic 
cells.  These toxins are produced in Shigella dysenteriae type I, Citrobacter freundii, 
Enterobacter cloacae, Shigella flexneri and E. coli (Herold et al., 2004).  In E. coli, 
strains that are capable of producing Stx are termed Shiga toxin-producing E. coli 
(STEC).   
Stx’s bind the glycolipid receptor globotriaosylceramide (Gb3) in eukaryotic cells 
and function as rRNA-N-glycosidases to inhibit protein biosynthesis and in some cases, 
induce apoptosis (Lingwood, 1993).  Stx’s are composed of a single A subunit which 
possess N-glycosidase activity and can catalyze the release of an adenine from 28S rRNA 
preventing it from interacting with elongation factors EF1 and EF2, needed for protein 
synthesis.  Five identical B subunits facilitate binding of Stx to the Gb3 receptor found in 
eukaryotic membranes (Takeda et al., 1993; Fraser et al., 2004).  Some STEC such as E. 
coli O157:H7 adhere to the enterocytes of the colon and cause effacement of the 
microvilli and diarrhea.  If sufficient Stx is produced, damage to the blood vessels in the 
colon results in bloody diarrhea and release of toxins into the bloodstream of the host 
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(Gyles, 2007).  This can lead to systemic illness such as hemolytic uremic syndrome 
(HUS) which is caused by thrombotic microvascular lesions in the renal glomeruli, the 
gastrointestinal tract and other organs, such as the brain, pancreas and lungs (Karmali, 
2004).   
There are two major types of antigenically distinct Stx termed Stx1 and Stx2.  In 
E. coli, Stx1 is identical to the Stx found in Sh. dysenteriae and Stx2 has 55% identity to 
Stx1 at the amino acid level (Gamage et al., 2004; Strauch et al., 2001; Kozlov et al., 
1988).  A STEC strain can produce either Stx1 or Stx2 or both toxins.  The Stx’s found in 
E. coli O157:H7 and other STEC strains are encoded by lysogenic bacteriophage 
(Yokoyama, et al., 2000; Plunkett, et al., 1999; Makino et al., 1999).  The complete 
genome sequences from at least seven Stx-converting phage in E. coli O157:H7 are 
available in GenBank.  Sequence analysis has shown that Stx genes from these phage are 
uniformly flanked by phage sequences indicating a bacteriophage origin (Schmidt et al., 
2001). These phage are variable in both structure and gene composition (Herold et al., 
2004).  Stx2- encoding phage include Ф933W which was isolated from EDL-933, 
prophage VT2-Sakai and Stx2Ф-I which were isolated from O157-Sakai strains, and 
ФP297 which was obtained from an STEC strain isolated from a patient in Belgium with 
HUS (Plunkett et al., 1999; Makino et al., 1999; Sato et al., 2003; De Greve et al., 2002).  
A study of eight E. coli O157:H7 strains by Ohnishi et al. (2002) shows that only one of 
the Stx2 phage characterized was identical to that of O157-Sakai and that these phage 
share limited homology to each other and exhibit high structural and positional diversity 
indicating that various types of Stx phage exist within E. coli O157:H7 populations.  
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Studies of Stx2 have revealed the presence of a family of closely related Stx2 
variants including Stx2, Stx2c, Stx2d, Stx2e and Stx2f, all of which appear to differ in 
their ability to cause severe disease (Recktenwald et al., 2002; Pierard et al., 1998; 
Strauch et al., 2004; Schmidt et al., 2000; Friedrich et al., 2002).  Several of these Stx 
variants appear to be widely distributed among STEC serotypes (e.g. Stx2) whereas 
others seem to be much more serotype restricted; e.g., Stx2e is only produced by E. coli 
serotypes associated with edema disease in pigs.  These variants have been shown to have 
different physiochemical properties, stability, receptor affinity and LD50 in mice (Law, 
2000; Karmali, 2004; Gyles, 2007; Melton-Celsa et al., 2002).  Therefore, virulence of E. 
coli O157 strains may be related to the type of Stx produced.  Severe human disease 
associated with HUS has been linked to bacterial strains possessing Stx2 and Stx2c. 
STEC strains possessing Stx2d and Stx2e are more likely to be isolated from patients 
with an uncomplicated infection suggesting that Stx2d and Stx2e may be less toxic for 
humans than Stx2 and Stx2c (Friedrich et al., 2002).  
 In contrast to the Stx2 family, Stx1 genes appear to be more homogeneous, with 
only one variant, Stx1c, isolated thus far, which is usually associated with asymptomatic 
or mild disease (Zhang et al., 2002). 
Despite the heterogeneity of Stx2 phage, most of these phage analyzed to date 
possess a typical lambdoid morphology with dsDNA and, regular or elongated hexagonal 
heads and non-contractile flexible tails (Herold et al., 2004; Strauch et al., 2004).  The 
typical lambda genome structure which most Stx2 phage possess is seen in Figure 1.3.1.  
In Stx-containing phage, stx1 and stx2 both appear to be inserted downstream of the 
promoter, pR’ and are regulated by the Q antiterminator protein (Herold et al., 2004; 
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Plunkett, et al., 1999; Yokoyama et al., 2000).  Final assembly of Stx-phage and lytic 
release from a host cell are controlled by the Q gene which is situated near the start of the 
“Late Lytic Expression” region of the prophage genome (Fig. 1.3.1.).  The Q protein acts 
by antiterminating rho-dependent and rho-independent terminators and stabilizing 
polymerases initiating from the pR promoter which will ultimately allow transcription 
through the entire late gene operon (Calendar, 2006).  Since late phage genes are only 
expressed during the lytic cycle, induction of the lytic cycle may trigger production of 
Stx in phage-infected cells. 
Induction of phage excision and release can occur after exposure of lysogenized 
bacteria to DNA damaging agents such as UV light, mitomycin C, neutrophil activation 
products such as hydrogen peroxide or antibiotics which interfere with DNA synthesis; 
e.g., Stx production has been shown to increase after induction of phage-containing 
bacteria with ciprofloxacin (Malone et al., 2007; Muhldorfer et al., 1996; Wagner et al., 
2001; Zhang et al., 2000; Walterspiel et al., 1992).  Ciprofloxacin is a quinolone 
antibiotic which is known to induce the SOS response in bacterial cells by trapping DNA 
gyrase on DNA and blocking movement of the replication fork (Drlica and Zhao, 1997).  
In the SOS pathway of E. coli, an activated RecA protein promotes autoproteolysis of the 
DNA repair repressor, LexA, as well as the phage repressor, cI, resulting in derepression 
of late phage lytic genes (Goerke et al., 2006; Smith and Walker, 1998) (Figure 1.3.1.).  
Treatment of Stx containing bacteria with ciprofloxacin resulted in enhanced Stx 
production as well as Stx phage release (Herold et al., 2004; Schmidt et al., 2001; Goerke 
et al., 2006).  Children and adults infected with E. coli O157:H7 show increased risk of 
HUS and death when they are prescribed antibiotics at the early stages of infection, since  
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      Very early expression       early expression             late lytic expression 
 
            attL  int/xis    cIII    N          cI/cro/O/P              Q           S/R                    attR  
                                                                                              Pr’             head/tail 
 
 
 
Figure 1.3.1. Structure of typical bacteriophage λ prophage.  
Left and right attenuation sites (AttL/R) flank prophage regions and are used in site 
specific recombination. (Int) and (xis) are for integration and excision of the prophage. 
The (cIII) and (N) are recombination genes. The (cI) and (cro) are early expression 
regulators. During the SOS response, the (cI) is cleaved by RecA resulting in 
derepression of late lytic gene expression. (O) and (P) are replication genes. The (Q) gene 
is an antiterminator which initiates transcription from the promoter Pr’ and late gene 
expression. The (S) and (R) are lysis proteins which lie upstream of the main head and 
tail genes (Calendar, 2006).  
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phage induction may lead to an increase in the amount of Stx toxin released (Herold et 
al., 2004).  Not all STEC strains produce the same amount of phage after induction and  
the diversity found in phage may be related to variations in virulence.  It has been 
suggested that greater levels of phage release could result in more toxin production which 
in turn could produce more damage to the host although more evidence is needed to 
support this (Muniesa et al., 2003).  
 
1.4.     Clinical disease associated with STEC and E. coli O157:H7  
There are over 200 serotypes of STEC but E. coli O157:H7 is the most common 
serotype isolated in North America.  Only a limited number of STEC serotypes are 
associated with clinical disease in humans and illness associated with other pathogenic 
STEC tends to be less common, sporadic in nature, and less severe than that associated 
with E. coli O157:H7 (Boyce et al., 1995; Johnson et al., 1996; Besser et al., 1999; 
Brooks et al., 2005).  E. coli O157:H7 (and strains of a few other STEC serotypes) are 
responsible for most outbreaks of hemorrhagic colitis (HC) which can result in hemolytic 
uremic syndrome (HUS) or death (Karmali et al., 1983; Obrig et al., 1998; Ochoa and 
Cleary, 2003).  Illness occurs after a 3 - 4 day incubation period during which the bacteria 
colonize the bowel resulting in non-bloody diarrhea and abdominal cramps.  Infected 
individuals may develop HC which is characterized by severe abdominal cramps, watery 
and bloody diarrhea with little or no fever (Wells et al., 1983).  In 5-10% of the children 
who are infected, HUS develops and leads to acute renal failure, thrombocytopenia and 
microangiohemolytic anemia and, may even result in death (Besser et al., 1999, Boerlin 
et al., 1999).  Severe neurological impairment of the central nervous system resulting in 
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seizures, coma, stroke and/or cerebral edema occurs in 20-30% of patients with HUS 
(Pickering et al., 1994; Siegler, 1994).  Many individuals with E. coli O157:H7 infections 
develop intestinal symptoms but historically, only 6% of patients in U.S. outbreaks, 
mainly infants and young children, develop life threatening HC or HUS while 1% of 
these cases result in death (Besser et al., 1999).  However, comparison of the incidence of 
hospitalization and death caused by E. coli O157:H7 infections from 1982 to 2002 with 
the incidence of these parameters during the past five years suggests that new, more 
virulent strains of E. coli O157:H7 are emerging as a serious threat to human health 
(Manning et al., 2008). 
 
1.5.       Serotypes/pathogroups/seropathotypes 
E. coli strains have been classified by several methods over the last century. 
When referring to the serotype of E. coli strains, the O refers to the somatic antigen and 
H to the flagellar antigen.  There are 174 O antigens and 53 H flagellar antigens and 
several non-motile (NM) strains (Gyles, 2007).  E. coli can be commensal organisms but 
some strains are pathogenic, capable of causing disease including diarrhea.  
Diarrheagenic E. coli are categorized into groups based on their virulence properties, 
clinical symptoms and host range (Table 1.5.1.).  These categories or pathogroups include 
enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. coli 
(EIEC), enteroaggregative E. coli (EAEC), diffuse-adhering E. coli (DAEC) and 
enterohemorrhagic E. coli (EHEC) (Orskov and Orskov, 1984; Meng et al., 2001).  
EHEC strains including E. coli O157:H7 produce Stx, attaching and effacing (A/E) 
lesions and have a characteristic large plasmid (Plunkett et al., 1999).  However, not all  
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Table 1.5.1. Pathogroups of E. coli.  
Categories are based on virulence properties and clinical symptoms (Parry and Palmer, 
2002). 
 
Pathogroup 
 
Abbreviation 
 
Virulence property 
 
Clinical symptoms 
 
Enteropathogenic 
 
 
  
EPEC 
 
 
 
Bundle forming pili and a type 
III secretion encoded 
enterocyte attaching and 
effacing activity 
acute diarrhea in 
children 
 
 
Enterotoxigenic  
 
 
ETEC 
 
 
heat stable or heat labile toxins 
 
 
acute watery diarrhea 
in infants, calves, lambs 
and piglets 
Enteroinvasive EIEC cell invasion acute dysentery 
Enteroaggregative EAEC aggregative adherence Persistent diarrhea 
Diffuse-adhering DAEC fimbrial adhesion Persistent diarrhea 
Enterohemorrhagic 
 
 
 
EHEC 
 
 
 
A type III secretion encoded 
enterocyte attaching and 
effacing activity as in EPEC,  
shiga toxin production 
bloody diarrhea, HC, 
HUS 
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E. coli that produce Stx’s fit the strict definition of EHEC, therefore these organisms have 
also been termed Shiga toxin-producing E. coli (STEC) or verocytotoxin-producing E. 
coli (VTEC).  STEC first were recognized after the description of a cytotoxin that was 
produced by E. coli strains associated diarrhea in infants and swine.  This toxin was 
referred to as vero toxins because it killed Vero cells (Konowalchuk et al., 1977).  
O’Brien et al. (1983) also described an E. coli toxin that had many characteristics in 
common with that produced by Sh. dysenteria type 1 and termed the cytotoxin a “Shiga-
like” toxin.  It was subsequently discovered that these toxins were the same and since 
then both terms have been used.   
 
A classification system of STEC groups has also been developed based on 
reported occurrence of certain serotypes in human disease outbreaks and HUS (Karmali 
et al., 2003).  Within this model STEC strains were grouped into five seropathotypes A to 
E.  Seropathotype A (SPA) contains strains of STEC O157:H7 and O157:NM that are 
considered to be highly virulent.  These bacteria are associated with a high frequency of 
disease in humans and are commonly isolated from outbreak situations.  Seropathotype B 
(SPB) contains bacterial serotypes that are similar to O157 but, are only moderately 
virulent to humans and are not commonly isolated under outbreak conditions. Both SPA 
and SPB have been associated with HUS and HC.  Seropathotype C (SPC) is associated 
with sporadic incidence of HUS and HC, but only rarely infects humans and is not 
typically isolated under outbreak situations.  Seropathotypes D (SPD) and E (SPE) are 
associated with diarrhea and include animal strains normally not implicated in human 
disease.  This system was designed to identify those STEC isolated from food or the 
environment that pose a significant risk of disease in humans.   
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1.6.      Pathogenesis of STEC and E. coli O157:H7 
Virulence factors contribute to the ability of a microorganism to cause disease. 
The main virulence factors associated with STEC are the Stx’s which target the intestinal 
epithelial barrier, enter the bloodstream and damage vascular cells of the colon, the 
kidneys and the central nervous system (Brussow et al., 2004).  No single factor is 
responsible for the virulence of STEC and several virulence factors are thought to 
contribute to the pathogenesis of STEC, in particular, E. coli O157:H7 (Table 1.6.1.).  
Both EPEC and STEC strains including E. coli O157:H7 are able to colonize the intestine 
by type III secretion system-mediated  injection of a receptor, the translocated intimin 
receptor (Tir), into epithelial cells in the intestine and attach to Tir using an adhesin  
called intimin which is  encoded by the eae gene (Chen and Frankel, 2005).  These 
virulence genes are located in a 45 kb pathogenicity island termed the locus of enterocyte 
effacement (LEE) (Mcdaniel et al., 1995).  In addition to encoding proteins which 
mediate adhesion, LEE encodes proteins (e.g., EspF, EspG, EspH, EspZ) which alter the 
structure of the cell and its microvilli and change the cell’s physiology (Gyles, 2007).  
Areas of bacterial attachment are characterized by effacement of microvilli and the 
accumulation of cytoskeletal actin under the bacteria, destroying the microvilli and 
allowing delivery of toxins to the cell surface (Gyles, 2007; Kaper et al., 1998).   
When E. coli O157:H7 and other STEC serotypes are considered, Boerlin et al. 
(1999) reported that  the combination of eae and Stx2 genes has been more frequently 
isolated from E. coli serotypes associated with human disease.  Similarly, a 60 MDA 
plasmid in EHEC is also more common in STEC associated with severe clinical disease 
in humans.  This has led some researchers to conclude that factors encoded by this large  
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Table 1.6.1. Putative virulence factors in E. coli O157:H7.  
STEC acid tolerance systems not listed here. 
 
Virulence 
factor 
 
Gene 
 
 
Location 
 
 
Size (~) 
 
 
Putative function  
 
 
Shiga toxins 
 
 
stx1, stx2 
 
 
Stx 
prophage 
 
 
60kb 
(variable) 
 
secreted toxins which target 
 endothelial cells in the  
intestine 
Intimin 
 
eae 
 
LEE island 
 
45kb 
 
A/E lesion 
 
translocated intimin 
receptor 
tir 
 
LEE island 
 
45kb 
 
adherence 
 
effector proteins 
 
EspF, EspG,  
EspH, EspZ 
LEE island 
 
45kb 
 
adherence 
 
type III secretion 
system 
several genes 
 
LEE island 
 
45kb 
 
translocation of proteins 
 
enterohemolysin 
 
ehxA 
 
plasmid 
 
60 MDA 
 
May cause mucosal  
Hemorrhage 
serine protease 
 
espP 
 
plasmid 
 
60 MDA 
 
May cause mucosal 
 Hemorrhage 
catalase peroxidase 
 
katP 
 
plasmid 
 
60 MDA 
 
interacts with hemolysin 
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plasmid such as an enterohemolysin (ehxA) and, a serine protease (espP) may contribute 
to disease associated with EHEC (Schmidt et al., 1995).  The catalase peroxidase 
encoded by katP also found on the same plasmid is present in all enteric E. coli 
pathotypes and, may act together with the hemolysin in E. coli O157:H7 (Brunder et al., 
1996).  However, the association of these factors with more virulent STEC strains does 
not necessarily demonstrate cause and effect.  These genes could simply be markers of 
specific pathogenic lineages or clades and may not play a direct role in illness associated 
with these pathogens.    
  E. coli O157:H7 has three identified acid resistance systems; i.e., an acid-
induced oxidative system, an acid-induced arginine-dependent system, and a glutamate-
dependent system.  These systems allow the bacteria to adapt to and survive in highly 
acidic environments (Meng and Doyle, 1996).  This acid tolerance is important to STEC 
pathogen virulence as it allows bacterial survival in mildly acidic foods and, protects it in 
the stomach, allowing for a low infectious dose of the pathogen to colonize the intestinal 
tract (Leyer et al., 1995). 
 
1.7. Epidemiology  
1.7.1.   Incidences of STEC and E. coli O157:H7 
In Canada, the National Laboratory of Enteric Pathogens (NLEP), Laboratory 
Center for Disease Control and Health Canada have been collecting information on STEC 
incidence since the 1970’s; they have defined an outbreak as two or more linked cases 
(Spika et. al, 1996).  In 1993-1995, E. coli O157:H7 was the most commonly isolated 
STEC identified by the NLEP, with 93% isolates confirmed, followed by serotypes 055 
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(1.1%), 0125 (0.8%), 026 (0.6%), 0126 (0.6%), 0128 (0.6%), 018 (0.5%) and other STEC 
strains (2.8%).  In Canada, the incidence of E. coli O157:H7 in the population from 1990 
to 1999 ranged from 4.1 to 7.1 / 100,000 with an average of 1407 cases reported annually 
(Alberta Health and Wellness, February, 2008).  However, levels of incidence can vary 
geographically, with those in southern Alberta reaching levels as high as 5.6 – 10.9 / 
100,000.  However, it should be taken into consideration that frequency of serotypes in 
these reports are likely biased toward O157 due to routine use of E. coli O157:H7 
selective isolation methods in clinical laboratories.  It is clear that there is need to develop 
strategies to isolate and accurately identify strains with other STEC serotypes. 
 
1.7.2.    Outbreaks of E. coli O157:H7 
 E. coli O157:H7 was first investigated after multiple outbreaks occurred in 
Oregon and Michigan in 1982, after consumption of contaminated hamburgers (Wells et 
al., 1983; Riley, et. al., 1983).  The E. coli O157:H7 strain EDL-933 was isolated from a 
Michigan ground beef outbreak and later the entire genome sequence of this pathogen 
was determined (Perna et al., 2001).  In Japan, several large outbreaks of E. coli O157:H7 
occurred between May and December, 1996.  One of the largest outbreaks occurred in 
Sakai City, Osaka, Japan in July 1996 where 6000 individuals exhibited gastrointestinal 
illness, and 1000 people were hospitalized.  Among the hospitalized there were 100 cases 
of HUS and 3 deaths.  Many of the victims were school children and the source of the 
infection was believed to have been white radish sprouts served at a school cafeteria 
(Michino et al., 1999; Watanabe, 1996).  The Sakai strain of E. coli O157:H7 isolated 
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during this outbreak, like EDL933 has been sequenced and is now commonly used as a 
reference strain (Hayashi et al., 2001; Yokoyama et al., 2000; Makino et al., 1999).  
 
1.7.3.   Sources of disease 
STEC strains are found mainly in the gastrointestinal tracts of cattle, sheep and 
goats but have also been found in swine, cats and dogs and can be shed and transmitted to 
humans via contaminated food, direct contact with animals or person to person spread in 
human populations (Koch et al., 2001; Beutin et al., 1995; Smith et al., 1996).  The most 
common form of contamination in North America of STEC is in ground beef, but 
outbreaks have also been linked to improper cooking of meats such as roast beef, salami 
and venison.  Most contamination of meats occurs during slaughter and meat processing 
(Griffin, 1996).  Rural areas in Canada are at particular risk especially in areas where 
intensive animal agriculture occurs in close proximity to human populations and direct 
contact of humans with cattle populations or exposure to contaminated surface and 
groundwater is of concern (Gannon et al., 2004; Hyland et al., 2003; Spika et al., 1996).  
STEC can also be spread to vegetables, fruits and other plants through irrigation water or 
soil contaminated with fecal material (Meng and Doyle, 1996; Besser et al., 1999).  In 
Canada 70.9% of cases originated within a family setting (Spika et al., 1996).  However, 
outbreaks also were found to occur elsewhere; i.e., within the community (9.2%), in 
nursing homes (7.6%), restaurants and at catered events (4.4%), in other institutions 
(2.5%), day car centers (2.2%), and at other places (3.2%).  These data suggest that 
illness may be attributable to common sources of infection such as foods or water, that 
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some illness may be associated with food which is not properly cleaned or cooked and 
that secondary person to person spread also plays a role in transmission of the organism. 
 
1.8. Evolution of STEC and E. coli O157:H7 
1.8.1.   Origin of Stx 
 The Stx genes found in STEC and other enteropathogenic bacteria are similar 
immunologically and biochemically to those of pathogen Sh. dysenteriae type 1 (Kozlov 
et al., 1988).  The Stx in Sh. dysenteria are considered to be chromosomally encoded 
rather than encoded by a lambdoid bacteriophage as is seen in most STEC strains (Herold 
et al., 2004; Paton et al., 1993).  Genetic studies suggest that E. coli O157:H7 may have 
evolved from an EPEC that acquired the Stx gene by phage-mediated gene transfer or 
conversion in which a fully functional mobile phage infected a Stx-containing Shigella 
strain and horizontally transferred the Stx gene to an EPEC strain (Besser et al., 1999).  
Evidence for continuous evolution of bacteria such as Shigella and E. coli O157 through 
phage infection and horizontal gene transfer has been reported and it has been suggested 
that lysogenic phages are responsible for picking up chromosomal genes such as Stx and 
transferring them horizontally to other non-pathogenic bacteria (Greco et al., 2004).  The 
Stx genes are incorporated into the genomes of these bacteria through lysogenic 
conversion and are responsible for converting them into more pathogenic forms.  The Stx 
phage have been known to convert strains of E. coli that do not produce Stx’s to Stx-
producers; e.g., multiple phage infections have been shown to lead to the coexistence of 
three Stx genes in the same bacteria (Furst et al., 2000).  Mobile phage containing Stx 
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genes may be major vehicles for their dissemination and, could lead to emergence of new 
STEC strains. 
 
1.8.2. Evolutionary groups  
          Investigations into E. coli O157:H7 evolutionary relationships based on multi-locus 
enzyme analysis and sequence typing have identified four clonal groups of E. coli  in 
which Stx-producing strains are concentrated; i.e., EHEC1, EHEC2, STEC1 and STEC2 
(Whittam, 1996).  In addition to E. coli O157:H7, the EHEC1 grouping also contained 
non-motile E. coli as well as E. coli 055:H7. Whittam et al. (1996) found that both E. coli 
055:H7 and E. coli O157:H7 were able to produce A/E lesions in human tissue culture 
cells.  These strains were genetically similar and may be closely related (Wick et al., 
2005; Whittam et al., 1993).  Furthermore, E. coli O157:H7 is not closely related to other 
clones of the O157 serotype, suggesting that E. coli O157:H7 is not recently derived from 
other strains of the O157 serogroup (Whittam et al., 1988).  Rather, Wick et al. (2005) 
have shown that many of the virulence genes found in E. coli O157:H7 are already 
present in O55:H7.  They suggest that a >100 kb region around the O-antigen gene 
cluster was transferred in its entirety from a nonpathogenic E. coli O157 strain to an 
O55:H7-like progenitor to create the pathogen E. coli O157:H7.  A stepwise process of 
evolution of the pathogen E. coli O157:H7 has been proposed (Whittam et al., 1993; 
Wick et al., 2005); 1) evolution of an ancestral E. coli which contained chromosomal 
gene sequences that produced A/E lesions (i.e., EPEC); 2) acquisition of virulence factors 
such as stx and plasmid-encoded hemolysins by horizontal transfer into an E. coli 
055:H7-like progenitor which already possesses A/E lesion forming capabilities.  The 
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modern human pathogen E. coli O157:H7 is unique among other E. coli serotypes in that 
it does not ferment sorbitol or produce β-glucuronidase.  However, some E. coli O157:H7 
(NM) strains have been described that ferment sorbitol and have β-glucuronidase activity.  
It is felt that these features and loss of motility in these E. coli O157 strains are 
characteristic of intermediate types that likely diverged from an ancestral form of  the 
now dominant pathogenic clone of  E. coli O157:H7 at various points along its 
evolutionary pathway (Kim et al., 2001).   
 
1.8.3.   Comparative genomics 
Comparative genomic analysis of E. coli K-12 MG1655, a non-pathogenic 
laboratory strain of these bacteria with two known isolates of pathogenic E. coli 
O157:H7, (Sakai and EDL-933) revealed that each of these strains possesses a common 
4.1Mb backbone of highly conserved chromosomal DNA (> 98 % nucleotide identity in a 
comparison of orthologous genes), suggesting that these bacteria all share a common 
ancestor (Perna et al., 2001; Hayashi, 2001).  Most differences in gene content can be 
attributed to horizontal transfer of large islands of DNA which are interspersed within the 
chromosomal DNA and, are referred to as “K-islands” in E. coli K-12 and either “S-
loops” or “O-islands” depending on whether they were identified in pathogenic isolates 
of either E. coli O157 Sakai or EDL-933 respectively.  Strain-specific sequences totaled 
0.5 MB for E. coli K12 (K-loops) and 1.4 MB for O157 Sakai (S-loops) in which the S-
loops consisted mainly of virulence related genes (Ohnishi et al., 2002).  Similarly, 
comparative analysis of E. coli O157 strain EDL-933 with E. coli K12 revealed strain-
specific sequences totaling 0.53 mB for K12 (K-Islands) and 1.34 mB for EDL-933 (O-
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Islands) (Perna et al., 2001).  These O-Islands include nine large regions (>15 kb), also 
termed pathogenicity islands (Table 1.8.1.).  Smaller O-Islands that were found are 
suspected to be involved in fimbrial biosynthesis, iron uptake and utilization gene 
clusters, and coding regions for suspect non-fimbrial adhesions (Perna et al., 2001).  
Use of genome-based oligonucleotide microarrays has allowed comparison of the 
sequenced reference strains of E. coli O157 (Sakai and EDL-933) with other E. coli O157 
strains. These studies have shown that there is a high level of genome diversity among 
different E. coli O157 strains (Ohnishi et al., 2002; Ogura et al., 2006; Ogura et al., 
2007); e.g., Ogura et al. (2006) identified more than 400 “variably absent or present” 
genes in different isolates of E. coli O157, many of which were virulence related.  Zhang 
et al. (2007) extended these observations to identify 1,751 “variably absent or present” 
open reading frames among 31 different E. coli O157 strains belonging to different phage 
types (PT) and bacterial variants which were identified using the lineage-specific 
polymorphism assay (LSPA) (Kim et al., 1999).  This approach resulted in identification 
of 15 lineage I strains in which 11 different genomic regions were present in most 
isolates and, 12 lineage II strains in which these genomic regions were mostly absent. 
Most “variably absent or present” regions of the genome were associated with S-loops 
and O-islands from E. coli O157 Sakai and EDL933.  In other studies Steele et al. (2007) 
were able to identify 12 conserved regions of genomic difference that were present in 
most lineage I bacteria and, absent in most lineage II bacteria.  Eleven of these conserved 
regions were associated with S-loops from E. coli O157 Sakai and the corresponding O-
islands from E. coli O157 EDL933.  One conserved region was located on the pO157 
virulence plasmid from E. coli O157. 
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Table 1.8.1. Strain specific O-Islands >15 kb present in EDL-933 (Perna et. al, 2001). 
 
O-Island >15kb Putative virulence factors 
OI#7 Macrophage toxin, ClpB-like toxin 
OI#28 RTX-toxin-like exoprotein and transport 
system 
OI#43, OI#48 2 urease gene clusters 
OI#47 Adhesion and polyketide or fatty-acid 
biosystem system 
OI#115 Type III secretion system 
OI#122 2 toxins, PagC-like virulence factor 
OI#138 Fatty acid biosynthesis system 
OI#148 Locus of enterocyte effacement (LEE)  
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1.8.4.  Lineages  
Octamer based genome scanning (OBGS) is a high resolution genotyping method 
which has been used to identify genome variation in populations of E. coli O157:H7.  It is 
based on the use of strand-biased octamers to amplify regions of the bacterial genome.   
Through this analysis, two major lineages of E. coli O157:H7 have been identified.   An 
examination of the data from strains of these lineages showed that they were non-
randomly distributed among host source.  Lineage I strains were isolated from both 
humans and cattle; however, lineage II strains were commonly isolated from cattle but 
were rarely isolated from humans.  These data suggest that lineage I may be more 
virulent for humans or may be more efficiently transmitted to humans from bovine 
sources than lineage II strains (Kim et al., 1999).  The lineage-specific polymorphism 
assays (LPSA) using six lineage-specific markers based on the OBGS were introduced to 
simplify strain lineage typing.  Based on LSPA-6 typing 91% of the strains are 
represented by five genotypes, suggesting that these subtypes are widespread (Yang et 
al., 2004).  Both OBGS and LPSA-6 data suggest that divergence of lineages was 
probably an ancestral event that preceded geographic dissemination (Kim et al., 2001).  It 
is likely that phage-mediated events contributed to the divergence of these E. coli 
lineages (Kim et al., 1999). 
 
1.9. Typing of STEC and E. coli O157:H7 
1.9.1. Detection/ Identification of STEC and E. coli O157:H7 
The majority of O157 strains are unable to ferment sorbitol rapidly, lack β-
glucuronidase production and are unable to grow at temperatures >45˚C (Besser et al., 
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1999; Doyle and Schoeni, 1984).  The most widely used isolation methods for E. coli 
O157:H7 are culture based detection methods such as MacConkey-sorbitol medium 
(SMAC) and SMAC with tellurite and cefixime (CT-SMAC) for increased selectivity 
followed by slide agglutination tests and immunomagnetic separation with O157 specific 
antibodies attached to paramagnetic beads (Strockbine et al., 1996).  Isolates for E. coli 
O157 isolates can be screened on 4-methylumbelliferyl-β-D-glucuronidase (MUG) in 
which a fluorescent product is detectable under UV light and by using PCR which is also 
valuable for identifying non-O157 STEC isolates (Strockbine et al., 1996).  Cytotoxic 
assays and Enzyme-linked immunosorbent assays (ELISA) have also been developed to 
confirm STEC strains (Lopez et al., 1996).  
 
1.9.2.  Typing Methods  
The enormous diversity found between STEC and within E. coli O157:H7 has 
lead to the need to develop methods to identify and characterize these pathogens.  
Subtyping or fingerprinting of pathogens is important for identification of pathogen 
isolates, tracing sources of infections and identifying outbreaks for the prevention of 
disease.  Subtyping is a standardized method in which there is a consensus criteria of 
reading and interpreting results, whereas fingerprinting involves comparison of isolates 
obtained by a single lab and is not always reproducible in all labs.  
 Several fingerprinting methods such as plasmid profile analysis, antimicrobial 
susceptibility testing, and ribotyping have been evaluated as typing methods for E. coli 
O157:H7 but, are not considered discriminating enough to generate epidemiological 
meaningful data (Grif et al., 1998; Strockbine et al., 1996).  Phage typing (PT), is a 
                                                                           28
standardized typing method for which 88 PT’s have been described.  In this method lysis 
patterns for a panel of lytic phages are used in subtyping E. coli O157:H7 strains.  
Unfortunately, many epidemiologically unrelated strains may belong to the same PT.  
Therefore, this typing method is best used as a first-line subtyping method especially if 
there is a rare phage-type (Khakhria et al., 1990; Barrett et al., 1994).  Multi-locus 
enzyme analysis (MLE), Random Amplification of Polymorphic DNA (RAPD) and 
Multi-Locus variable-number tandem repeat analysis (MLVA) also provide evidence for 
characterization of isolates but, like PT, varying degrees of sensitivity have been noted 
among methods (Grif et al., 1998).  PFGE is currently the “gold standard” in E. coli 
O157:H7 typing since it allows discrimination between O157:H7 isolates from different 
geographic regions in specific outbreaks.  Barett et al. (1994) found that 25 out of 74 E. 
coli O157:H7 isolates in a Washington outbreak and, 10 out of 27 isolates from other 
states associated with the same outbreak had the same PT, yet only one isolate had the 
same PFGE pattern indicating that PFGE may be more sensitive but, should still be used 
in conjunction with other molecular subtyping methods for reliable typing.  PFGE is also 
not consistent between laboratories and requires complex computer-dependent analysis.  
Genotyping microarrays have advantages over PFGE and ribotyping because they can 
discriminate between specific genes of interest and have a higher resolution than MLE 
(Borucki et al., 2004).  Microarray-based comparative genomic hybridizations has been 
developed to identify genomic differences within E. coli O157 lineages and support 
phylogeny evidence of other methods such as PT and LSPA (Zhang et al., 2007).  
However, experimental procedures and analysis of strain data from planar microarrays is 
time-consuming, expensive and laborious, so new methodologies need to be developed. 
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 Multiplex PCR has been widely used to provide fast, accurate results for 
identifying STEC strains, as well as variants of E. coli O157:H7 (Nakao et al., 2002; 
Bastian et al., 1998).  Gannon et al. (1997) developed a multiplex PCR which targets the 
genes coding for Stx (stx1 and stx2), intimin (eae) and flagellar (flicC) proteins of E. coli 
O157:H7; this method can  be used to supplement other  molecular fingerprinting 
methods and is a valuable tool for use in epidemiological investigations and clinical 
diagnosis. 
 
1.9.3.  Suspension arrays for detection and identification of strains 
 Nucleic acid suspension microarrays used with the Luminex (Luminex, TX) and 
Bioplex (BioRad, CA) microbead technologies can be used for rapid detection of 
multiple genes, allowing up to 100 different reactions in a single well.  These systems use 
nucleic acid or protein-coupled microbeads, each with its own fluorescent spectral 
address in conjunction with a reporter dye which are activated by lasers to produce a 
signal which is detected by a high-speed digital photomultiplier.  Several assays for 
nucleic acids have been developed with this technology.  Most detect DNA by direct 
DNA to DNA hybridization to bead-coupled probes; e.g., single base chain extension, 
allele specific primer extension and ligation end-labeling (Dunbar and Jacobson, 2007; 
Dunbar, 2006).  Direct DNA hybridization, often using several DNA oligonucleotides in 
the same multiplex reaction mixture, can be used simultaneously to detect multiple genes 
amplified in an unknown sample.  This approach can be used for, genotyping as well as 
for virus and bacterial gene detection.  Colinas et al. (2000) developed a Luminex-based 
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multiplex genotyping scheme that uses allele-specific beads to distinguish between 
mutant and wild-type β-globin genes from newborn, blood spot DNA.  Multiplex assays 
for viruses such as HIV, Hepatitis C and Herpes Simplex virus also have been developed 
for detection of multiple infections in susceptible patients (Smith et al., 1998). 
Asymmetric PCR is another useful way to identify multiple infections by pathogens and 
has been expanded for genotyping strains of animal pestivirus (Deregt et al., 2006).  
Spiro et al. (2000) used multiplex hybridization of 16S/23S intergenic spacer region 
DNA to develop probes to detect and quantify microorganisms found in ground water at a 
nuclear waste site.  Serovar-specific probes for the food-borne pathogen, Listeria 
monocytogenes were developed using oligonucleotide dendrimers to detect up to 98% of 
known strains and classify four serogroups (Borucki et al., 2005).  L. monocytogenes 
along with three common bacterial pathogens, E. coli, C. jejuni and Salmonella were 
detected simultaneously using organism-specific 23S ribosomal RNA gene (rrl) coupled 
probes (Dunbar et al., 2003).  These studies suggest that the suspension array technology 
can be useful in detection, typing, and genotypic analysis of E. coli O157:H7.  
 
1.10.  Thesis Goals and Objectives   
Stx2 production is thought to be one of the most important virulence attributes of 
E. coli O157:H7.  Characterization of the Stx2 phage found in E. coli O157:H7 strains 
will not only be important for detecting genetic variations within this serotype but will 
also help us to identify an important phenotypic trait associated with virulent E. coli 
O157:H7 strains. 
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This study will help us to detect and identify factors that may be contributing to the 
evolution and virulence of E. coli O157 and other STEC strains. The main thesis goals 
and specific objectives are: 
 
I) Contribute to efforts of the laboratory team in identification and 
characterization of a Stx2c-encoding bacteriophage from an E. coli O157:H7 
lineage II strain 
1) Help clone and determine the nucleotide sequence of a Stx2c phage  
2) Help annotate the genes in the Stx2c phage and determine the integration     
 site of the phage in the chromosome 
3) Determine if regions of this Stx2c phage are lineage-specific 
4) Determine if the integration sites for Stx2c and Stx2 are lineage-specific 
 
II) Detection of Stx2-encoding bacteriophage in lineage I and II strains 
1) Develop methods for specific detection of genes found within E. coli 
 O157:H7 and other STEC 
2) Assess the variation in lineage-specific genes found within E. coli O157:H7 
 containing Stx2 and Stx2c in different isolates of the bacteria 
3) Assess the variation in lineage-specific genes found within seropathotypes 
 of STEC which contain Stx2 and Stx2c 
 
III) Examine phenotypic differences between Stx2-encoding bacteriophage from 
E. coli O157:H7 lineage I and II strains.  
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1) Determine if Stx2 phage is released in a lineage-specific manner after 
 exposure to specific chemical and physical inducers 
2) Determine if relative toxin release following induction by strains is lineage-
 specific  
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CHAPTER TWO 
2.    Characterization of a Shiga toxin 2c-encoding bacteriophage from an E. coli 
O157:H7 lineage II strain 
2.1.  Introduction 
Escherichia coli (E. coli) O157:H7 is a food- and waterborne bacterial pathogen 
responsible for outbreaks and sporadic cases of hemorrhagic colitis (HC).  The disease is 
most severe in children and 5-10% of infections in children with HC develop the 
sometimes fatal hemolytic uremic syndrome (HUS) (Besser et al., 1999; Monnens et al., 
1998, Karmali et al., 1983; Obrig et al., 1998; Ochoa and Cleary, 2003).  
 The single most important virulence factor of this pathogen is thought to be the 
production of Shiga toxins (Stxs) (Law, 2000; Karmali, 2004; Gyles, 2007).  These toxins 
are bipartite protein molecules composed of one large A subunit (32 kDa) and a pentamer 
of smaller B-subunits (7.7 kDa).  The A subunit contains the enzymatically active portion 
of the toxin which inhibits protein synthesis in eukaryotic cells by N-glycosidase 
cleavage of an adenine residue of the 28 S ribosomal RNA subunit.  The five B-subunits 
of Stx 1 and Stx 2 bind to glycolipid receptor globotriaosylceramide (Gb3) on cells and 
trigger internalization of the toxin molecule.  Stx produced by the organism in the colon 
is taken up and released into the bloodstream of the host.  It is thought that the toxin 
binds to receptor-bearing endothelial cells lining the human microvasculature resulting in 
cell death, release of cytokines, and formation of microthrombi.  This leads to anoxic 
damage to organs such as the brain and kidney and complications such as HUS.   
While E. coli O157:H7 is the most common serotype of Stx-producing E. coli 
(STEC) in North America (Boyce et al., 1995; Johnson et al., 1996; Besser et al., 1999; 
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Brooks et al., 2005), these toxins are also produced by over 200 other serotypes of E. 
coli.  However, only a limited number of other STEC serotypes are associated with 
clinical disease in humans and illness associated with these other pathogenic STEC 
serotypes tends to be less common, sporadic in nature and less severe than that associated 
with E. coli O157:H7.  Further, many other STEC serotypes have never been associated 
with human disease.  The apparent serotype-specific differences in virulence among 
STEC has lead to the classification of these organisms into different seropathotypes (SP)  
(Karmali et al., 2003).   
Two major antigenic types of Stx are produced by E. coli O157:H7; Stx1 and 
Stx2, and individual strains of this serotype produce either Stx1 or Stx2 or both toxins.  In 
addition, several variants of Stx2 (Stx2c, Stx2d, Stx2e, and Stx2f) have been identified as 
being produced by E. coli O157:H7 and other STEC.  Several of these Stx variants 
appear to be widely distributed among STEC serotypes (e.g., Stx2) whereas others seem 
to be much more serotype-restricted; e.g., Stx2e is only produced by E. coli serotypes 
associated with edema disease in pigs.  These toxin variants have been shown to have 
different physiochemical properties, stability, receptor affinity and LD50 in mice (Law, 
2000; Karmali, 2004; Gyles, 2007; Melton-Celsa et al., 2002).   It is therefore not 
surprising that E. coli which produce different toxin variants also differ in their ability to 
cause disease (Strauch et al., 2004; Pierard et al., 1998; Recktenwald et al., 2002; 
Schmidt et al., 2000; Freidrich et al., 2002).  However, the virulence of the E. coli strains 
which produce these toxins may not only be influenced by the type of Stx but also the 
quantity of the toxin produced (Lejeune et al., 2004).  
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In E. coli O157:H7 and several other STEC, Stx1 and Stx2 have been shown to be 
encoded by bacteriophage integrated into the host genome.  The genomes of at least 
seven Stx-converting phage from various STEC serotypes have been sequenced and 
characterization of these phage shows that they are heterogeneous in structure and gene 
composition (Herold et al., 2004).  Stx-containing phage integrate into at least four 
different sites in STEC genomes.  These include the genes wrbA, yehV, sbcB and yecE 
(Ohnishi et al., 2002).  In E. coli O157:H7 EDL933, the Stx1 bacteriophage is integrated 
into the yehV gene and the Stx2 phage is integrated into wrbA (Plunkett et al., 1999).  
However, it is clear that the Stx phage, the toxin variants they produce and the 
phage integration sites not only differ among STEC serotypes but also among E. coli 
O157:H7 strains themselves (Besser et al., 2007; Ohnishi et al., 2002; Serra-Moreno et 
al., 2007; Shaikh and Tarr, 2003).  Lejeune et al. (2004) reported that a collection of  E. 
coli O157:H7 strains isolated from cattle produced less Stx2 than strains of the pathogen 
isolated from human infections and that these bovine strains lacked the phage-encoded Q 
anti-terminator gene present in the human pathogen E. coli O157:H7 strain EDL933. 
Besser et al. (2007) have also reported that bovine strains were significantly more likely 
to produce Stx2c than strains of human origin.    
Kim et al. (1999) reported that E. coli O157 strains could be divided into two 
lineages using octamer-based genome scanning (OBGS).  Lineage I strains were the 
common genotype and were equally likely to be isolated from humans with clinical 
disease and cattle, however, lineage II strains were commonly isolated from the faeces of 
cattle but rarely isolated from clinical disease in human disease. Recently, Ziebell et al. 
(2008) have made a “phenotypic link” which could explain these observations.  They 
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reported that Stx2 type and levels of Stx production are associated with lineage and phage 
types (PT) specific to different E. coli O157:H7 strains.  These workers found that E. coli 
O157:H7 lineage II strains were significantly more likely to produce the Stx2c variant 
while lineage I strains commonly carry Stx2. This difference in toxin type and levels of 
toxin production could explain differences in apparent virulence of lineage I and II strains 
as inferred from their biased host distribution.  While the Stx2 phage sequence from 
lineage I strains EDL 933 and Sakai has been determined little is known about the phage 
associated with Stx2c variant production in lineage II strains.  
In this study, the nucleotide sequence and the integration sites for one lineage II 
Stx2c phage was determined. The nucleotide sequence was annotated and compared to 
that of other Stx2 phage that have been sequenced.  The distribution of lineage II Stx2c 
and lineage I Stx2 phage in a collection of E. coli O157:H7 strains was also determined 
using PCR screening.   Specific objectives of this study were to: 
 1)  clone and determine the nucleotide sequence of Stx2c prophage from the E. coli  
  O157:H7 lineage II strain EC970520. 
 2)   annotate the genes in the new Stx2c phage sequences and determine the 
integration site of the Stx2c phage into the chromosome of strain EC970520   
 3)  determine if regions of the Stx2c phage genome from strain EC970520 are lineage 
II-specific 
4)  determine if regions of this Stx2 phage genome from EDL933 are lineage I-
specific 
 5)  determine if the integration sites for Stx2 and Stx2c phage are lineage-specific 
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2.2.  Material and Methods 
2.2.1.  Bacterial strains  
 In this study, 30 lineage-specific strains of E. coli O157:H7 which were isolated 
from different sources and contained several different phage types (PT) were used (Kim 
et al., 1999; Khakhria et al., 1990) (Table 2.2.1.).  These strains previously used by 
Zhang et al., 2007 were determined to possess different lineage-specific polymorphism 
assay (LPSA) types by microarray-based comparative genomic hybridization (CGH).  
LI/II strains were treated as subgroups often within lineage I strains but were identified as 
LI/II strains.  Studies involving integration of the bacteriophage into host bacteria were 
done on an extended group of E. coli O157:H7 strains consisting of 112 isolates (Table 
2.2.2.).  
 
2.2.2. Screening an EC970520 cosmid genomic library for Stx2  
 A cosmid genomic library for EC970520 was prepared to allow isolation or 
‘fishing’ of conserved Stx2 prophage DNA.  Genomic DNA was digested and ligated into 
Supercos I according to the manufacturer’s instructions (Stratagene, CA) and stored in 
glycerol stocks at -80 ° C (personal communication, Zhang).  Bacteria were resuscitated 
by placing about 3*108 CFU in LB broth in a 37 º C shaker for exactly 2 hours.  Serial 
dilutions of cells containing the cosmid were prepared, then plated on kanamycin (KM) 
agar plates (50 µg/ml) and incubated at 37 ºC overnight; the Supercos I cosmid contains 
an neor gene which confers kanamycin resistance and bacteria containing this construct 
can be selected by growth on KM.  Fifty individual colonies were picked and transferred  
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Table 2.2.1.  E. coli O157:H7 lineage-specific strains used in this study.   
Strains were previously used and characterized for LPSA type by Zhang et al. (2007) by 
analysis of microarray-based comparative genomics hybridizations (CGH).  
 
Strain Serotype 
Phage   
type Source LSPA type Lineage 
LRH16 O157:H7 14 Human IIIIII I 
LRH27 O157:H7 14 Human IIIIII I 
LRH6 O157:H7 14 Human IIIIII I 
TS97 O157:H7 14 Bovine IIIIII I 
F1299 O157:H7 14 Bovine IIIIII I 
F5 O157:H7 14 Bovine IIIIII I 
EDL933 O157:H7 21 Human IIIIII I 
63154 O157:H7 31 Human IIIIII I 
58212 O157:H7 31 Human IIIIII I 
F1095 O157:H7 31 Bovine IIIIII I 
Sakai O157:H7 32 Human IIIIII I 
H4420 O157:H7 87 Bovine IIIIII I 
E2328 O157:H7 87 Bovine IIIIII I 
F1082 O157:H7 87 Bovine IIIIII I 
59243 O157:H7 2 Human 2IIIIII I/II 
71074 O157:H7 2 Human 2IIIIII I/II 
EC20030338 O157:H7 2 Human 2IIIIII I/II 
Zap0046 O157:H7 2 Human 2IIIIII I/II 
LRH13 O157:H7 23 Human 222222 II 
R1797 O157:H7 23 Human 222222 II 
LS68 O157:H7 23 Bovine 222222 II 
F12 O157:H7 23 Bovine 222222 II 
F1081 O157:H7 23 Bovine 222222 II 
FRIK 920 O157:H7 23 Bovine 222222 II 
FRIK 1999 O157:H7 23 Bovine 222222 II 
FRIK 1985 O157:H7 45 Bovine 22222I II 
FRIK 1990 O157:H7 54 Bovine 2222II II 
FRIK 2001 O157:H7 54 Bovine 222222 II 
EC970520 O157:H7 67 Bovine 222222 II 
12491 O157:H7 74 Human 2222I2 II 
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Table 2.2.2. Extended list of E. coli O157:H7 strains used for the integration studies. 
Some strains from Table 2.2.1 are included in this list. 
 
STRAIN SOURCE PHAGE TYPE LINEAGE 
F1150 Bovine 1 I 
TS104 Bovine 1 I 
EC20020294 Human 1 I 
R1388 Human 1 I 
E1572 Human 2 I 
107718 Human 2 I 
111570 Human 2 I 
R910 Human 14 I 
F832 Bovine 14 I 
F1042 Bovine 14 I 
F1135 Bovine 14 I 
S2476 Human 14 I 
45550 Human 14 I 
72143 Human 14 I 
65576 Human 14 I 
33336 Human 14 I 
AA7821 Water 14 I 
TS52 Bovine 14 I 
LS7 Bovine 14 I 
LS225 Bovine 14 I 
EC20020290 Human 14 I 
TS97 Bovine 14 I 
LRH6 Human 14 I 
LRH16 Human 14 I 
LRH27 Human 14 I 
97701 Human 14 I 
F5 Bovine 14 I 
F1299 Bovine 14 I 
E1112 Human 14 I 
EC20020292 Human 21 I 
EC20020293 Human 21 I 
EC20030103 Human 21 I 
R776 Human 31 I 
R1277 Human 31 I 
LRH17 Human 31 I 
63154 Human 31 I 
58212 Human 31 I 
F1095 Bovine 31 I 
F1104 Bovine 32 I 
93178 Human 32 I 
Sakai Human 32 I 
R904 Human 33 I 
EC20020291 Human 34 I 
120290 Human 45 I 
EC19980119 Bovine 87 I 
74909 Human 87 I 
LN7264 Water 87 I 
F1082 Bovine 87 I 
E2328 Bovine 87 I 
F801 Bovine 87 I 
F1099 Bovine 87 I 
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STRAIN 
continued SOURCE PHAGE TYPE LINEAGE 
94023 bovine 87 I 
F1083 bovine 87 I 
F1084 bovine 87 I 
F1085 bovine 87 I 
F1090 bovine 87 I 
F1097 bovine 87 I 
F1106 bovine 87 I 
EDL933 human 21 I 
71074 human 2 I/II 
59243 human 2 I/II 
EC20020462 bovine 15 I,II 
EC20030338 bovine 15 I,II 
EC20030282 bovine 15 II 
EC20030348 bovine 15 II 
EC20030351 bovine 15 II 
EC19920026 bovine 23 II 
EC19920171 bovine 23 II 
EC19920283 human 23 II 
EC19930086 human 23 II 
EC19930200 bovine 23 II 
F1081 bovine 23 II 
EC20030186 bovine 23 II 
EC20030216 bovine 23 II 
EC20030226 bovine 23 II 
EC20030275 bovine 23 II 
EC20030277 bovine 23 II 
EC20030278 bovine 23 II 
EC20030289 bovine 23 II 
EC20030340 bovine 23 II 
EC20030495 human 23 II 
LS68 bovine 23 II 
FRIK 920 bovine 23 II 
FRIK 1999 bovine 23 II 
LRH13 human 23 II 
R1797 human 23 II 
EC20000623 bovine 23 II 
EC19920283 human 23 II 
EC19930086 human 23 II 
R1797 human 23 II 
LRH13 human 23 II 
EC20030528 human 23 II 
EC20030547 human 23 II 
EC20030292 bovine 45 II 
FRIK 1985 bovine 45 II 
R834 human 54 II 
EC20030154 bovine 54 II 
FRIK 1990 bovine 54 II 
FRIK 2001 bovine 54 II 
EC19920005 bovine 67 II 
EC19920192 bovine 67 II 
EC19970520 bovine 67 II 
EC20030317 bovine 67 II 
12491 human 74 II 
EC20030193 bovine 74 II 
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STRAIN 
continued SOURCE PHAGE TYPE LINEAGE 
EC20030223 bovine 74 II 
EC20030281 bovine 74 II 
EC20030422 human 74 II 
EC20011139 bovine 82 II 
AA579-2 unknown 87 II 
EC20030496 human  - II 
EC20030497 human  - II 
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to two separate KM plates and then incubated at 37 ºC over night.  Colonies from one of 
the duplicate plates were prepared by adding 5 ml of sterile milli Q water to the surface 
and were screened using a l µl aliquot of the cosmid mixture for the presence of Stx2 by 
PCR using VT2 conserved primers (Table 2.2.3.). Individual cosmid clones were 
subsequently isolated by individual colony picking of Stx2 positive plates.  Regions 
upstream (personal communication, Zhang) and downstream of the Stx2 were screened 
by PCR analysis and cosmid clone isolation. 
 
2.2.3.  Screening of Stx2 bacteriophage genes by PCR    
 Forward and reverse primers either were identified within the literature (Gannon 
et al., 1997) or were designed from a previous sequence (933W accession no. AF125520) 
or a partial sequence as each cosmid was sequenced (EC970520) (Table 2.2.3) (personal 
communication, Zhang).  PCR’s were performed using genomic DNA (100 ng), a 1 µl 
aliquot of cosmid mixture as previously described or a picked colony template.  PCR’s 
producing amplified products <2 kb in size were performed in a 25 µl reaction volume 
which contained 200 µM of each deoxynucleoside triphosphate, 10 pmol of each primer, 
1X PCR buffer (Qiagen) and 1U DNA Taq polymerase (Qiagen).  PCR’s were conducted 
using the following parameters: 3 min denaturation at 94 ºC, followed by 25 cycles of 45 
s at 94 ºC, 30 s at 55 ºC and 90 s at 72 ºC with a final 10 min 72 ºC extension step.  PCR 
products were visualized under UV light on a 1.0% (w/v) agarose gel stained with 
ethidium bromide (0.5 µg/ml).  PCR’s producing amplified products >2 kb were 
performed as long template PCR’s which also used genomic DNA (100 ng), a 1 µl 
aliquot of cosmid mixture or picked colony templates.  However, each 25 µl reaction 
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volume contained 200 µM of each deoxynucleoside triphosphate, 10 pmol of each 
primer, 1X Advantage 2 PCR buffer (BD) and 1X Advantage 2 Taq polymerase (BD).
 44  
Table 2.2.3. Nucleotide sequences and locations of primers used for fishing Stx2 phage from a cosmid genomic DNA library, PCR 
screening for lineage-specific strains and identification of potential integration sites. 
 
 
Primers  Nucleotide sequence (5'-3') Location 
Predicted 
amplicon 
size (~bp) Source 
P7 ATCACCTTCCGCCGCAATGG Upstream stx2c  n/a EC970520 
pyz2 TCCAGTACCTATTACGCCTTG Upstream stx2c  n/a EC970520 
pyz6 GCTCTTCTGTTGCCAGTCTTA Upstream stx2c  n/a EC970520 
pyz7 AGAAGGTGGAGAACTCCATG Upstream stx2c  n/a EC970520 
R104-13  CGCCACATAGACAAAGCCCT Downstream stx2c 6500 EC970520 
R104-RC  TGTGCCTTGATCTCTTCCAGTG Downstream stx2c     
VT2-F CCATGACAACGGACAGCAGTT Stx2 conserved gene 2000 Gannon et al. (1997) 
VT2-R CCTGTCAACTGAGCACTTTG Stx2 conserved gene     
R104-23r  TGCAGAAGGCGGTGAATGA Downstream stx2c 10,000 EC970520 
302-T3-9r  TCGTTGGTCCGTCTGGCTCA Downstream stx2c     
pyz1 CCTAAGACTGGCAACAGAAG Downstream stx2c 9000 EC970520 
rstx1 GTGGTATAACTGCTGTCCGTTGTC stx2c region     
stx2-f TATATCAGTGCCCGGTGTGA stx2 in EDL933 753 
933W (accession no. 
AF125520) 
stx2-r TTCTTTCCCGTCAACCTTCA stx2 in EDL933     
stx2c-f TATATCAGTGCCCGGTGTGA stx2c in EC970520 750 EC970520 
stx2c-r TTTTCCGGCCACTTTACTG stx2c in EC970520     
SBC  GCGTGTGACTTCGTCGTCGAAAC sbcB insertion site forward 1500 K12 (NC_000913) 
PBP  CTGGCGTAATGCGATGACTA sbcB insertion site reverse  EC970520 
SBC  GCGTGTGACTTCGTCGTCGAAAC sbcB insertion site forward 2000 K12 (NC_000913) 
pyz8  GAAGATTGGACGGCGGATAAC sbcB/phage left junction   EC970520 
PBP  CTGGCGTAATGCGATGACTA sbcB insertion site reverse 1700 EC970520 
406phage  TCATTTTGATTTTGCTGCAC sbcB/phage right junction   
wrbA-C AGGAAGGTACGCATTTGACC wrbA insertion site reverse 314 Besser et al. (2007) 
wrbA-D CGAATCGCTACGGAATAGAGA wrbaA insertion site forward   
wrbA-C AGGAAGGTACGCATTTGACC wrbA insertion site reverse 592 Besser et al. (2007) 
 wrbA-G ATCGTTCGCAAGAATCACAA wrbA/phage left junction     
wrbA-D CGAATCGCTACGGAATAGAGA wrbaA insertion site forward 506 Besser et al. (2007) 
wrbA-H CCGACCTTTGTACGGATGTAA wrbA/phage right junction     
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 PCR’s were conducted using the following parameters: 30 s denaturation at 95 ºC, 
followed by 30 cycles of 30 s at 95 ºC and 12min at 68 ºC with a final 7 min 70 ºC 
extension step. PCR products were visualized under UV light on a 0.6% (w/v) agarose 
gel stained with ethidium bromide (0.5 µg/ml).  Negative controls incorporated all 
reagents of the PCR except water was used as a template. 
  
2.2.4.  Data analysis   
 Sequencing of cosmids and amplificons were completed at the University of 
Guelph (University of Guelph Molecular Supercenter, ON).  DNA sequences were 
analyzed by homology searching using Blast (NCBI) and annotated by KodonTM total 
genome and sequence analysis software (Applied Maths, TX).  A blastn (NCBI) 
comparison was performed with the EC970520 sequence and other Stx2 phage sequences 
in order to assess their homology.  The similarity percentages were derived from % 
identity and length of alignment.  
 
2.2.5. PCR identification of genes specific to Lineage I and II in E. coli O157:H7   
 To determine if the isolated Stx2c phage genes were lineage-specific, 5 sets of 
primers were designed from the completed sequence and used for PCR screening of 
lineage specific strains from Table 2.2.1.(personal communication, Zhang).  A primer set 
specific for Stx2 from the lineage I strain EDL933 was also PCR amplified in lineage-
specific strains.  
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2.2.6.  Integration sites of Stx2 phage   
 E. coli O157:H7 isolates from Table 2.2.2. were analyzed by PCR for insertion 
sites using selected primers from Table 2.2.3.  Primers for sbcB were designed and tested 
in EC970520 and E. coli K12 to determine the site of interruption by the phage genome.  
Primers were then designed for both the left and right phage-chromosome junctions of 
the sbcB integration sites.  To confirm the presence or absence of phage integration into 
sbcB loci, isolates were also screened for intact gene products.  It has previously been 
determined that the integration site for Stx2 phage of EDL933 is wrbA (Plunkett et al., 
1999) and strains were further assessed by PCR using primers for wrbA integration that 
were previously identified by Shaikh and Tarr (2003).   
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2.3.  Results 
2.3.1.  Cloning and sequencing of the Stx2c phage genome   
 A cosmid genomic library was prepared for E. coli O157:H7 strain EC970520 
(personal communication, Zhang).  Cosmid clones containing Stx2 regions were 
identified from the genomic library by PCR screening using primers with homology to 
the Stx2 gene (primers VT2F and VT2R Table 2.2.3.).  A cosmid clone, #302 was 
isolated that contained the Stx2 genes (Figure 2.3.1.).  However, when sequenced, this 
clone did not contain the gene sequence of the entire bacteriophage nor the bacteriophage 
bacterial host DNA junction. Therefore, PCR primers from clone #302 were developed 
(primers pyz1, pyz2, rstx1, P7 Table 2.2.3.) (personal communication, Zhang) and used 
to isolate cosmid clones containing upstream and downstream gene sequences.  Cosmid 
clone #406 was isolated using these primers and nucleotide sequencing determined this 
clone contained sequence downstream of cosmid clone #302 and a possible integration 
site for the phage into the host genome.  Primers specific for the integration site were 
developed based on the interrupted gene, sbcB, in the clone #406. Since the sbcB gene 
may be an integration site for other phage, primers for intact sbcB were designed from E. 
coli strain K12 which contains no phage DNA at the sbcB gene (Table 2.2.3.).  
Verification of the intact chromosome-phage right junction was confirmed by 
amplification of a 1.7 kb fragment using primers 406phage and PBP with DNA from 
strain EC970520 (Figure 2.3.1.).  The intact chromosome-phage left junction primer, 
SBC, and clone#302 upstream primer, pyz2, was used in a long template PCR to amplify 
long pieces of phage DNA (>2kb) to isolate the upstream sequence of clone #302 (Figure 
2.3.1.) (personal communication,  
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Figure 2.3.1. Relative location of primers found within the Stx2c phage sequence.  
The numbers 302 and 406 represent the length of cosmid DNA sequences. 181 represents 
the length of the PCR product (personal communication, Zhang).  The SbcB gene is 
interrupted by phage sequence.  Total size of the phage genome is 62,147 bp.  
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 DNA sequence information for the bacteriophage DNA was annotated using 
Kodon ORF finder (personal communication, Zhang).  This program was defined to 
identify ORFs of at least 100 amino acids.  Blastx (NCBI) was used to identify 
homologous gene segments (Figure 2.3.3.; Table 2.3.1.).  The entire DNA sequence of 
the Stx2c phage contained 62,147 bp.  Comparison of the phage sequence to the E.coli 
K12 genome, which contains no Stx2 phage, revealed only homology to the sbcB gene, 
which encodes a penicillin binding protein.  However, as previously stated, this region of 
DNA was interrupted by phage DNA sequence and is the integration site for this Stx2c- 
2.3.2.  Annotation of the Stx2c phage genome sequence   
 
 A blastn ORF comparison of the Stx2c from lineage II strain EC970520 to other 
Stx2 phages 933W, Stx2Φ-I, VT2-Sakai, VT2-Sa showed high sequence similarity (96-
100%) to several ORF surrounding the Stx2 genes including Stx2A, Roi, dam, ninB and  
several other hypothetical proteins (Figure 2.3.2.).  However, there was weak similarity 
between the phages in the Q antiterminator and putative anti-repressor proteins in this 
region (Figure 2.3.2.).  Sequence similarity existed within Stx2B although the % identity 
(80-95%) was lower in this area than the other highly homologous regions.  
                                                                         
Zhang).  Since pyz2 yielded only partial upstream sequence, primers pyz6 and pyz7 were 
designed and used in a long template PCR to complete the upstream sequence.  
Sequencing of the products termed #181 confirmed the upstream sequence of clone#302 
and the sbcB integration site (Figure 2.3.1.).  
 
 50  
                     96-100%          
 
 
                      80-95% 
 
 
                      <10% 
 
 
 
 
Figure 2.3.2.  Blastn homo  of EC970520 (LII) to EDL933 (LI), Stx2Φ VT2-Sa regions n genes based on % 
identity and length of alignment (%).  
logy -I, VT2-Sakai, and  surroundi g Stx2 
gene             
             
HP ninB dam AR Roi HP HP Q Stx2A Stx2B HP HP HP
ORF location start in 
EC970520 18923 19224 19745 20753 21586 22314 22916 23578 24715 25686 26252 26819 28939
ORF location end in 
EC970520 19372
 
             
             
19775 20299 21517 22314 22919 23586 24066 25674 25955 26575 78756 29365
EDL933 (AF125520)
% Identity 99             
              
              
98 96 <10 99 97 <10 <10 99 95 <10 96 96
Alignment % 99 100 100 <10 100 99 <10 <10 100 100 <10 84 98
Stx2Φ-I (AP004402)
% Identity 97             
              
              
97 97 <10 98 98 <10 <10 96 96 <10 96 96
Alignment % 99 98 96 <10 99 96 <10 <10 99 95 <10 84 98
VT2-Sakai 
(AP004402)
% Identity 98             
              
             
98 98 94 94 94 <10 <10 96 96 <10 96 96
Alignment % 99
 
99 96 34 90 90 <10 <10 99 95 <10 84 98
VT2-Sa (NC_000902)
% Identity 98             
              
98 98 98 94 94 <10 <10 96 96 <10 94 94
Alignment % 99 98 96 33 90 96 <10 <10 99 95 <10 84 88
dam Roi Q 
Stx2A
Stx2B
AR 
Stx2 phage 933W                         
ninB
HP represents hypothetical protein. Arrows represent ORF’s found within the Stx2 phage from EC970520 compared to EDL933 Stx2 phage 933W 
(accession no. AF125520) and labeled based on the percentage of coverage of homologous regions to the EC970520 sequence. HP are not labeled. 
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Figure 2.3.3. Annotation of ORF’s found within the Stx2c phage within EC970520. Putative functions are based on homologous 
regions from NCBI blastx searches. The annotation includes cosmids 302 and 406 but not the PCR cloned region. Hypothetical 
proteins are not shown. 
t
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Table 2.3.1. ORF with putative genes and homologs of Stx2 phage identified within E. 
coli O157:H7 strain EC970520 (personal communication, Zhang).   
start end Gene orientation Notes 
1 699 sbcB > sbcB fragment, penicillin binding protein 
657 669  > direct repeat (cgtaatcgtaaaa) 
884 2062 Int > phage integrase family protein 
2312 2656  > putative lipoprotein 
2844 3194  > hypothetical protein within CP-933W 
3413 3547 > N-terminal of Z3371 in EDL933  
3544 4059 > homolog to phage P7  
4061 5008 > hypothetical protein within CP-933W  
5325 5606 >  hypothetical protein within CP-933W 
5781 5969  > hypothetical protein within VT2-Sakai 
5960 6640 Exo > putative exonuclease 
6637 7422 Betw > putative bet recombination protein 
6985 7461  > homolog to stx2 II p107 
7428 7844 Gam > host-nuclease inhibitor 
7799 8068 Kil > Kil protein, host killing 
7911 8015 cIII > λ homolog regulatory protein, antitermination 
8146 8516  > 
λ homolog, single-stranded DNA binding 
protein 
9018 9290  > ECs1181 in Sakai 
9018 9362 N > 
phage nil2 homolog, early antiterminator N 
protein 
9277 9450  > ECs1182 in Sakai 
9575 9841  > homolog to stx1p118 
9747 9905  > ECs1183 in Sakai 
10019 10540  > ECs1184 in Sakai 
11042 11695 cI  > phage nil2 homolog, cI repressor 
11812 12027 Cro > phage nil2 homolog, control of repressor 
12169 12465 cII  > phage nil2 homolog, repressor 
12498 12659  > phage nil2 homolog 
12646 12659 O > origin binding protein, replication of DNA 
12646 13467  > phage nil2 homolog, replication of DNA 
13464 14841  > APEC 01 homolog, helicase 
14947 15348  > hypothetical protein in ISEC8 (EDL933) 
15345 15348  > hypothetical protein in ISEC8 (EDL933) 
15742 17280  > hypothetical protein in ISEC8 (EDL933) 
17369 17980  > phage HK022 putative endonuclease 
18228 18443  > ORF 69 homolog in phage ST64T 
18445 18777  > gene 48 homolog in phage Sf6 
18923 19372  > ECs2983 in Sakai 
19224 19775 ninB > pfam05772, ninB protein 
19745 20299 Dam > 
pfam05869, DNA N-6-adenine 
methyltransferase of phage 
20753 21517  > putative antirepressor protein (AR) 
21586 22314 Roi > 
pfam003374, putative DNA-binding protein roi 
of phage 
22314 22919  > phage nil2 homolog 
22916 23586  > 2A homolog protein phosphatase  
23578 24066 Q > Q protein, antitermination 
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start 
(continued) end Gene orientation Notes 
24715 
25686 
25674 
25955 
Stx2cA 
stx2cB 
> 
>  
verocytotoxin 2 variant 2c subunit A 
verocytotoxin 2 variant 2c subunit B 
26252 26575  <  CACO5542 in E.coli 
26819 28756  >  CACO5543 In E.coli 
28939 29385  >  hypothetical protein in BP-933W 
29462 29677 S >  holin protein S homolog 
29677 30174  >  phage related lysozyme 
30171 30608  >  hypothetical protein in E.coli B171 
30811 31308  >  pfam04383, kilA- N domain 
31305 31562  >  hypothetical protein in phage HK620 
32093 32251  >  ECs1788 in Sakai 
32293 32658  >  restriction endonuclease 
32950 33513  >  phage terminase, small subunit 
33510 34142  <  phage terminase-like protein, large subunit 
34186 35073  >  
phage BP-4795 homolog, transposase orfA 
protein 
35929 36486  >  
phage D3 homolog, putative large terminase 
subunit 
36517 38487  >  pfam05065, phage head maturation protease 
38699 40063  >  putative portal protein 
40060 41283  >  putative portal protein 
41280 41616  >  BP-4795 homolog 
41616 41966  >  head-tail adaptor 
41963 42409  >  ECs1547 I Sakai 
42679 43521  >  BP-4795 homolog, putative major tail subunit 
43530 43904  >  putative tail assembly chaperone 
43928 44143  >  hypothetical protein in CP-933W 
44263 47505  >  phage-related minor tail protein 
47498 47839  >  minor tail protein 
47839 48537  >  phage minor tail protein 
49146 50150  >  antirepressor protein 
50204 50785  >  K homolog, putative tail component 
50840 51520  >  putative tail component 
51846 55259  >  tail component, fibronectin type 3 domain 
55326 55925 Lom >  
CP-1639 homolog, opacity protein, related 
surface antigen 
55990 57303  >  putative tail fiber 
57715 58590  >  hypothetical protein in CA143897 
58815 59516  >  hypothetical protein in CP--933W 
59450 59734  >  ECs2227 in Sakai 
60532 60544  >  direct repeat (cgtaatcgtaaaa) 
60532 60580 sbcB >  sbcB n terminal, pencillin binding protein 
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encoding phage.  The entire prophage sequence was also flanked by direct repeats 
(cgtaatcgtaaaa) which may be sites which facilitate recombination between the phage and 
the host (ORF location 657…669, 60532…60580, Table 2.3.1.).  Integrase int and 
exonuclease exo genes downstream of  the direct repeats were identified; these genes may 
encode proteins which enable phage integration and excision from the host genome.  The 
genes betw and gam are involved in recombination and the kil and cIII genes are 
important for host-killing and establishment of lysogeny, respectively.  An N gene also 
was identified as the first anti-terminator, which is an important phage regulatory protein 
and essential for Q protein mediated regulation of late phage genes.  The cI repressor, a 
well known λ repressor, follows the N gene; this repressor blocks expression of lytic 
genes and is required for the phage to remain in a lysogenic state.  The cro and cII genes 
identified are early lytic genes in λ.  In phage λ cI and cro recognize the same promoter, 
cI is expressed in the lysogenic state and cro is expressed in the lytic state.  The O gene 
codes for an important replication protein in phage λ.  An IS element ISEC8 is present 
after the O gene and precedes the recombination genes ninB and dam, which encode a 
DNA N-6-adenine methyltransferase.  The roi gene encodes for a DNA-binding protein 
and precedes the antiterminator Q gene which encodes an important antiterminator 
responsible for initiating transcription of lysis genes and an antirepressor AR. 
Downstream genes encoding Stx2cA and Stx2cB subunits found in the Stx2c variant code 
for these toxins and may be under the control of the Q antiterminator.  The S gene is a 
cell lysis holin gene and is found upstream of several structural genes belonging to the 
phage.  Specifically, the lom gene encodes a major head protein.  Within these structural 
genes, a transposase found within the IS element IS629 is found.  The sbcB gene 
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fragment and a direct repeat located at the end of the sequence marks the beginning of the 
chromosomal DNA backbone and the phage insertion site. 
  
2.3.3.  Identification of Stx2 phage among strains of E. coli O157:H7 from different 
lineages   
 In order to determine if the Stx2c phage from the lineage II strain EC970520 was 
related to the Stx2c phage from other lineage II strains, five sets of primers (Table 2.2.3.) 
representative of the phage sequence from EC970520 were used in PCR analysis of DNA 
from a collection of E. coli O157:H7 lineage I, I/II and II strains of human and bovine 
origin listed in Table 2.2.1.  All of these primer pairs were able to amplify products of 
expected band sizes in 12/12 lineage II strains but did not amplify the expected bands in 
17/18 lineage I and I/II strains (Table 2.3.2.). One lineage I/II strain was positive with 
primers VT2-F and P7 and for forward and reverse Stx2c primers. In addition, some 
variations ~2kb smaller than the expected product size were observed for lineage II 
strains using primers R104-23r/ 302-T3-9r.  A primer set targeting Stx2 genes  (Table 
2.2.3.) designed from EDL933 Stx2 phage amplified DNA from 18/18 lineage I and I/II 
strains but 12/12 lineage II strains were negative with these primers (Table 2.3.2.).  This 
confirmed that all lineage II strains were only positive for Stx2c genes and that the 
majority of lineage I and I/II were only positive for Stx2 genes (Figure 2.3.4.).  The only 
exception observed was the strain Zap0046, a lineage I/II strain that produced the 750bp 
expected band size using the Stx2 primer set (Stx2-f/r) and the Stx2c primer set.  
Zap0046 also produced a 1.8kb band for the VT2-F/P7 which is the same size as that  
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Table 2.3.2. Distribution of PCR amplified products obtained using lineage-specific 
primers from EC970520 and EDL933 Stx2 phage in Lineage I, I/II and Lineage II strains 
of E. coli O157:H7.  
        EC970520       EDL933 
  R104-RC VT2-F 
R104-
23r pyz1 
Stx2c-
F  Stx2-F 
Strain Lineage R104-13a P7b
302-T3-
9rc rstx1d
Stx2c-
Re   Stx2-Rf
LRH16 I +*1 - - - -  + 
LRH27 I +*1 - - - -  + 
LRH6 I +*1 - - - -  + 
TS97 I +*1 - - - -  + 
F1299 I +*1 - - - -  + 
F5 I +*1 - - - -  + 
EDL933 I +*1 - - - -  + 
63154 I +*1 - - - -  + 
58212 I +*1 - - - -  + 
F1095 I +*1 - - - -  + 
Sakai I +*1 - - - -  + 
H4420 I +*1 - - - -  + 
E2328 I +*1 - - - -  + 
F1082 I +*1 - - - -  + 
59243 I,II +*1 - - - -  + 
71074 I,II +*1 - - - -  + 
EC20030338 I,II +*1 - - - -  + 
Zap0046 I,II +*1 + - - +   + 
LRH13 II + + + + +  - 
R1797  II + + + + +  - 
LS68  II + + + + +  - 
F12  II + + + + +  - 
F1081  II + + + + +  - 
FRIK 920  II + + + + +  - 
FRIK1999  II + + + + +  - 
FRIK1985  II + + +*2 + +  - 
FRIK1990  II + + +*2 + +  - 
FRIK2001  II + + +*2 + +  - 
EC970520  II + + + + +  - 
12491  II + + +*2 + +   - 
Expected band sizes: a6kb, b1.8kb, c9.5kb, d9kb, e750bp, f750bp 
*1unexpected band sizes of 10kb 
*2unexpected band sizes of 7.5-8.0kb 
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A) Stx2c     
 
 LII LI
LI 
 
 
B) Stx2 
 
LII LI
LI 
Figure 2.3.4. PCR of A) Stx2c-F/R and B) Stx2-F/R primers.  
Expected band sizes were 750bp for each primer set. Positive control was EC970520 for 
Stx2c for (A) and EDL933 for (B). Lanes 1, 30, 31, 36: 1kb plus ladder. Lanes 2-13: 
lineage II strains; 14-29, 32-34: lineage I, I/II strains; Lane 35: PCR negative.  
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Strains listed in Figure 2.3.4. were as follows: 
 
1. EC970520 (II) 
2. LRH13 (II) 
3. R1797 (II) 
4. LS68 (II) 
5. F12 (II) 
6. F1081 (II) 
7. FRIK 920 (II) 
8. FRIK 1999 (II) 
9. FRIK 1985 (II) 
10. FRIK 1990 (II) 
11. FRIK 2001 (II) 
12. 12491(II) 
13. LRH16 (I) 
14. LRH27 (I) 
15. blank 
16. LRH6 (I) 
17. TS97 (I) 
18. F1299 (I) 
19. F5 (I) 
20. 71074 (I/II) 
21. 59243 (I/II) 
22. EC20030338 (I/II) 
23. 63154 (I) 
24. Zap0046 (I/II) 
25. 58212 (I) 
26. F1095 (I) 
27. H4420 (I) 
28. E2328(I) 
29. F1082 (I) 
30. Sakai (I) 
31. EDL933 (I) 
+ positive control 
- negative control   
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observed for lineage II strains.  However, unlike the other stx2c bearing strains, Zap0046 
did not yield expected bands for other EC970520 primers sets (R104-RC/13, R104- 
23r/302-T3-9r, pyz1/ rstx1 Figure 2.3.1.) flank the Stx2c genes, suggesting this phage is 
distinct from that found in lineage II strains.  
 
2.3.4.  Identification of Stx2 phage integration sites within lineage-specific strains of 
E. coli O157:H7   
 An extended collection of lineage-specific strains of E. coli O157:H7 was 
analyzed by PCR in order to determine if the integration sites of the Stx2 phage within 
the sbcB gene of EC970520 could be identified in other lineage I, I/II or II strains using 
the oligonucleotide primers described in Table 2.2.3.  These primers are specific to the 
phage-chromosome junctions (SBC/pyz8, PBP/406phage) and were identified within the 
sbcB gene from EC970520 and used to screen each of the strains within the collection.  In 
this experiment, EC970520 was used as a positive control where the phage-chromosome 
junctions were PCR positive for phage occupation.  Consequently K12 was used as a 
negative control for phage integration as phage-chromosome junctions were PCR 
negative.  Primers designed from K12 were also used to identify intact sbcB genes since 
no phage occupation occurs in this region.  The SBC/PBP primers were positive if the 
gene was intact but negative if the phage was inserted into the sbcB.  Most lineage I 
strains 58/59 (98.3%) were negative for sbcB chromosome-phage junctions and positive 
for the intact sbcB gene (Table 2.3.3.).  Only the Lineage I strain R1388 was shown to 
contain a sbcB chromosome-phage junction and an interrupted sbcB gene.  In lineage II 
strains 44/49 (89.8%) were positive for the sbcB chromosome junctions, although strains  
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Table 2.3.3. PCR results for integration of phage in E. coli O157:H7 lineage-specific 
strains.  
(+) expected band size present, (–) no band present, (weak) weak band detected. Primers 
used were as follows: a406phage/PBP; bpyz8/sbc-j1r; cPBP/sbcB-r; dwrbA C/G; ewrbA 
H/D; fwrbA C/D.   
sbcB/ sbcB/ wrbA/ wrbA/ 
phage 
right  
phage 
 left 
phage  
left  
phage  
right 
Strain Lineage junctiona junctionb
 sbcB 
intactc junctiond junctione
wrbA 
intactf
F1150 I  -  -  +  +  + Weak 
TS104 I  -  -  +  +   + Weak 
EC20020294 I  -  -  +  +   +  - 
R1388 I  +  +  -  -  +  + 
E1572 I  -  -  +  -  -  + 
107718 I  -  -  +  -  -  + 
111570 I  -  -  +  -  - Weak 
R910 I  -  -  +  +  + Weak 
F832 I  -  -  +  +  +  - 
F1042 I  -  -  +  +  + Weak 
F1135 I  -  -  +  +  +  - 
S2476 I  -  -  +  +  + Weak 
45550 I  -  -  +  -  -  - 
72143 I  -  -  +  +  + Weak 
65576 I  -  -  +  +  + Weak 
33336 I  -  -  +  +  + Weak 
AA7821 I  -  -  +  +   + Weak 
TS52 I  -  -  +  +   +  - 
LS7 I  -  -  +  +   +  - 
LS225 I  -  -  +  +   + Weak 
EC20020290 I  -  -  +  +   + Weak 
TS97 I  -  -  +  +   +  - 
LRH6 I  -  -  +  +  + Weak 
LRH16 I  -  -  +  +  +  - 
LRH27 I  -  -  +  +  +  - 
97701 I  -  -  +  +  + Weak 
F5 I  -  -  +  +  +  - 
F1299 I  -  -  +  +  +  - 
E1112 I  -  -  +  +  +  - 
EC20020292 I  -  -  +  +   + Weak 
EC20020293 I  -  -  +  +   + Weak 
EC20030103 I  -  -  +  +   +  - 
R776 I  -  -  +  +  + Weak 
R1277 I  -  -  +  +  +  - 
LRH17 I  -  -  +  +  + Weak 
63154 I  -  -  +  +  + Weak 
58212 I  -  -  +  +  + Weak 
F1095 I  -  -  +  +  + Weak 
F1104 I  -  -  +  +  + Weak 
93178 I  -  -  +  +  + Weak 
Sakai I  -  -  +  +  +  - 
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 Strain 
continued Lineage 
sbcB/ 
phage 
right 
junctiona
sbcB 
phage left 
junctionb
sbcB 
intactc
wrbA/ 
phage 
right 
junctiond
wrbA/ phage left 
junctione
wrbA 
intactf
R904 I  -  -  +  +  + Weak 
EC20020291 I  -  -  +  +   + Weak 
120290 I  -  -  +  +  + Weak 
EC19980119 I  -  -  +  +  +  - 
74909 I  -  -  +  +  +  - 
LN7264 I  -  -  +  +   +  - 
F1082 I  -  -  +  +  +  - 
E2328 I  -  -  +  +  +  - 
F801 I  -  -  +  -  +  - 
F1099 I  -  -  +  +  +  - 
94023 I  -  -  +  +  +  - 
F1083 I  -  -  +  +  +  - 
F1084 I  -  -  +  +  +  - 
F1085 I  -  -  +  +  +  - 
F1090 I  -  -  +  +  + Weak 
F1097 I  -  -  +  +  +  - 
F1106 I  -  -  +  +  +  - 
EDL933 I  -  -  +  +  + Weak 
71074 I/II  -  -  +  -  -  + 
59243 I/II  -  -  +  -  -  + 
EC20020462 I/II  +  +  -  -  -  + 
EC20030338 I/II  -  -  +  -  -  + 
EC20030282 II  -  -  +  -  -  - 
EC20030348 II  -  -  +  -  -  - 
EC20030351 II  -  -  +  -  -  + 
EC19920026 II  +  +  -  -  -  + 
EC19920171 II  +  +  -  -  -  + 
EC19920283 II  +  +  -  -  -  + 
EC19930086 II  +  +  -  -  -  + 
EC19930200 II  +  +  -  -  -  - 
F1081 II  +  +  -  -  -  + 
EC20030186 II  +  +  -  -  -  + 
EC20030216 II  +  +  -  -  -  + 
EC20030226 II  +  +  -  -  -  - 
EC20030275 II  +  +  -  -  -  + 
EC20030277 II  +  +  -  -  -  + 
EC20030278 II  +  +  -  -  -  + 
EC20030289 II  +  +  -  -  -  + 
EC20030340 II  +  +  -  -  -  + 
EC20030495 II  +  +  -  -  -  + 
LS68 II  +  +  -  -  -  + 
FRIK 920 II  +  +  -  -  -  + 
FRIK 1999 II  +  +  -  -  -  + 
LRH13 II  +  +  -  -  -  + 
R1797 II  +  +  -  -  -  + 
EC20000623 II  +  +  -  -  -  + 
EC19920283 II  +  +  -  -  -  + 
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 Strain 
continued Lineage 
sbcB/ 
phage 
right 
junctiona
sbcB 
phage  
left 
junctionb
sbcB 
intactc
wrbA/ 
phage 
right 
junctiond
wrbA/  
phage  
left  
junctione
wrbA 
intactf
EC19930086 II  +  +  -  -  -  + 
R1797 II  +  +  -  -  -  + 
LRH13 II  +  +  -  -  -  + 
EC20030528 II  -  -  +  -  -  + 
EC20030547 II  +  +  -  -  -  + 
EC20030292 II  +  +  +  -  -  - 
FRIK 1985 II  +  +  -  -  -  + 
R834 II  +  +  +  -  -  + 
EC20030154 II  +  +  -  -  -  + 
FRIK 1990 II  +  +  +  -  -  + 
FRIK 2001 II  +  +  +  -  -  + 
EC19920005 II  +  +  -  -  -  + 
EC19920192 II  +  +  -  -  -  + 
EC19970520 II  +  +  -  -  -  + 
EC20030317 II  +  +  -  -  -  + 
12491 II  +  +  +  -  -  + 
EC20030193 II  +  +  -  -  -  + 
EC20030223 II  +  +  +  -  -  + 
EC20030281 II  -  +  +  -  -  + 
EC20030422 II  +  +  +  -  -  + 
EC20011139 II  +  +  +  -  -  + 
AA579-2 II  -  -  +  +  +  - 
EC20030496 II  -  +  +  -  -  + 
EC20030497 II  +  +  +  -  -  + 
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EC20030281 and EC20030496 were only positive in one sbcB phage junction.  The sbcB 
gene was interrupted in 33/49 (67.3%) of the lineage II strains but 32.6% (16/49) still 
contained an intact sbcB gene with these primers.  Five lineage II strains were similar to 
lineage I strains as they were negative for sbcB chromosome-junctions and contained an 
intact sbcB gene.  In the lineage I/II strains, only strain Zap0046 was negative with sbcB 
primers and positive for EC970520 phage junctions at the sbcB gene. 
            Oligonucleotide primers specific to the phage-chromosome junctions and intact 
gene identified within the wrbA gene insertion site identified by Shaikh and Tarr (2003) 
also were used to screen each of the strains. Most lineage I strains 55/59 (93.2%) were 
positive for wrbA chromosome-phage junctions with the exception of strains F801 and 
R1388, both of which were only positive for the right side of the insert.  Most lineage I 
strains, 56/59 (94.9%) also were negative or had a weak PCR product for an intact wrbA 
gene.  The lineage I strains, E1572 and 107718, were negative for wrbA phage junctions 
and positive for an intact wrbA gene. Most lineage II strains, 48/49 (98.0%) were 
negative for wrbA chromosome-phage junctions and most 43/49 (87.8%) were positive 
for intact wrbA genes.  Lineage II strain AA579-2 was positive for the wrbA 
chromosome-phage junction, but negative for an intact wrbA gene.  All lineage I/II 
strains had intact wrbA genes and no phage integration.  Overall, most lineage I strains 
were positive for wrbA phage integration and negative for sbcB phage integration while 
lineage II strains were positive for sbcB integration and negative for wrbA integration 
(Table 2.3.3.). The Stx2c in lineage I/II strains did not appear to integrate in either sbcB 
or wrbA with the exception of Zap0046 which is integrated at sbcB. 
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2.4.  Discussion 
2.4.1.  Sequence of the Stx2c phage genome   
 The genome of EC970520 Stx2c phage is highly mosiac.  It contains similar 
regions to several bacteriophages indicating that many recombination events may have 
occurred to create it (Table 2.3.1.).  This is consistent with the theory that the majority of 
phage have common ancestry and undergo an exchange of genetic elements from a 
common gene pool (Hendrix et al., 1999).  This can also be seen in the downstream 
structural proteins as these genes are composed from a much larger pool of sequences 
from other bacterial species, which is similar to the Stx2 phage 933W (Plunkett et al., 
1999).  The entire sequence is flanked by direct repeats which may be involved in phage 
integration into the bacterial genome. Temperate phage integrate into their hosts by site-
specific recombination between short common sequences within the phage (attP) and the 
bacteria (attB) which generate two flanking sequences within the prophage (attR and 
attL) (Makino et al., 1999).  The presence of these repeats in the Stx2c phage provide 
additional evidence of the integration site, sbcB, within the EC970520 genome.  
                The Q gene found within the sequence functions as an antiterminator for the 
expression of late genes downstream including the Stx2 genes.  The location of these 
toxin genes within EC970520 with the late phage genes demonstrates that these genes 
may only be expressed during the lytic cycle when phage are released from the bacterial 
genome.  Plunkett et al. (1999) have suggested that Stx2 in EDL933 may be expressed by 
a Q-dependent promoter and that this expression would be expected to increase after 
phage induction.  Presence of IS elements represents possible inhibitors to Q-dependent 
expression present in the EC970520 Stx2c phage.  Upstream of the Q gene, an IS element 
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(ISEC8) is present in EC970520 which may reduce the transcription of Q-dependent 
expression of downstream lytic genes.  In Sakai, an IS element IS629 is found upstream 
of the lysis genes and this element may have been inserted due to a nonhomologous 
recombination event or improper excision of bacterial genes after phage transduction and 
may be responsible for the absence of plaque-forming ability of the phage (Makino et al., 
1999; Creutzburg et al., 2005).   A transposase homolog found within IS629 was found 
downstream of the Stx2c genes in EC970520 and the presence of this element may also 
inhibit the ability of phage release after phage induction.  This inability to release Stx2 
phage by IS may reduce the virulence of the strain as lytic infection and hence Stx2 
expression may be hindered.  Not all Stx2 phages contain these IS elements which may 
explain why some phages are capable of lytic infection whereas others such as Sakai are 
reported not to be lytic (Sato et al., 2003).  It is also possible that some defective proteins 
involved in lytic induction may be provided by other prophage lysogenized in the same 
strain although this has not been fully explored (Makino et al., 1999).   
                The complete sequence for the Stx2c genome from E. coli O157:H7 strain 
EC970520 was 62,147 bp which is larger than those obtained from other Stx2 phage 
genomes such as Stx2Φ-I (61,765), VT2-Sa (60,942) and 933W (61,663), but smaller 
than the phage genome VT2-Sakai (62,703) (Sato et al., 2003).  Homology searches to 
these Stx2 phage genomes revealed several conserved and divergent genes surrounding 
the Stx2c phage genes of EC970520 (Figure 2.3.2.).  Similar to other Stx2 variants, 
EC970520 contained >99% similarity to the A subunit and ~96% identity to the B 
subunit of Stx2 (Strauch et al., 2004).  The low homology of the AR and Q to other Stx2 
genomes may account for differences in Stx2 expression between strains since the Q 
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protein and the anti-repressor are important regulators of gene activation governing cell 
lysis.  This is similar to Lejeune et al. (2004) who reported that a lack of phage-encoded 
Q gene may produce less Stx2.  In EC970520, a different type of Q gene or AR may 
result in less Stx2 toxin release.  
 
2.4.2.  Lineage specificity of Stx2 phage genomes   
 The Stx2c phage sequence from EC970520 produced similar PCR profiles to 
Stx2c phage from other lineage II strains. The lineage II strains all carried Stx2c and all 
were similar in band size for regions surrounding Stx2c in EC970520 although there was 
a small range of PCR product sizes and therefore variability in regions furthest 
downstream (Figure 2.3.1.; Table 2.3.2.).  The lineage I, I/II strains all contained Stx2 
genes found in phage 933W and were divergent from EC970520 in this region except for 
the downstream Stx2c region where a larger product was amplified in lineage I strains 
(Figure 2.3.4.; Table 2.3.2.).  It is likely that Zap0046 has one copy of Stx2 and one copy 
of Stx2c in phage which are distinct from EC970520 since both of these genes were 
amplified but the strain did not contain all genes found in EC970520. A closer 
examination of more genes from the 933W Stx2 phage will determine if the Stx2 phage is 
lineage-I and I/II specific.   
 
2.4.3.  Integration of the Stx2 phage in E. coli O157:H7 strains  
 Four insertion sites for Stx phage have been determined thus far for E. coli 
O157:H7 strains which include wrbA, yehV, and sbcB, and yecE (Ohnishi et al., 2002).  
The preferred site may depend on the host and availability of the site in the host strain.  
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The insertion site for EC970520 was determined to be sbcB since the gene is found intact 
in K12 but interrupted by phage sequence and direct repeats at integration sites in 
EC970520.  This is the same integration site of the E.coli O157:H7 Stx2 transducing 
phages found by Ohnishi et al., 2002. Analysis of the sbcB integration site determined 
that most lineage II strains had phage DNA inserted into the sbcB site whereas lineage I 
strains did not (Table 2.2.3.).  The lineage I strain, R1388, may contain more than one 
copy of Stx2 so a Stx2c phage found in lineage II strains may occupy the interrupted 
sbcB site.  The strains positive for phage DNA only on one side may have integrated at 
slightly different sites within sbcB or may have been duplicated and improperly excised. 
A subset of lineage II strains which contain intact sbcB genes likely were integrated at a 
different site.  Most lineage I Stx2 phage occupy the wrbA sites although there is 
commonly a faint band for the intact wrbA band which is found with DNA from only this 
lineage.  Shaikh and Tarr (2003) proposed the faint intact wrbA bands may be due to a 
subset of bacteria that no longer contain the inserted element; i.e., the phage has been 
lost.  This apparent instability of the Stx2 phage DNA in lineage I strains may increase 
expression of lysis and toxin genes, promote recombination and the ability to release 
phage and create new pathogenic strains.  No lineage II strains except for AA579-2 were 
found to have phage DNA inserted into the wrbA site. AA579-2 may also be distinct from 
other lineage II strains due to the presence of multiple copies of Stx similar to Zap0046.  
It has been suggested that the insertion site occupancy may be determined by the 
availability of a preferred locus in the host strain (Serra-Moreno et al., 2007).  It seems 
the wrbA site is the preferred site for Stx2 phage while sbcB is the preferred site for Stx2c 
phage and yehV is used by Stx1 phage.  It is important to note that there is an intact wrbA 
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gene in most lineage II strains although these strains still choose sbcB and this is opposite 
for lineage I strains where there is a presence of intact sbcB but these strains choose wrbA 
sites so the availability of a locus site may not be the only factor in deciding how these 
phages integrate.  The data suggests that there are Stx phage-specific integration sites.  
Most lineage I/II strains did not integrate into sbcB or wrbA as most of these sites 
appeared to be available in these strains.  It is likely that these strains use another 
integration site not considered in the present study. These lineage I/II strains may have an 
integration site unique to the Stx2 phage found in these strains.  However, it is also 
interesting to note that the Stx2 phage in lineage I/II strains seem to share a number of 
phage loci with 933W (see Table 2.3.1.). The phage in lineage I/II strain Zap0046 
presents a somewhat confusing situation in that both Stx2 and Stx2c are present in this 
strain and the sbcB site is occupied while the wrbA site is not. It is tempting to conclude 
that the Stx2c phage is occupying the sbcB site and the Stx2 phage is present in the 
undefined lineage I/II-specific Stx2 phage site mentioned above. However, further study 
will be required to determine the nature of the Stx2 phage in lineage I/II strains and 
identify the integration site (s).  It has been suggested that the attL regions or types of 
integrase could cause differences in the selection of insertion sites (Serra-Moreno et al., 
2007).  Phage acquisition and interaction into specific sites and phage stability in 
bacterial chromosomes may play an important role not only in the pathogenicity of 
certain strains of E. coli O157:H7 and lineages but also aid in understanding the 
evolution of new pathogenic strains.  
 
                                                                           69
2.5.  Conclusions  
 Little is known about phage associated with Stx2c production in lineage II strains.  
In this study,  
1) Sequencing of a Stx2c prophage from the E.coli O157:H7 strain EC970520 
revealed a 62,147bp genome with an organization similar to that of other Stx-
encoding lambdoid phage.  This genome is highly mosaic and contained several 
phage gene homologs implying that these phages have undergone several 
recombination events over time. 
2) Annotation of the genes revealed the integration site of the EC970520 Stx2c 
phage to be the sbcB gene.  IS elements found within the genome may interrupt 
Q-dependent expression and lytic activity of the phage. This inability to release 
Stx2 phage may reduce the virulence of the strain since Stx2 expression may be 
hindered. 
3) The Stx2c phage are highly lineage-II specific and contain Stx2c phage genes 
found in strain EC970520. 
4) The Stx2 genes from EDL933 are lineage I and I/II specific. Comparison of 
EC970520 Stx2c and EDL933 Stx2 identified several divergent regions between 
the lineages including the Q-antiterminator protein.  Differences between lineages 
in this gene may account for in differences in Stx2 expression between the 
lineages. 
5) The Stx2c phage integration site is sbcB for lineage II strains and wrbA for Stx2 
phage in lineage I strains.  Most lineage I/II strains integrate at a third undefined 
site in the host genome. The lineage I Stx2 phage appear to be excised from wrbA 
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in a minority of bacteria in the population.  This instability of Stx2 phage may 
contribute to the level of Stx2 expression and dissemination of this bacteriophage.  
  
 The information determined from this study will be used in future studies.  First, 
conserved and variable regions identified within the Stx2 phage genomes will be used in 
the specific detection of E. coli O157:H7 isolates as well as in detecting lineage-specific 
genetic variations within this serotype.  The distribution of E. coli O157:H7 Stx2 phage 
genes among other STEC serotypes will also be studied to determine if any of these 
phage genes are widely disseminated or restricted to certain pathogenic STEC clones.  
Further, STEC gene presence/absence data will be used to genotype STEC strains.  This 
study has helped us to understand if genotypic differences in Stx phage observed in E. 
coli O157:H7 strains contribute to phenotypic differences observed between the lineages 
of this organism.   
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CHAPTER THREE 
3.   Detection of Shiga toxin-producing bacteriophage in E. coli O157:H7 and 
other Shiga toxin-producing E. coli 
3.1. Introduction 
Shiga toxin-producing Escherichia coli (STEC) including E. coli O157:H7 are 
food- and water borne zoonotic bacterial pathogens capable of causing outbreaks of 
severe illness in humans (Parry and Palmer, 2002; Herold et al., 2004).  E. coli O157:H7 
is responsible for numerous outbreaks of HC which can result in HUS and is the STEC 
serotype most frequently isolated from clinical illness in humans in North America 
(Boyce et al., 1995; Johnson et al., 1996; Besser et al., 1999; Brooks et al., 2005).  Cattle 
act as reservoirs of these pathogens and spread the bacteria via contaminated feces, in 
food and water (Spika et al., 1996).  STEC can also be spread to vegetables, fruits and 
other plants through irrigation water or soil contaminated with fecal material (Meng and 
Doyle, 1996; Besser et al., 1999).  Since E. coli O157:H7 is most commonly associated 
with human disease, it poses a significant risk to human health and the need to develop 
rapid and specific methods for detecting this pathogen in food and water are needed.  
Culture-based techniques used in the detection of STEC can be biased and 
exclude viable but non-culturable cells (Dunbar et al., 2003).  In addition, culture based 
tests are generic in nature and additional techniques are required to identify the species, 
serotype and molecular subtype of the organism isolated.  This typing information is 
essential in determining the source of infection in outbreak investigations.  Several 
molecular subtyping and fingerprinting methods have been developed for E. coli strains.  
These include phage typing, plasmid profile analysis, antimicrobial susceptibility testing 
and ribotyping.  However, these methods are not discriminating enough for determining 
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the epidemiological relatedness of strains (Khakhria et al., 1990; Barrett et al., 1994; 
Grif, et al., 1998; Strockbine et al., 1996).  Pulsed-field gel electrophoresis (PFGE), 
random amplification of polymorphic DNA (RAPD) and multi-locus enzyme analysis 
(MLE) also been used to characterize isolates and PFGE is currently considered the “gold 
standard”  among the molecular typing methods (Prager et al., 2002; Grif et al., 1998).  
However, many of these techniques are also time-consuming, expensive, require multiple 
tests and are unable to give us specific information about the gene content of the 
organism or phenotype of the strain of interest.  Planar microarrays provide large 
amounts of specific genetic information but can be time-consuming, expensive and 
laborious.  New methodologies such as bead-based suspension microarrays may provide 
an alternative to current molecular E. coli typing methods such as PFGE, with similar or 
greater discrimination, more efficiently, more quickly and at a lower cost.  
The Bioplex suspension array technology uses beads which promote 3-D 
hybridizations to nucleic acids which are more advantageous than traditional planar 
microarrays allowing faster and cheaper detection of genes (Spiro et al., 2000).  The bead 
suspension array incorporates up to 100 different types of microspheres (beads) with each 
bead containing an internal fluorescent dye with its own spectral address.  This spectral 
address is specific to a given probe, nucleic acid, protein or otherwise, and assays can be 
carried out in a single reaction vessel (Biorad, CA).  A reporter dye in conjunction with 
hybridized beads is interrogated by two lasers (red and green) in the Bioplex and digitally 
processed based on the reported fluorescence signals and quantified.  The technology can 
be used to target PCR amplified products and has great multiplexing potential as it is able 
to target up to 100 different analytes in any given reaction which reduces time and cost of 
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the assay.  Direct DNA hybridizations, in particular using multiplexed PCR DNA in 
which several genes are amplified in a single reaction, have lead to many applications of 
the technology such as genotyping, multi-virus detection assays and bacterial gene 
detection (Smith et al., 1998; Deregt et al., 2006; Wilson et al., 2005).  Multiplexed 
assays which target agents such as HIV, hepatitis C and herpes simplex virus have 
enabled detection of these agents in patients susceptible to multiple infections (Smith et 
al., 1998).  An eight probe multiplex for animal pestivirus which used asymmetric PCR 
to allow strand-biased amplification for increased signal detection and a 10-plex PCR 
assay for biothreat agents have been developed for simultaneous detections of probes and 
can be expanded for use in genotyping strains of a specific virus (Deregt et al., 2006; 
Wilson et al., 2005).  
Gannon et al. (1997) have developed a multiplex PCR assay for specific 
identification of E. coli O157:H7 based on the genes eaeO157, VT1, VT2 and FlicH7.  
The eaeO157 gene encodes the protein intimin which is responsible for attaching and 
effacing of microvilli found on intestinal cells of the host. Stx’s 1 and 2 (VT1 and VT2) 
are phage-encoded toxins released by the bacteria which damage human microvascular 
endothelial cells and lead to blockage of the vascular cells and tissue damage in the 
colon, kidneys and central nervous system (Brussow, et  al., 2004).  The FlicH7 gene 
encodes a flagellar antigen and was included to increase specificity of the multiplex PCR 
(Gannon et al., 1997).  Based on this multiplex, the same gene targets would be expected 
to provide specific detection of E. coli O157:H7 in the Bioplex suspension array.  The 
Bioplex technology can subsequently be used to identify genetic variations within E. coli 
O157:H7 strains.  Within E. coli O157:H7 strains, octamer based genome scanning has 
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revealed the presence of two lineages; lineage I (LI) is associated with human and bovine 
isolates while lineage II (LII) is associated with mainly bovine isolates (Kim et al., 1999).  
As LI strains appear to be more virulent in humans than LII strains, the presence of these 
Lineage-specific phage genes may also provide insight into their potential for production 
of human disease in other STEC strains.  The seropathotype (SP) scheme has been 
developed to facilitate identification of the rate of occurrence of strains responsible for 
human disease (Karmali et al., 2003).  The presence of LI or LII related phage genes 
found within E. coli O157:H7 may also be related to SP strains and higher frequencies of 
human disease occurrence.   
In this study we detect Stx toxin-producing bacteriophage variation among E. coli 
O157:H7 isolates and STEC and consider the evolution of these bacteriophage.  The 
objectives of this study were: 
1) Specific detection of genes found within E. coli O157:H7 and STEC  
 Stx-encoding bacteriophage  
 2)  An examination of the variation in specific genes within E. coli O157:H7 
bacteriophage encoding Stx2 and Stx2c. 
 3) An examination of the variation in specific genes in Stx-encoding bacteriophage 
found in STEC strains from different seropathotypes. 
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3.2.  Materials and Methods 
3.2.1.  Bacterial Strains  
 In this study, thirty E. coli O157:H7 strains from Zhang et al. (2007) previously 
described in chapter two were used (Table 2.2.1.).  These strains were isolated from 
different sources and contained several different phage types (PT) and lineage-specific 
polymorphism types (LPSA).  Lineage I/II strains were treated as subgroups often within 
lineage I strains but were identified as L I/II strains.  Forty-six E. coli strains (Table 
3.2.1.) classified based on seropathotype (SP) by Karmali et al. (2003) were used for the 
SP studies as described below.  
 
3.2.2. Nucleic Acid Probe and Primer Design  
 The Bioplex suspension array system (Bio Rad, CA) was used for identifying E. 
coli O157:H7 strains and screening lineage-specific and SP collections for strains 
possessing phage genes.  All probes and primers were purchased from Integrated DNA 
technologies (IDT).  Each probe contained a 5’amino group modified with a C12 spacer 
to allow coupling to carboxylated microspheres.  The reverse primers were coupled to a 
5' biotin group to allow interaction with the reporter dye, streptavidin (Figure 3.2.1.). 
Probes for detection of E. coli O157:H7 were designed from DNA sequences targeting E. 
coli O157:H7 regions of the Shiga toxin 1 (VT1), Shiga toxin 2 (VT2), intimin (eaeO157) 
and Flagella (FlicH7) previously described in the multiplex PCR by Gannon et al. (1997) 
(Table 3.2.2.).  Upstream phage genes for the probes were chosen from conserved and 
variable regions found within EC970520 and EDL933.  Each  
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Table 3.2.1. E. coli strain seropathotype collection previously used by Karmali et al., 
2003.  
Strain # SEROTYPE HOST SOURCE SEROPATHOTYPE 
OK1 O157:H7 Human T.Whittam A 
93111 O157:H7 Human T.Whittam A 
Sakai  O157:H7 Human Osaka,Japan  A 
EDL933 O157:H7 Human J.Kaper A 
E32511 O157:NM Human H.Smith A 
R82F2 0111:NM Human LFZ B 
N01-7015 0103:H2 Human BCCDC,NLEP B 
CL9 026:H11 Human LFZ B 
CL1 026:H11 Human LFZ B 
NO2-1626 0103:H2 Human BCCDC,NLEP B 
N00-6496 0145:NM Human BCCDC,NLEP B 
N01-2454 0103:H2 Human BCCDC,NLEP B 
Z3F1 0121:H19 Human LFZ B 
CL106 0121:H19 Human LFZ B 
CL101 0111:NM Human LFZ B 
NO1-2051 0145:NM Human BCCDC,NLEP B 
N02-5149 0145:NM Human BCCDC,NLEP B 
C69F1 0111:NM Human LFZ B 
CL4 O26:H11 Human LFZ B 
N99-4390 0121:NM Human BCCDC,NLEP C 
N89-0541 0113:H121 Human APLPH C 
EC7-181 091:H21 Human LFZ C 
N90-0657 0113:H121 Human CPL C 
B2F1 091:H21 Human LFZ C 
G5506 0104:H121 Human T.Whittam C 
N00-4541 05:NM Human BCCDC,NLEP C 
N00-4067 05:NM Human BCCDC,NLEP C 
N99-3504 0113:H121 Human BCCDC,NLEP C 
EC6-936 091:H21 Human L.Beutin C 
EC6-990 091:H21 Human S.Alessic C 
CL3 0113:H121 Human LFZ C 
N00-4859 0103:H25 Human LFZ D 
N02-2616 0103:H25 Human BCCDC,NLEP D 
N02-4495 0117:H7 Human BCCDC,NLEP D 
EC7-821 069:H11 Human LFZ D 
N02-1625 0146:H21 Human BCCDC,NLEP D 
EC6-484 0172:NM Bovine LFZ D 
EC2-032 0171:H2 Bovine LFZ D 
EC6-371 0113:H4 Bovine LFZ D 
EC2-265 O119:H25 Human LFZ D 
EC9-377 098:H25 Bovine LFZ E 
EC6-626 06:H34 Bovine APLPH E 
EC4-453 088:H25 Bovine LFZ E 
EC2-293 039:H49 Bovine LFZ E 
EC2-020 0156:NM Bovine LFZ E 
EC2-211 0113:NM Bovine LFZ E 
 
 
 
                                                                           77
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.1. Hybridization of probes with their reverse complement.  
COOH 
  bead Amino 
Biotin 
Strepta-
vidin 
     Probe 
Reverse 
Complement 
Beads with carboxy (COOH) attachments interact with the amino modified probe and the 
reporter dye streptavidin interacts with the biotin of the reverse complement. Under 
optimal conditions, the probe and reverse complement hybridize. 
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Table 3.2.2. Nucleotide probes used in Bioplex suspension arrays for identification of E. 
coli O157:H7 and upstream phage genes.  
All probes were designed with a 5’amino group which was coupled to a C12 spacer 
linked to a fluorescently tagged microsphere. 
 
 
 
Probes Probe Sequence with 5'amino modified C12 (5'-3')  
Size 
(bp) 
Melting 
Temperature 
(˚C) 
VT1 AGTATACAAAATATAATGATGACGATACCTTTACA 35 59.9 
VT2 ATAAAAATAAACAATACATTATGGGAAAGTAATAC 35 60.0 
eaeO157 TAAGGATGCTATTAAATATACTGTAAAAGTTATGA 35 59.9 
FlicH7 CTTTAACGTAAATGGTAAAGGTACTATTACCAAC 34 61.6 
AR-933 GGCAAATAACTATGAGGATGTTACATGGTC 30 57.4 
AR-970520 GTTCTTTAATCTCGATTACGACAAAGAAAT  30 54.3 
Q-933 AAATCGCATATAGCACTATTAGTTTTCTAAATATT 35 54.3 
Q-970520 TATGACAAGGCCAATGTGTAATGATGATGATGGAA 35 60.9 
Stx2B-933 AGATACTCGTTTTAATAATCGAAATCATTTTAACC 35 55.0 
Stx2cB-
970520 CGATGATTAAAACACTTATCTGTGATATTTCCTGT 35 57.2 
Roi GTCAATACAAATCACGGAATACAGATATCG 30 55.7 
Stx2A TACTTTCTACCGTTTTTCAGATTTTACACATATAT 35 55.4 
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probe was designed using the primer design program, Primer 3, with probe lengths 30-
35bp, melting temperatures 54-61 °C and checked for secondary structures using the IDT 
oligo analyzer program (Table 3.2.2.).   
 
3.2.3.  PCR for multiplexes and Bioplex assays  
            PCR’s were designed using the primers from Table 3.2.3. Genomic DNA 
templates were amplified in 50 µl reaction volumes which contained 200 µM of each 
deoxynucleoside triphosphate (Qiagen), each primer at 10 pmol, 1X PCR buffer 
(Qiagen), 1 U DNA Taq polymerase (Qiagen) and 1µl template (100 ng/µl).  Negative 
control incorporated all reagents of the PCR except water was used as a template.  The 
reactions were amplified using a 9600 Gene Amp thermocycler (Applied biosystems Inc, 
CA). PCR was conducted as follows: 3min denaturation at 94 °C, followed by 25 cycles 
of 45 s at 94 °C, 30 s at 55 °C and 90 s at 72 °C with a final 10min 72 °C extension step.  
PCR products were visualized under UV light on a 1.0% (w/v) agarose gel stained with 
ethidium bromide. DNA molecular 1kb plus ladders (Invitrogen) were included in each 
gel electrophoresis run.  To increase detection, asymmetric PCR was used to 
preferentially amplify the reverse biotinlyated strand more than the forward strand since 
the probe and reporter dye only interact with the reverse strand to produce a signal and 
therefore should increase the signal intensity.  The amount of reverse primer was varied  
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Table 3.2.3. Primers used in Bioplex suspension arrays for identification of E. coli 
O157:H7 and upstream phage genes.  
All reverse primers were designed with a 5’Biotin which was coupled to the reporter dye, 
streptavidin-R-phycoerythrin. 
 
 
 
Probes Forward primer (5'-3') 
Reverse primer with 5'Biotin 
(5'-3') 
Expected 
Size (bp) 
Source 
sequence 
VT1 AGCTGCATCGCTTTCATTTT TGCGCACTGAGAAGAAGAGA 171 H19B 
VT2 CCATGACAACGGACAGCAGTT CCTGTCAACTGAGCACTTTG 779 
Gannon et 
al. (1997) 
eaeO157 AATAGTGCCAAAACGGATGC TTACCGTTGAACATCCCAAA 296 EDL933 
FlicH7 TTGATGAAATTGACCGCGTA GCGCCAGCAGAAGTTAAATC 229 E32511 
AR-933 ATCAGACCGAGGTAGCCAGA CGGGGATCAGTCCCTTAAAT 200 EDL933 
AR-
970520 AATCACATTCCCCTGGTTCA GGCAAGAGCTTTAGCCAGAA 200 EC970520 
Q-933 CGGAGGGGATTGTTGAAGGC GCAAAATGCTGTTACGCAAA 700 
Lejeune et 
al. (2004)  
Q-
970520 AATTCATGGAGAGCGTGGAG AGGTCTTGCGACGCTATGAT 197 EC970520 
Stx2B-
933 TCATAGCAGGGGCCTTTTTA TAAAATAAGGAGCGGGCTGA 200 ECL-933 
Stx2cB-
970520 GACACCGGACTGAACTCACC CAACGTGGCCCCATTTAATA 245 EC970520 
Roi GATCGCGGCTATTTCACAGT ATTAAGCAGCCTCCCCTGTT 157 EC970520 
Stx2A AATTTATATGTGGCCGGGTTC TGACGACTGATTTGCATTCC 176 EC970520 
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but the rest of the PCR remain unchanged.  A multiplex PCR assay for all lineage-
specific genes, including the conserved genes was created under the same conditions to 
determine if the phage patterns produced by the multiplex assays also could be found in 
other strains of E. coli O157:H7. 
 
3.2.4. Coupling of beads to Nucleic Acid probes   
Beads with carboxy (COOH) attachments for coupling to amino group modified 
probes were purchased from Biorad and selected using the bead table guide provided by 
the Luminex Corp. (Luminex, TX).  Beads (1.0 X 106 ) were Vortexed and sonicated for 
30s, pelleted at 10,000x g for 3min and resuspended in 10 µl of 0.1 M MES (2[N-
Morpholino] ethanesulfonic acid) (Sigma) pH 4.5.  Nucleic acid probes (0.10 nmol) were 
added to the resuspended beads with 2.5 µl of fresh 10 mg/ml EDC (1-ethyl-3-
[3dimethylaminopropyl] carbodiimide hydrochloride) (Sigma) and incubated at room 
temperature for 30 min in the dark.  A second addition of fresh EDC solution was added 
to the mix and incubation repeated.  Coupled microspheres were washed with 0.02% 
Tween-20 (Sigma) followed by a wash with 0.1% SDS in TE (10 mM Tris HCl [pH8.0], 
1mM EDTA). The beads were pelleted and resuspended in 20 µl TE.  The suspension 
was enumerated using a hemacytometer and diluted to 150 beads/µl in 4.5 M Tris-HCl 
(pH 8.0), 75 mM EDTA (pH 8.0), 0.15% Sarkosyl. Coupled beads were stored in the 
dark at 4 °C. 
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3.2.5. Direct Hybridization  
All hybridizations were done using 96-well PCR plates (Costar, MD). Stored 
beads were Vortexed and then sonicated for 30 s.  A total of 24µl of beads (150beads/µl) 
was added to each well with 24 µl 1.5X TMAC (Tetramethyl ammonium chloride) 
(Sigma) hybridization solution (4.5 M TMAC, 4.5 M Tris-HCl (pH 8.0), 75 mM EDTA 
(pH 8.0), 0.15% Sarkosyl) in a 96-well Costar PCR plate.  PCR product or 
complementary oligo was added to selected wells except for the background control and 
the plate was sealed and Vortexed.  Hybridization was performed in a thermocycler 
programmed for a denaturation at 95 °C for 5min followed by a 20 min 50 °C 
hybridization.  While the plate was still in the thermocycler, 1 µl of the reporter dye, 
streptavidin-R-phycoerythrin (0.1 mg/ml) (Invitrogen), was added to each well followed 
by a quick Vortex and incubated for another 20 min.  Samples were mixed by pipetting 
up and down to prevent bead aggregation and analyzed in the Bioplex 200 (Biorad, CA).  
The platform temperature was set at 50 °C with a bead count of 100.  Assay conditions 
for coupling beads and hybridizations were optimized.  To determine coupling 
efficiencies, reverse complements of the probe sequences were designed with 5’biotin 
modifiers for coupling to reporter dye, streptavidin-R-phycoerythrin.  Coupling 
efficiencies for each probe were initially tested using reverse complement sequences.   
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3.3.  Results 
3.3.1.  Specific detection of genes found within E. coli O157:H7 in STEC strains by 
multiplex PCR and O157 Bioplex assay  
An O157 Bioplex assay was developed from a multiplex PCR using Stx 1 (VT1), 
Stx2 (VT2), FlicH7 and eaeO157 specific genes found within E. coli O157:H7.  To test 
the O157 Bioplex assay for reproducibility and accuracy in detecting  E. coli O157:H7, a 
collection of 30 E. coli O157:H7 strains (Table 2.2.1.) were assayed with the Bioplex 
following three different PCR protocols as well as testing the reproducibility of the 
Bioplex by testing replicates obtained from a single PCR experiment.  All strains (30/30) 
that produced a target-specific PCR product on agarose gels also produced positive 
signals for their respective Bioplex probes (Table 3.3.1.).  E. coli strains contain different 
combinations of Stx genes and the O157 Bioplex assay was able to accurately 
differentiate among strains which produced Stx1, Stx2 and both toxins.  Most 
importantly, the O157 Bioplex assay was able to detect eaeO157 PCR products from all 
strains (30/30).  An E. coli K12 and a blank DNA sample were used as negative controls 
and both produced negative signals.  Forty-six non-O157 E. coli strains (Table 3.2.1.) 
were tested to determine the ability of the O157 Bioplex assay to detect specific genes 
found in other STEC strains.  A positive isolate for E. coli O157:H7 contained eaeO157, 
FlicH7, and either Stx1, Stx2 or both. As expected, all (5/5) of E. coli O157:H7 strains 
were positive for these markers in the O157 Bioplex assay (Table 3.3.2.).  All 46/46 
STEC strains that produced a positive or negative Stx1 PCR band also produced their 
corresponding absolute positive or negative Stx1 signal on the Bioplex.  Most Stx2 PCR 
positives were also detected in the Bioplex except for Stx2 genes from strains of  
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Table 3.3.1. Bioplex assay (O157) mean detection of E. coli O157:H7 specific genes in 
E. coli O157:H7 strains.   
Mean detection in 1:1:2:3 (VT1:VT2:eaeO157:FlicH7) reverse primer ratio PCR 
multiplex assay.  PCR results prior to O157 Bioplex assay are displayed. K12 and PCR 
water were used as negative controls. 
Strain Serotype PCR positives VT1 VT2 eaeO157 FlicH7 
LRH16 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ -+ 
LRH27 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
LRH6 O157:H7 VT2, eaeO157, FlicH7 - + ++ + 
TS-97 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
F1299 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ -+ ++ + 
F5 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
EDL933 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
63154 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + +++ + 
58212 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
F1095 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
Sakai O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
H4420 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
E2328 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
F1082 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ ++ ++ + 
59243 O157:H7 VT2, eaeO157, FlicH7 - + ++ + 
71074 O157:H7 VT2, eaeO157, FlicH7 - + ++ + 
EC20030338 O157:H7 VT2, eaeO157, FlicH7 - + ++ + 
Zap0046 O157:H7 VT2, eaeO157, FlicH7 - + +++ ++ 
LRH13 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
R1797 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
LS68 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
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F12  O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ -+ ++ + 
F1081 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
FRIK 920 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ -+ ++ + 
FRIK 1999 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
FRIK 1985 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
FRIK 1990 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ -+ ++ + 
FRIK 2001 O157:H7 VT2, eaeO157, FlicH7 - + +++ + 
EC970520 O157:H7 
VT1, VT2, eaeO157, 
FlicH7 +++ + ++ + 
12491 O157:H7 VT2, eaeO157, FlicH7 - + +++ + 
K12      - - - - 
PCR negative     - - - - 
- negative signal (MFI 0-500) 
-+ weak signal (MFI 500-1000) 
+positive signal (MFI 1000-3000) 
++strong positive signal (MFI 3000-5000) 
+++absolute positive signal (MFI 5000+) 
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Table 3.3.2.  Bioplex assay (O157) mean detection of E. coli O157:H7 specific genes in 
STEC strains.   
Mean detection in 1:1:2:3 (VT1:VT2:eaeO157:FlicH7) reverse primer ratio PCR 
multiplex assay. PCR results prior to O157 Bioplex assay are displayed.  K12 and PCR 
water were used as negative controls. 
E. coli 
strain Serotype PCR positives VT1 VT2 eaeO157 FlicH7 
OK1 O157:H7 VT1,VT2,eaeO157,FlicH7  +++  +  ++  + 
93111 O157:H7 VT1,VT2,eaeO157,FlicH7  +++  +  ++  + 
Sakai  O157:H7 VT1,VT2,eaeO157,FlicH7  +++  +  ++  + 
EDL933 O157:H7 VT1,VT2,eaeO157,FlicH7  +++  +  ++  + 
E32511 O157:NM VT2,eaeO157,FlicH7  -  +  ++  + 
R82F2 0111:NM VT1,eaeO157  +++  -  -   - 
N01-7015 0103:H2 VT1  +++  -  -  - 
CL9 026:H11 VT1  +++  -  -  - 
CL1 026:H11 VT1  +++  -  -  - 
NO2-1626 0103:H2 VT1  +++  -  -  - 
N00-6496 0145:NM VT1,VT2,eaeO157  +++  +  +  - 
N01-2454 0103:H2 VT1  +++  -  -  - 
Z3F1 0121:H19 VT2  -  +  -  - 
CL106 0121:H19 VT2  -  +  -  - 
CL101 0111:NM VT1,eaeO157  +++  -  -  - 
NO1-2051 0145:NM VT2,eaeO157   -  +  +  - 
N02-5149 0145:NM VT1,VT2,eaeO157  +++  +  ++  - 
C69F1 0111:NM VT1,eaeO157  +++  -  -  - 
CL4 O26:H11 VT1  +++  -  -  - 
N99-4390 0121:NM VT1,FlicH7  +++  -  -  + 
N89-0541 0113:H121 VT2  -  -  -  - 
EC7-181 091:H21 VT2  -  +  -  - 
N90-0657 0113:H121 VT2  -  -+  -  - 
B2F1 091:H21 VT2  -  +  -  - 
G5506 0104:H121 VT2  -  -+  -  - 
N00-4541 05:NM VT1  +++  -  -  - 
N00-4067 05:NM VT1  +++  -  -  - 
N99-3504 0113:H121 VT2  -  -+  -  - 
EC6-936 091:H21 VT2  -  +  -  - 
EC6-990 091:H21 VT2  -  -+  -  - 
CL3 0113:H121 VT2  -  +  -  - 
N00-4859 0103:H25 VT1,eaeO157  +++  -  -  - 
N02-2616 0103:H25 VT1,eaeO157  +++  -  -  - 
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E. coli 
strain 
continued Serotype PCR positives VT1 VT2 eaeO157 FlicH7 
N02-4495 0117:H7 VT1,FlicH7  +++  -  -  + 
EC7-821 069:H11 VT1  +++  -  -  - 
N02-1625 0146:H21 VT1  +++  -  -  - 
EC6-484 0172:NM VT2   -  -  -  - 
EC2-032 0171:H2 VT2  -  -+  -  - 
EC6-371 0113:H4 VT1,VT2  +++  -   -  - 
EC2-265 O119:H25 VT2  -  ++  -  - 
EC9-377 098:H25 VT1  +++  -  -  - 
EC6-626 06:H34 VT2  -   -  -  - 
EC4-453 088:H25 VT2  -  +  -  - 
EC2-293 039:H49 VT1,VT2  +++  -+  -  - 
EC2-020 0156:NM VT2  -  +  -  - 
EC2-211 0113:NM VT2  -  ++  -  - 
K12      -  -  -  - 
PCR –ve      -  -  -  - 
 
- negative signal (MFI 0-500) 
-+ weak signal (MFI 500-1000) 
+positive signal (MFI 1000-3000) 
++strong positive signal (MFI 3000-5000) 
+++absolute positive signal (MFI 5000+) 
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serotypes 0113:H121, 0172:NM, 0113:H4 and 06:H34.  The eaeO157 Bioplex probe was 
PCR and Bioplex positive for all O157:H7 strains and all three 0145 strains as well as an 
EPEC O55:H7 strain.  PCR products for eaeO157 were generated from two 0103 and 
three 0111 strains and produced the expected band size; however, they were not positive 
in the Bioplex assay. The PCR and Bioplex FlicH7 probe was able to detect all H7 
bearing STEC strains. 
 
3.3.2. Variation in Stx2 and Stx2c-encoding bacteriophage genes in EC970520 and 
EDL933  
           Primers specific to the Stx2 upstream genes found in the LI strain EDL933 and 
Stx2c upstream genes found in LII strain EC970520 were developed to examine variation 
of the phage-specific genes within E. coli strains using the Bioplex assay.  PCR primers 
specific to genes coding for a putative anti-repressor protein (AR-933), an anti-terminator 
Q protein (Q-933) and Β subunit found in Stx2 (Stx2B-933) were chosen to identify 
genes found within the Stx2 phage from EDL933.  Other PCR primers specific to Stx2c 
variant found in EC970520 also were developed: i.e., gene segments specific to a putative 
anti-repressor protein (AR-970520), an anti-terminator Q protein (Q-970520) and Β 
subunit found in Stx2c (Stx2B-970520).  Primers specific for conserved Stx2 phage 
genes coding for a DNA-binding protein (Roi) and Α subunit in Stx2 were chosen as 
positive controls which would produce amplified products in both EDL933 and 
EC970520.  The EDL933 PCR primers (AR-933, Q-933 and Stx2B-933) were able to 
amplify gene segments when DNA from E. coli O157:H7 strain EDL933 was used as a 
template but not EC970520 (Figure 3.3.1.).  Similarly, EC970520  primers (AR-970520, 
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Q-970520, Stx2B-970520) were able to amplify gene segments when DNA from E. coli 
O157:H7 strain EC970520 was used as a template but not EDL933 (Figure 3.3.1.).  
Expected bands were amplified in both strains EDL933 and EC970520 for the conserved 
Stx2A and Roi targets.  No bands were amplified in E. coli K12 or distilled water, both of 
which were PCR negative controls.  
 
3.3.3.  Identification of genes specific to Stx2 and Stx2c-encoding phage in E. coli 
O157:H7 strains in the Stx2 phage Bioplex assay   
A Stx2 phage Bioplex assay was developed to determine if the variation of phage 
genes from LI strain EDL933 and LII strain EC970520 can be used to identify these gene 
targets in other E. coli O157:H7 strains.  Multiplexes for each gene from both lineages 
were prepared for use with the PCR products in the Stx2 phage Bioplex assay.  Multiplex 
PCR product detection was compared to uniplex PCR’s in the Bioplex assay  to ensure 
that the products produced were the same for both and was found to be useful  in 
discriminating products between primer sets when the PCR products were similar in size 
(Figure 3.3.2.; Figure 3.3.3.).  The multiplex and uniplex PCR products produced similar 
signals in the Bioplex assay, therefore, multiplex PCR assay products were employed in 
the Bioplex assay in subsequent experiments.  In all LII strains, 12/12 strong positive 
signals were obtained in the Bioplex assay for all EC970520 Stx2-encoding 
bacteriophage upstream genes and negative signals were obtained for all EDL933 Stx2-
encoding bacteriophage upstream genes (Table 3.3.3.).  For LI E. coli O157:H7  
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Figure 3.3.1. Expected band sizes using primers based on sequences of Stx2 (EDL933) 
and Stx2c (EC970520) upstream phage genes.  
Each primer set: AR-933; AR-EC970520; Q-L 933; Q-970520; Stx2B-933; Stx2B-
970520; Stx2A; Roi was screened for PCR products using the strains EC970520 (LII), 
EDL933 (LI), K12 (no Stx phage), and PCR negative (water). 
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LII
LI
LI
 
Figure 3.3.2. Expected band sizes for AR-933/ AR-EC97020 multiplex PCR in E. coli 
r 
34: lineage I, I/II 
trains; 16: blank; 35: K12; 36: water; 1, 20, 21, 37:1 kb plus ladder. 
 
 
 
 
O157:H7 lineage-specific strains.  
This multiplex was used as a representative example of several multiplexes developed fo
phage Bioplex assay. Lanes 2-13: lineage II strains; 14-15, 17-19, 22-
s
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A) AR-933 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LI
LILII
B) AR-EC970520 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LI
LILII
Figure 3.3.3. Expected band sizes in E. coli O157:H7 lineage-specific strains using A) 
AR-933 and B) AR-970520 PCR.  
These uniplexes were used as a representative example of PCR’s developed for phage 
Bioplex assay. Lanes 2-13: lineage II strains; 14-15, 17-19, 22-34: lineage I, I/II strains; 
16: blank; 35: K12; 36: water; 1, 20, 21, 37:1 kb plus ladder.  
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Strains listed in Figure 3.3.2. and Figure 3.3.3. were as follows: 
 
1) EC970520 (II) 
2) LRH13 (II) 
3) R1797 (II) 
4) LS68 (II) 
5) F12 (II) 
6) F1081 (II) 
7) FRIK 920 (II) 
8) FRIK 1999 (II) 
9) FRIK 1985 (II) 
10) FRIK 1990 (II) 
11) FRIK 2001 (II) 
12) 12491 (II) 
13) LRH16 (I) 
14) LRH27 (I) 
15) blank 
16) LRH6 (I) 
17) TS-97 (I) 
18) F1299 (I) 
19) F5 (I) 
20) 59243 (I/II) 
21) 71074 (I/II) 
22) EC20030338 (I/II) 
23) Zap0046 (I/II) 
24) 63154 (I) 
25) 58212 (I) 
26) F1095 (I) 
27) H4420 (I) 
28) E2328 (I) 
29) F1082 (I) 
30) Sakai (I) 
31) EDL933 (I)  
32) K12 
33) PCR -ve 
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Table 3.3.3.  Bioplex phage assay mean detection of Stx2 (933) and Stx2c (970520) 
genes in E. coli O157:H7 strains.  K12 was used as a negative control. 
Strain Serotype lineage 
AR-
933 
Q-
933 
Stx2B-
933 
AR-
970520 
Q-
970520 
Stx2B-
970520 Stx2A Roi 
LRH16 O157:H7  I  -  -+  ++  +++  -  -  +++  +++ 
LRH27 O157:H7  I  -  -+  ++  +++  -  -  +++  ++ 
LRH6 O157:H7  I  -  +  +++  ++  -  -  +++  +++ 
TS-97 O157:H7  I  -  -+  ++  +++  -  -  +++  ++ 
F1299 O157:H7  I  -  -+  +++  +++  -  -  +++  ++ 
F5 O157:H7  I  -  +  +++  +++  -  -  +++  ++ 
EDL933 O157:H7  I  ++  +  +++  -  -  -  +++  +++ 
63154 O157:H7  I  ++  -+  ++  -  -  -  +++  ++ 
58212 O157:H7  I  ++  +  ++  -  -  -  +++  ++ 
F1095 O157:H7  I  ++  +  ++  -  -  -  +++  ++ 
Sakai  O157:H7  I  -  +  +++  +++  -  -  +++  +++ 
H4420 O157:H7  I  -  +  ++  +++  -  -  +++  +++ 
E2328 O157:H7  I  -  +  +++  +++  -  -  +++  ++ 
F1082 O157:H7  I  -  +  ++  +++  +  -  +++  +++ 
59243 O157:H7  I/II  -  -+  +++  -  -  -  +++  - 
71074 O157:H7  I/II  -  +  +++  -  -  -  +++  - 
EC20030338 O157:H7  I/II  -  +  +++  -  -  -  +++  - 
Zap0046 O157:H7  I/II  -  -  +++  +++  ++  +++  +++  ++ 
LRH13 O157:H7  II  -  -  -  +++  ++  +++  +++  +++ 
R1797 O157:H7  II  -  -  -  ++  ++  ++  +++  +++ 
LS68 O157:H7  II  -  -  -  +++  ++  +++  +++  +++ 
F12  O157:H7  II  -  -  -  +++  ++  ++  +++  ++ 
F1081 O157:H7  II  -  -  ++  +++  +++  +++  -  +++ 
FRIK 920 O157:H7  II  -  -  -  +++  ++  +++  +++  ++ 
FRIK 1999 O157:H7  II  -  -  -  +++  ++  +++  +++  +++ 
FRIK 1985 O157:H7  II  -  -  -  +++  +++  +++  +++  ++ 
FRIK 1990 O157:H7  II  -  -  -  +++  ++  +++  +++  ++ 
FRIK 2001 O157:H7  II  -  -  -  +++  ++  +++  +++  ++ 
EC970520 O157:H7  II  -  -  -  +++  ++  +++  ++  +++ 
12491 O157:H7  II  -  -  -  ++  +++  ++  +++  ++ 
K12       -  -  -  -  -  -  -  - 
- negative signal (MFI 0-500) 
-+ weak signal (MFI 500-1000) 
+ positive signal (MFI 1000-3000) 
++strong positive signal (MFI 3000-5000) 
+++absolute positive signal (MFI 5000+)
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strains, only 4/14 (28.6%) which include 63154, 58212, F1095 and EDL933 produced a 
positive signal for all upstream genes for EDL933 and negative EC970520 genes.  All LI 
strains (14/14) and most L I/II strains 3/4 (75%) produced positive signals for Q-933 and 
Stx2B-933 genes, however, 10/14 (71%) of the LI strains also produced positive AR-
970520 signals.  Neither AR-933 nor AR-970520 genes were found in three of the four L 
I/II strains (59243, 71074 and EC20030338).  The L I/II strain Zap0046 produced 
positive signal for all LII EC970520 upstream genes in addition to the Stx2B-933 gene. 
No signal was obtained for DNA from E. coli K12.  
 
3.3.4. Identification of gene specific to Stx2 and Stx2c-encoding phage in 
seropathotype strains in phage Bioplex assay  
 The phage Bioplex assay was used to determine if the genes found in E. coli 
O157:H7 LI strain EDL933 and LII strain EC970520 were present in any of the other 
STEC strains belonging to different serotypes and seropathotypes (SP).  E. coli O157:H7 
strains OK1 (SPA) and EDL933 (SPA) had positive signal for all LI EDL933 genes and 
negative for EC970520 LII genes (Table 3.3.4.).  E. coli O157:H7 E32511 (SPA) and 
EC970520 produced positive signal for all of its own primers, however, E32511 also 
contained EDL 933 genes. The EDL933 genes were found in all SPA 5/5 (100%) strains 
but in only 9/41 (22.0%) SPB to SPE strains. The EC970520 phage genes were 
distributed throughout strains of  SPA to SPE and occurred in 27/46 (58%) of all strains. 
When the sizes of bands obtained using a  multiplex PCR with the two sets of phage 
primers (EDL933  or EC970520) were compared on agarose gels, three strains, OK1 
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(SPA), 93111 (SPA) and EC6-371 (SPD) had a  pattern of bands the same as EDL933 
and 13/46 (28%) in SP collection had the same pattern as  LII EC970520  pattern.   
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Table 3.3.4.  Bioplex phage assay mean detection of Stx2 (933) and Stx2c (970520) 
genes in SP strain collection.  K12 was used as a negative control. 
Strain Serotype 
Sero- 
pathotype 
AR-
933 
Q-
933 
Stx2B-
933 
AR-
970520 
Q-
970520 
Stx2B-
970520 Stx2A Roi 
OK1 O157:H7 A ++ -+ ++ - - - +++ + 
93111 O157:H7 A - + + ++ - - - + 
Sakai  O157:H7 A - -+ +++ +++ - - +++ ++ 
EDL933 O157:H7 A +++ + ++ - - - +++ + 
E32511 O157:NM A - + + ++ ++ ++ + + 
R82F2 0111:NM B - - - - - - - + 
N01-
7015 0103:H2 B - - - +++ - - - ++ 
CL9 026:H11 B - - - +++ - - - ++ 
CL1 026:H11 B - + +++ +++ - - +++ ++ 
NO2-
1626 0103:H2 B - - - +++ - - - ++ 
N00-
6496 0145:NM B - - - - - - +++ + 
N01-
2454 0103:H2 B - - - +++ - - - ++ 
Z3F1 0121:H19 B - - - +++ - - - ++ 
CL106 0121:H19 B - -+ +++ +++ - - +++ ++ 
CL101 0111:NM B - - - - - - - ++ 
NO1-
2051 0145:NM B - -+ - - - - +++ - 
N02-
5149 0145:NM B - - - - - - +++ + 
C69F1 0111:NM B - - - - - - +++ +++ 
CL4 O26:H11 B - - - +++ - - - ++ 
N99-
4390 0121:NM C - - - +++ ++ - - ++ 
N89-
0541 0113:H121 C - - - - - +++ +++ - 
EC7-181 091:H21 C - - - - - - +++ - 
N90-
0657 0113:H121 C - - - - - - +++ - 
B2F1 091:H21 C - - - - - +++ +++ - 
G5506 0104:H121 C - - - - - +++ +++ - 
N00-
4541 05:NM C - - - +++ -+ - - + 
N00-
4067 05:NM C - - - +++ -+ - - ++ 
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- negative signal (MFI 0-500) 
-+ weak signal (MFI 500-1000) 
+ positive signal (MFI 1000-3000) 
++strong positive signal (MFI 3000-5000) 
+++absolute positive signal (MFI 5000+) 
 
 
Strain 
continued Serotype 
Sero- 
pathotype 
AR-
933 
Q-
933 
Stx2B-
933 
AR-
970520 
Q-
970520 
Stx2B-
970520 Stx2A Roi 
EC6-936 091:H21 C - - - - - - +++ - 
EC6-990 091:H21 C - - - - - - +++ - 
CL3 0113:H121 C - - - - - - +++ - 
N00-4859 0103:H25 D - - - - - - - ++ 
N02-2616 0103:H25 D - - - - - - - ++ 
N02-4495 0117:H7 D - - - ++ ++ - - ++ 
EC7-821 069:H11 D - - - +++ - - - ++ 
N02-1625 0146:H21 D - - - - - - - - 
EC6-484 0172:NM D - + ++ ++ - - +++ ++ 
EC2-032 0171:H2 D - - - - - + +++ - 
EC6-371 0113:H4 D ++ + - +++ - ++ +++ + 
EC2-265 O119:H25 D - ++ + - - - +++ + 
EC9-377 098:H25 E ++ - - +++ - - + ++ 
EC6-626 06:H34 E - -+ +++ +++ - - +++ + 
EC4-453 088:H25 E - - - - - ++ ++++ + 
EC2-293 039:H49 E - - - - - - +++ - 
EC2-020 0156:NM E - - - - - +++ +++ - 
EC2-211 0113:NM E  -  ++  -  -  -  -  +++  + 
EC970520 O157:H7   -  -  -  ++  -+  ++  +++  + 
K12      -  -  -  -  -  -  -  - 
                                                                           99
3.4. Discussion 
3.4.1. Specific detection of genes found within E. coli O157:H7 in STEC strains by 
multiplex PCR and O157 Bioplex assay  
The O157 Bioplex assay developed based on genes specific to E. coli O157:H7: 
e.g., shiga toxins (VT1, VT2), flagella (FlicH7) and intimin (eaeO157); accurately and 
consistently identified 30/30 (100%) E. coli O157:H7 strains and identified the type(s) of 
Stx found in each strain.  Not only did the PCR and Bioplex assays allow specific 
detection of E. coli O157:H7, they were also able to identify E. coli O157:H7 genes in 46 
STEC from other serotypes.  The virulence of the STEC strains may be related the type 
of Stx produced and presently, severe human diseases such as HUS have been linked to 
strains possessing Stx2 (Freidrich et al., 2002).  Therefore, the ability to detect those E. 
coli O157:H7 and STEC strains that possess Stx2 may be important in identifying highly 
pathogenic E. coli O157:H7 strains.  The Bioplex assay may also contain detection 
probes more specific to E. coli O157:H7 strains than the multiplex PCR.  This was 
evidenced by the fact that some eaeO157 and Stx2 (VT2) PCR positive strains from non-
O157 serotypes failed to produce a signal in the O157 Bioplex assay (Table 3.3.2.).  This 
is likely due to low homology of these genes to the detection probe.  As reported by 
Gannon et al. (1997), eaeO157 primers also amplified DNA from 0145:NM strains, 
however,  FlicH7 and VT genes aid in the discrimination among strains and increased the 
specificity of the Bioplex assay in the identification of  E. coli O157:H7. 
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3.4.2. Variation in Stx2 and Stx2c-encoding bacteriophage genes from EC970520 
and EDL933 
 The upstream gene primers were found to be specific to LI EDL933 or LII 
EC970520 phage gene.  The Stx2A and Roi genes were present in both lineages (Figure 
3.3.1.).  The Stx2c phage genes from EC970520 were present in all LII E. coli O157:H7 
strains tested. In contrast, only 4 strains including EDL933 contained all of the same 
upstream Stx2 phage genes from EDL933.  It seems that only a subset of LI strains 
contain these EDL933 Stx2 phage genes.  Several LI strains were missing the AR-933 
gene but contained the AR-970520 gene. These LI strains may have been missing the AR 
or contain a different type of AR.  Sequencing of E. coli O157:H7 strains have identified 
several cryptic prophages within the genomes although most do not contain the full 
complement of genes needed for lytic phage release (Perna et al., 2001; Ohnishi et al., 
2002).  These phage are highly heterogeneous but may have shared a common ancestor 
and derive new genes from related phage (Hendrix et al., 1999).  Therefore these genes 
may be somewhat randomly distributed throughout phage genomes. The Stx1 phage is 
the most likely to contain similar genes to the Stx2 phage since the Stx2 is about 55% 
similar to Stx1 at an amino acid level (Gamage et al., 2004).  The L I/II strains were AR 
negative differing from other LI and LII strains and this gene heterogeneity may be 
responsible for unique properties associated with this intermediate lineage. A unique 
distribution of phage genes was also seen in the L I/II strain Zap0046.  
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3.4.3. Upstream Stx2 phage assay and multiplex patterns in SP strains   
 STEC serotypes have been classified into SPA to SPE based on the frequency and 
severity of human disease with which they associated (Karmali et al., 2003). SPA are 
most frequently associated with outbreaks of disease and the sometimes fatal HUS and 
this group consists only of E. coli O157:H7 strains. SPB, C and D are also pathogens but 
are associated with less serious disease.  SPB are serotypes occasionally associated with 
outbreaks and cases of HUS; SPC serotypes are associated with sporadic cases of human 
illness and rarely with HUS; SPD serotypes are associated with diarrhea; and SPE 
serotypes have been isolated from animals but have never been implicated in human 
disease.  The benefit of this system is that it allows identification of STEC strains of 
specific serotypes which have been implicated in human disease of varying frequency 
and severity and provides a framework in which to identify virulence traits responsible 
for the specific epidemiological and clinical characteristics of these strains.  Since Stx2 
phage carry important virulence factors, characterization of these phage in different 
seropathotypes may help us to determine if these phage are associated with higher 
occurrences of severe disease (HC, HUS and death) and disease outbreaks.  
          In the phage Bioplex assay of upstream genes of Stx2 phage, only one other strain, 
OK1 (SPA), had the same complement of genes as E. coli O157:H7 strain EDL933.  An 
important trend in the Bioplex assay data was that the EDL933 genes regions were found 
in SPA strains and less commonly in the strains of other SPs.  The EC970520 genes were 
found in E32511 (SPA) but this strain also contains Stx2c genes and therefore both 
phages.  The EC970520 genes were more randomly distributed throughout the SP and not 
specifically associated with a particular SP. 
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            The multiplex PCR patterns also determined that 93111 (SPA) and EC6-371 
(SPD) appear to be similar to the EDL933 Stx2 phage and that 28% of strains were 
closely related to the EC970520 Stx2 phage.  It is clear that the Bioplex assay was able to 
more accurately distinguish between similar genes found within Stx2 phage than simple 
PCR assays.  It is evident that many more Stx2 phage contain gene variants not present in 
EDL933 and EC970520. While the phage probe sets used in the Bioplex assays in this 
study were valuable for detection of Stx2 phage genes and in the differentiation among 
Stx2 phage types found in E. coli O157:H7 strains and other STEC, the use of more 
genes targets in Bioplex assays would be valuable in the identification of other variants of 
these Stx2 phages.  
 
3.4.4.  Applications of E. coli O157:H7 and phage gene Bioplex assays  
The development of these assays can be used for a number of applications.  
Individuals living in rural areas in Canada are at particular risk where high agriculture 
activity occurs and there is direct contact with cattle populations which can act as 
reservoirs for the disease, contaminating groundwater (Spika et al., 1996).  The assay can 
be developed to identify contamination of E. coli O157:H7 and STEC strains in food and 
water samples. Wilson et al. (2005) have developed a suspension array for multiplexed 
PCR detection of biothreat pathogens using simulated environmental samples 
demonstrating the suspension array as a viable and cost-effective technology for this 
application.  Environmental multiplexed suspension arrays have also been developed to 
detect Enterococcus spp. in river samples, marine recreational water and beach sand but 
there has been no development of an environmental assay to detect specific pathogenic E. 
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coli strains (Baums et al., 2007). The assay can also be used to identify strains that may 
have previously gone undetected by other methods. Current culturing techniques to 
identify E. coli O157:H7 in water sources do not detect viable but non-culturable cells 
encouraging the need to develop efficient techniques to identify these strains. This assay 
may have the capability to identify strains of this nature since detection is determined by 
the genetic composition of the organism, not the ability for these cultures to grow on 
selective media. Bacterial strains are highly diverse organisms and this assay can also be 
developed to detect diversity within E. coli O157:H7 strains. The addition of Stx2 and 
Stx2c probes specific to bovine and human strains can be used to identify sources of 
infection and the pathogenic capabilities of strains within E. coli O157:H7 and other 
STEC strains in the medical and agricultural industries. 
 
3.4.5.  Future tests  
A significant limitation to the current Bioplex assay developed here is the use of 
PCR amplified product for detection. The use of genomic DNA in the suspension array 
would remove the PCR step improving efficiency and decreasing costs but genomic DNA 
suspension arrays have been difficult to develop since signal intensity has not been 
adequate for detection.  Borucki et al. (2005) have increased genomic DNA detection by 
using DNA dendrimers hybridized to the bead-DNA complex to increase target labeling 
therefore increasing signal to accurately detect the pathogen Listeria monocytogene. This 
option may improve the efficiency of the E. coli O157:H7 assay and should be 
investigated.  The E. coli O157:H7 assays developed here are sensitive and specific 
enough to detect E. coli O157:H7 as well as those genes found within other STEC strains 
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and are useful in identifying genetic variations between STEC human and bovine 
isolates. 
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3.5. Conclusions 
We detected variation in Stx toxin-producing bacteriophage among E. coli 
O157:H7 and STEC. In this study, 
    1) The Bioplex O157 assay developed was able to specifically detect E. coli 
O157:H7 and the types of Stx(s) found within each strain. These genes were also 
identified in STEC which shows that this method is useful for identifying those 
STEC strains with pathogenic potential.  The Bioplex assay may also contain 
detection probes more specific to E. coli O157:H7 strains than the multiplex PCR. 
   2) Phage genes of Stx2c found in EC970520, were lineage II specific but only a 
subset of lineage I strains contained the Stx2 phage genes found in EDL933.  
Lineage I/II strains contain phage genes different from both lineages that may 
contribute to its unique properties. 
    3) The Stx2 phage genes identified by the phage Bioplex assay were found to be 
distributed mainly in SPA whereas the Stx2c phage genes were distributed 
throughout the SP.  The phage Bioplex assay may be more specific than multiplex 
PCR as the Bioplex was able to distinguish differences within specific genes.  
 
 These assays can be used for screening environmental samples, viable but non-
culturable cells and identifying sources of infection. Future testing to improve Bioplex 
assay signal can be useful in developing more assays to specifically identify more genetic 
variations within human and bovine isolates of E. coli O157:H7 which is important for 
determining the source of infections and identifying evolving strains with pathogenic 
potential.  
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CHAPTER FOUR 
4. Phenotypic differences of Shiga toxin 2-encoding bacteriophage between E. 
coli O157:H7 lineage I and II strains 
4.1.  Introduction  
Escherichia coli (E. coli) O157:H7 is a food and water borne bacterial pathogen 
that is associated with outbreaks of gastrointestinal illness such as hemorrhagic colitis 
(HC) and a sometimes fatal systemic toxemia termed hemolytic uremic syndrome (HUS) 
(Karmali et al., 1983; Obrig et al., 1998; Ochea and Cleary, 2003).  These pathogens 
colonize the bowel and create attaching and effacing (A/E) lesions in epithelial cells of 
the intestinal mucosa.  The adherence to the intestine is aided by a type-III secretion 
system which is encoded on an ~45 kb pathogenicity island termed the locus of 
enterocyte effacement (LEE) (Perna et al., 1998).  This island also produces several 
secreted proteins including intimin, an outer membrane protein required for intimate 
adherence.  Once bacteria have adhered to the mucosa they produce one of the most 
important virulence factors in E. coli O157:H7, the potent cytotoxins termed Shiga toxins 
(Stx) which damage the large bowel.  These toxins have N-glycosidase activity which 
target 28s rRNA resulting in inhibition of protein synthesis and cell death (Karmali, 
2004; Law, 2000).  These toxins are thought to directly lead to systematic damage of 
other organs such as the brain, pancreas and lungs resulting in development of HUS in 
infected individuals (Obrig et al., 1988; Monnens et al., 1998).  There are two major 
types of Stx termed Stx1 and Stx2.   A Stx-producing E. coli (STEC) strain can produce 
either Stx1 or Stx2 or both toxins.  Sequencing of several Stx phages has shown that 
these genomes are highly heterogeneous in nature.  Several variants of Stx2 have been 
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identified (Stx2c, Stx2d, Stx2e, and Stx2f) and virulence of STEC strains including E. 
coli O157:H7 may be related to the type of toxin produced; e.g., severe human disease 
associated with HUS has been linked to bacterial strains producing Stx2 or the variant 
Stx2c rather than Stx1 (Friedrich et al., 2002; Herold et al., 2004).  
Stx genes found in E. coli O157:H7 and other STEC are located in temperate 
lambdoid bacteriophages.  During lysogeny, the bacteriophage DNA is inserted into the 
bacterial chromosome and in this inactive state the phage DNA is referred to as a 
prophage.  Upon induction, the integrated bacteriophage enters the lytic cycle and phage 
progeny are assembled with the help of the host’s machinery resulting in death of the 
host, and spread of the phage to new E. coli host bacteria.  The Stx genes in E. coli O157 
strains are present in the late region of the phage genome and are expressed only in the 
lytic stage of the phage life cycle (Gamage, 2004).  Induction of lysogenic phage into the 
lytic cycle can occur after exposure to DNA damaging agents such as UV light or the 
mutagen mitomycin C, following exposure to neutrophil activation products such as 
hydrogen peroxide or after treatment with antibiotics such as ciprofloxacin.  These 
treatments activate a cellular SOS response which results in removal of inhibitors of the 
lytic cycle, derepression of phage lytic genes and increased Stx synthesis and release 
(Goerke et al., 2006; Smith and Walker, 1998; Muhldorfer et al., 1996; Zhang et al., 
2000).  
The type of phage, the ability to enter a lytic cycle and Stx release differs among 
E. coli O157:H7 strains.  Stx phages from clinical isolates have been shown to be highly 
variable and differ in the level of toxin production (Gamage et al., 2004).  High 
resolution genotyping methods have shown that human and bovine isolates of E. coli 
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O157:H7 are not randomly distributed among lineage I and lineage II (Kim et al., 1999).  
Lineage I strains are found in human and bovine isolates whereas lineage II are most 
commonly associated with cattle.  This indicates that one of the lineages may be less 
virulent to humans or may not be efficiently transmitted to humans from a bovine source 
(Kim et al., 1999).  Ziebell et al. (2008) have also determined that Stx2 type and the level 
of Stx production are specific to these lineages.  
  In Chapter two of the thesis, genetic relationships among different STEC strains 
of human and bovine origin were examined.  It was determined that in E. coli O157:H7, 
lineage I strains of both human and bovine origin produced Stx2 whereas lineage II 
strains produced the variant Stx2c and were mainly of bovine origin.  In this chapter, 
lineage-specific differences in the Stx2 bacteriophage and toxin production by lineage I 
and II strains are examined.  Specific objectives of this study were to: 
1) Determine if Stx2 phage is released in a lineage-specific manner after exposure to 
specific chemical and physical inducers 
2) Determine if  relative toxin release following induction by strains is lineage-
specific 
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4. 2. Materials and Methods 
4.2.1.  Bacterial strains 
   A collection of 18 E. coli O157:H7 lineage-specific strains which were isolated 
from different sources and contained several different phage types (PT) were used in this 
study (Table 4.2.1.) (Khakria et al., 1999; Kim et al., 1999).  Lineage-specific 
polymorphism assay (LPSA) types of the bacteria were previously determined by 
microarray-based comparative genomic hybridization (Zhang et al., 2007).  LI/LII strains 
were treated as subgroups within lineage I but were identified as lineage I/II.  EDL933 
and EC970520 were used as representative examples of lineage I and lineage II strains 
respectively.  These bacteria contain Stx2 phage with known sequence and lineage-
specificity (Plunkett et al., 1999; Zhang et al., 2007).  E. coli K12 strain MG1655 was 
used as a negative control because it contains no intact Stx bacteriophage (Blattner et al., 
1997).  Several E. coli non-pathogenic strains, LE392, DH5α, C600 and 
ML:1061OR:H48 were used as bacteriophage-free, plating bacteria. 
  
4.2.2.  Induction and isolation of bacteriophage from E. coli O157:H7 strains 
 Bacteriophage production was induced with ciprofloxacin, mitomycin C or UV 
light. Bacteria were grown from single colonies in 50 ml Luria-Bertani (LB) Broth and 
placed in a 37 °C shaker overnight at 200 cycles/min (Orbital shaker D52-500-2, VWR). 
Inductions were performed by making a 1/10 dilution of the overnight culture after which 
0.15 µg/mL ciprofloxacin (Biochemika) or 0.5 µg/mL mitomycin C (Sigma) was added 
and the mixture shaken at 37 °C for 3 hr.  Bacteriophages were isolated from the induced 
cultures by pelleting the cells and lysed debris at 8000 rpm in a (Thermo IEC centrifuge,  
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Table 4.2.1. E. coli O157:H7 lineage-specific strains used in this study.  
Strains were previously used and characterized for LPSA type by Zhang et al. (2007) 
from microarray-based comparative genomic hybridizations.  
 
Strain # Serotype Phage Source 
LPSA 
type Lineage Stx1 Stx2 
53722 O157:H7 14 Human IIIIII I + + 
F1299 O157:H7 14 Bovine IIIIII I + + 
EDL933 O157:H7 21 Human IIIIII I + + 
63154 O157:H7 31 Human IIIIII I + + 
58212 O157:H7 31 Human IIIIII I + + 
F1095 O157:H7 31 Bovine IIIIII I + + 
Sakai O157:H7 32 Human IIIIII I + + 
F1082 O157:H7 87 Bovine IIIIII I + + 
59243 O157:H7 2 Human 2IIIII I/II - + 
71704 O157:H7 2 Human 2IIIII I/II - + 
LRH13 O157:H7 23 Human 222222 II + + 
R1797 O157:H7 23 Human 222222 II + + 
L568 O157:H7 23 Bovine 222222 II + + 
F1081 O157:H7 23 Bovine 222222 II + + 
FRIK 1999 O157:H7 23 Bovine 222222 II + + 
R834 O157:H7 54 Human 222212 II - + 
EC970520 O157:H7 67 Bovine 222222 II + + 
12491 O157:H7 74 Human 222222 II - + 
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Micromax) for 30 min. The supernatant was filtered through a 0.45 µm-pore size 
membrane (Micro Filtration Systems) and stored at 4 ºC with 5 µL chloroform (Sigma). 
For UV light inductions, overnight cultures were centrifuged at 8000 rpm for 30 min, 
resuspended in 10 ml saline and then exposed to UV light for 10 min.  A 1/10 dilution of 
saline solution in LB was placed into a 37 °C shaker for 3 hr. Induced cultures were 
centrifuged, filtered and stored with chloroform at 4 ºC as previously described.  
 
4.2.3.  Measurement of cells and lysates  
 The optical density of bacterial cultures was measured at 600 nm (OD600) using a 
spectrometer prior to and after bacteriophage induction to monitor bacterial lysis (DU800 
spectrometer, Beckman Coulter).  Control and induced cultures were compared in each 
experiment.  Strains EDL933 and EC970520 were measured prior to and after every hour 
to measure the rate of phage production post induction.  Measurements were repeated 
three times for each isolate.  
 
4.2.4.  Plating of bacteriophage  
 Bacteriophages were plated using the protocol described by Sambrook, (1986). 
Bacteriophage-free E. coli were used to assess the presence or absence of phage from 
different strains of bacteria which were capable of plaque production.  A single colony of 
plating bacteria was inoculated in 50mL of LB broth with 0.2% maltose and placed in a 
37 °C shaker overnight at 200 cycles/min. The culture was pelleted by centrifugation at 
10,000 rpm for 30 min and re-suspended in 0.01 M MgS04 until an OD600 of ~2.00 was 
obtained. Tenfold serial dilutions of induced bacteriophage were prepared in an SM 
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medium consisting of 2.9 g NaCl, 1 g MgS04 7H20, 1 M Tris-Cl (pH 8.0) and 2% gelatin. 
In a sterile tube, 100 µL of plating bacteria plus 100 µL of induced bacteriophage 
supernatant were mixed and incubated together for 15 min with either 1 µl ciprofloxacin 
or mitomycin C at room temperature (RT).  No treatment or chemical was added to the 
UV induced cultures.  The mixture was added to 4 mL of 65 °C LB agar, mixed gently 
and poured onto prewarmed (37 ºC) LB agar plates and incubated overnight at 37 ºC.  
Plates were examined for plaque formation the following day.  K12 and Sakai were used 
as negative controls since K12 does not contain viable phage and Sakai has been shown 
previously to lack plaque-forming ability (Blattner et al., 1997; Makino et. al, 1999). 
 
4.2.5. DNAse treatment of bacteriophage DNA 
 Bacterial cultures containing Stx2 bacteriophage released into the supernatant 
during a lytic cycle were identified using PCR.  Prior to amplification, template DNA 
from the bacteriophage supernatants were treated with DNAse (Ambion) to ensure that 
the PCR product was the result of amplification of bacteriophage DNA and not 
chromosomal DNA from integrated prophage.  DNAse treatment of phage supernatants 
has been utilized previously to digest the nucleic acids liberated from lysed bacteria 
without disturbing phage nucleic acids which are protected by a phage protein coat 
(Yokoyama et al., 2000).  The supernatant was incubated at 37 ºC for 30 min with 2U 
DNAse and 1X DNAse buffer and inactivated at 95 ºC for 10 min.  A PCR was 
performed using 3 µL of bacteriophage DNA as template.  The PCR was replicated for 
ciprofloxacin, mitomycin C and UV induced cultures. 
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4.2.5.1.Confirmation of Stx2 bacteriophage lysates by PCR    
 PCR of DNAse treated phage supernatants for identification of Stx2 phage were 
prepared in 50 µl reaction volumes. Each contained 10 pmol each of primer VT2-F 
(5’CCATGACAACGGACAGCAGTT3’) and VT2- R 
(5’CCTGTCAACTGAGCACTTTG3’), 200 µM of each deoxynucleoside triphosphate, 
1X PCR Buffer (Qiagen) and 1 U of Taq DNA polymerase (Qiagen).  The PCR was 
conducted as follows: 3 min denaturation at 94 ºC, followed by 25 cycles of 45 s at 94 ºC, 
30 s at 55 ºC and 90 s at 72 ºC with a final 10 min extension step at 72 ºC.  The same 
conditions were applied for Stx1 identification except that the primers used in the PCR 
reaction were VT1-F (5’CATTGTCTGGTGACAGTAGCT) and VT1-R 
(CCCGTAATTTGCGCACTGAG).  The VT1 and VT2 primers were designed from 
conserved regions in STEC strains which identify both Stx’s and their variants and 
previously used in the E. coli O157:H7 assay from Gannon et al. (1997).  PCR products 
were visualized under UV light on a 1.0% (w/v) agarose gel stained with ethidium 
bromide (0.5 µg/ml).  Negative controls incorporated all reagents of the PCR except 
water was used as a template. 
 
4.2.6.  Stx2 plaque hybridization  
 A method to identify bacteriophage plaques by Wang and Cutler (1992) which 
uses nitrocellulose membrane hybridization and PCR to characterize plaques was used to 
identify the number of Stx2 plaques present on plates.  Nitrocellulose membrane 
(Transblot) discs were prepared using a glass Pasteur pipette to puncture small holes in 
the membrane and placed on plaques from EDL933 and EC970520 for ~30 s.  The discs 
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were then used as a template for PCR.  Discs were treated with 2U DNAse (Ambion) in 
1X DNAse I Buffer for 30 min at 37 ºC and deactivated for 10min at 95 ºC prior to PCR.  
All transfers were made with sterile tweezers to prevent cross-contamination of discs.  
K12-induced plated cultures were used as a negative control.  All results were replicated.  
 
4.2.7. Evaluation of toxin production   
 To determine the relative amount of toxin produced by induced and non-induced 
cultures of lineage-specific strains, an enzyme-linked immunosorbent assay (ELISA) was 
performed. A Premier EHEC kit (Meridian Bioscience Inc.) was used for detection of Stx 
produced by enterohemorrhagic E. coli (EHEC) according to manufacturer’s instructions. 
Prior to detection, overnight cultures were diluted 1/10, and half of the cultures were 
induced with ciprofloxacin for 3 hrs at 37 ºC shaking as previously described.  The 
cultures were then diluted with LB to an OD600 of 0.2. All samples and readings were 
done in triplicate.  
 
4.2.8. Toxin production of phage after cellular lysis in LE392 
 The ability of bacteriophage to propagate, undergo cellular lysis and release Stx in 
LE392 was tested using the infection procedure described in the Expand cloning kit 
manual (Roche Applied Science).  A single colony of plating bacteria (LE392) was 
inoculated in 20 mL of LB broth with 0.2% maltose and 10mM MgSO4 and placed in a 
37 °C shaker at 200 cycles/min until an OD600 of 0.8-1.0 was obtained.  Plating bacteria 
were centrifuged at 3500 rpm for 5 min and resuspended in 10 mM MgSO4 and adjusted 
to an OD600 of 0.8-1.0.  In a sterile tube, 400 µL of plating bacteria and 200 µL of 
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induced bacteriophage supernatant obtained as previously described were incubated in a 
37 ºC shaker.  Toxin production was measured by ELISA. 
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4.3.  
4.3.1.   Bacteriophage production in res
 Both 
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Results   
ponse to antibiotic, mutagen or UV light 
treatment 
E. coli O157:H7 lineage I strain EDL933 and E. coli O157:H7 lineage II 
strain EC970520 displayed a similar response to treatments with antibiotic 
(ciprofloxacin), chemical mutagen (mitomycin C) and UV light (Figure 4.3.1.; Figure 
4.3.2.).  The OD600 in the untreated cultures increased in density steadily over time to 
~0.55.  After UV treatment the OD600 increased over time but the density was lower than 
that obtained for non-induced cultures; i.e., the cell density increased to a maximum of 
~0.4 for EC970520 and to ~0.45 for EDL933 by 180 min post-treatment.  Treatment with 
mitomycin C and ciprofloxacin resulted in smaller increases in cell density; i.e., when 
both E. coli O157:H7 strains EDL933 and EC970520 were treated with mitomycin C, 
cell density rose from ~0.10 to 0.25 and 0.20, respectively, by 120 min post-induction.  
While values remained similar in EC970520 up to 180 min (Figure 4.3.2.), they 
decreased to ~0.15 by 180 min in EDL-933 (Figure 4.3.1.).  Treatment with ciprofloxacin 
had the greatest effect on OD600 for both strains of bacteria.  In E. coli O157:H7 strain 
EDL933 treatment with ciprofloxacin caused values to only increase from 0.09 to 0.11 by 
60 min and remained constant up to 180 min (Figure 4.3.1.).  For E. coli O157:H7 strain 
EC970520 values increased from 0.05 to 0.16 by 60 min after which the OD600  only 
increased to 0.19 by 180 min (Figure 4.3.2.).   
The OD600 of eight randomly selected lineage I, I/II and lineage II strains after a 3 hr 
induction was compared to that of untreated cultures to determine if any lineage-specific  
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Figure 4.3.1. The mean OD600 of EDL933, a representative strain of lineage I, over 3hr after addition of ciprofloxacin, mitomycin C or 
exposure to UV light verses no treatment.  
Standard deviations (values < 0.01) are not shown.  
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Figure 4.3.2. The mean OD600 of EC970520, a representative strain of lineage II over 3hr after addition of ciprofloxacin, mitomycin C 
or exposure to UV light verses no treatment.  
Standard deviations (values < 0.01) are not shown.
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differences were eviden
 120
t.  Few differences in the OD600 were observed among the 
lineages (Figure 4.3.3.; Figure 4.3.4.; Figure 4.3.5.).  In each case, the observed cell 
density was lower for bacteria treated with ciprofloxacin, followed by mitomycin C, and 
little difference in densities was observed for UV light treatment compared to the 
uninduced control cultures (Figure 4.3.6.).   E. coli K12 was used as a negative control in 
each case and displayed less of a difference in OD600 between induced and non-induced 
cultures than the E. coli O157 strains.  
 
4.3.2.  Plaque production after induction of bacteriophage  
 To determine if plaque formation after induction was lineage-specific, 
supernatants of the induced cultures from above were mixed and plated with E. coli K12 
strain LE392.  Filtered supernatants of 3 hr ciprofloxacin-induced E. coli O157:H7 
EDL933 cultures were used as positive controls (Plunkett et al., 1999) (Figure 4.3.6.).  
For E. coli O157:H7 EDL933, a decrease in bacterial growth was evident when undiluted 
phage supernatants were plated with E. coli LE392 compared to the negative control plate 
where an even lawn of bacterial growth was observed (Figure 4.3.7.).  Isolated plaques 
were also present in the 1/100 dilution for induced cultures of E. coli O157:H7 EDL933.  
For the lineage II strain, E. coli O157:H7 EC970520, bacterial growth was sparse and 
several large spots were evident when the undiluted EC970520 supernatant was plated 
(Figure 4.3.8.).  As the dilution increased, no plaques or clearing were seen and an even 
layer of bacterial growth was observed similar to the negative control.  With mitomycin 
C and UV light similar results were obtained for E. coli O157:H7 EDL933  
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Figure 4.3.3. The mean OD600 of lineage I, I/II and lineage II strains of UV induced and non-induced cultures after 3 hr. 
Measurements were repeated three times for each isolate. Standard deviations are not shown (<0.01). The strains are 63154, EDL933, 
Sakai, F1095, F1082, F1299, 59243, 71074, FRIK 1999, R834 R1797, 12491, EC970520, LRH13, F1081, L568 and K12.  
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Figure 4.3.4. The mean OD600 of lineage I, I/II and lineage II strains of mitomycin C induced and non-induced cultures after 3 hr. 
Measurements were repeated three times for each isolate. Standard deviations are not shown (<0.01). The strains are 63154, EDL933, 
Sakai, F1095, F1082, F1299, 59243, 71074, FRIK 1999, R834, R1797, 12491, EC970520, LRH13, F1081, L568 and K12. 
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Figure 4.3.5. The mean OD600 of lineage I, I/II and lineage II strains of ciprofloxacin induced and non-induced cultures after 3 hr. 
Measurements were repeated three times for each isolate. Standard deviations are not shown (<0.01). The strains are 63154, EDL933, 
Sakai, F1095, F1082, F1299, 59243, 71074, FRIK 1999, R834, R1797, 12491, EC970520, LRH13, F1081, L568 and K12.
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Figure 4.3.6.  The mean OD600 of lineage I, (I/II) and lineage II strains of UV light, mitomycin C, and ciprofloxacin induced cultures 
verses non-induced cultures after 3 hr.  
Error bars represent standard deviations.
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A) LE392: no phage                                                   B) EDL933/LE392: no dilution 
                         
 
 
 
 
 
                                                                                    
  C) EDL933/LE392: 1/10 dilution                            D) EDL933/LE392: 1/100 dilution 
 
 
Figure 4.3.7. Plating ciprofloxacin induced bacteriophage from EDL-933 on 
bacteriophage-free E. coli strain, LE392. 
A) no induced phage; B) undiluted induced EDL933 phage; C) 1/10 dilution of EDL933 
phage; D) 1/100 dilution of EDL933. 
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 C) EC970520/LE392: 1/10 dilution                           D) EC970520/LE392 :1/100 dilution 
 
 
Figure 4.3.8. Plating ciprofloxacin induced bacteriophage from EC970520 on 
bacteriophage-free E. coli strain, LE392. 
A) no induced phage; B) undiluted induced EC970520 phage; C) 1/10 dilution of 
EC970520 phage; D) 1/100 dilution of EC970520. 
 
520/LE392: no dilution A) LE392: no phage                            
                                                                                              
 
 
 
 
 
 and EC970520 cultures except that plaques were very small for EDL933.  E. coli K12 
and E. coli O157:H7 Sakai induced cultures did not produce plaques.  
 To determine if E. coli O157:H7 strain EC970520 and EDL933 were 
representative of the lineages in terms of plaque formation, one additional  lineage I, two 
lineage I/II and three additional lineage II strains were compared in their ability to form 
plaques on E. coli LE392 following induction with ciprofloxacin (Table 4.3.1.). The other 
lineage I strain (F1299) and lineage I/II strains (59243) and (71074) produced plaques 
similar to those produced by E. coli O157:H7 EDL933 following induction.  Like E. coli 
O157:H7 EC970520, the three other lineage II strains’ undiluted supernatants inhibited 
growth of E. coli LE392 but did not produce clearly defined plaques.  Similar results 
were obtained from tests of the supernatants of these induced lineage I, I/II and II  E. coli 
O157:H7 strains using three other E. coli test strains including ML:1061OR:H48, C600 
and DH5α (Table 4.3.1.).  Lineage I and I/II strains produced plaques similar to EDL933 
on most E. coli strains whereas lineage II strains did not.  However, lineage II strain 
R834 produced a few plaques when plated on E. coli DH5α.  It was also observed that 
some lineage I and I/II strains produced plaques when no inducer was present (Table 
4.3.1.). 
 
4.3.3.  Presence of Stx2 producing-bacteriophage  
 To determine if Stx2-encoding bacteriophage were induced but not detected in E. 
coli K12 plaque assays, the supernatants from induced cultures were treated with DNAse  
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Table 4.3.1.  Plating ciprofloxacin induced bacteriophage from lineage specific (I, I/II or 
II) E. coli O157:H7 strains on bacteriophage-free E. coli strain, ML:1061OR:H48, 
LE392, C600, or DH5α..  
Plaques (P):+,++,+++,++++ - increasing number of plaques; Bacteria (B) (No plaques 
present) +,++,+++,++++ - increasing layer of bacteria. 
Lineage Strain ML:1061O
R:H48 
LE392 C600 DH5α No 
chemical-
LE392 
P++++ P++++ P+++ P++++ P++++ I EDL933 
plaques 
touching 
plaques 
touching 
few 
plaques 
touching 
plaques 
touching 
plaques 
touching 
P+++ P+++ P+ P++++  P++ I F1299 
plaques 
touching 
few 
plaques 
touching 
few 
individua
l plaques 
big, 
touching 
plaques 
spots, not 
well 
defined 
plaques 
P++ P+++ 
single 
plaques 
plaques 
touching 
I/II 59243 P+++ 
  
B++++ 
  
B+++ 
P++++ B++++ B++++ P++++ P+++ I/II 71074 
plaques 
touching 
even 
growth 
even 
growth 
plaques 
touching 
plaques 
touching 
B+++ B+++ B++ B+++ B++++ II EC970520 
even 
layered but 
clearer 
clear 
corner 
with 
spots 
clearing 
with big 
spots 
corner 
clearing 
with big 
spots 
almost 
even layer
B+++ B++ B++ B++ B++++ II F1081 
even layer 
but clearer 
clearing 
with big 
spots 
clearing 
with big 
spots 
half 
cleared 
with 
spots 
even layer 
but 
slightly 
clearer 
B+++ B+ B+++ B++ B++++ 
even layer 
but clearer 
clearing 
with 
spots 
big spots half 
cleared 
with 
spots 
even layer 
but 
slightly 
clearer 
II L568 
          
II R834 B+++ B++++ B+++ P+ B+++ 
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 to destroy any free chromosomal DNA, DNAse was inactivated by heat treatment, and a 
Stx2-specific PCR was performed.  Most lineage I and I/II bacterial strains were positive 
for the Stx2 gene target following use of at least one induction method including E. coli 
O157:H7 Sakai (Table 4.3.2.A).  E. coli O157:H7 strain F1299 was an exception; 
although belonging to lineage I and producing plaques (Table 4.3.1.), its culture 
supernatant tested negative for the Stx2 bacteriophage.  By contrast, culture supernatants 
of lineage II strains were mostly negative for the Stx2 except for E. coli O157:H7 strain 
R834 which tested positive following both mitomycin C and ciprofloxacin but not UV 
treatment (Table 4.3.2.A).  
  All lineage II strain culture supernatants were negative for the Stx1 gene whereas 
lineage I strains were positive for Stx1 genes following use of at least one induction 
method (Table 4.3.2.B).  However, supernatants from both lineage I/II strains, 71074 and 
59243, were Stx1 negative.  It was also observed that following treatments with UV light 
supernatants from most strains were Stx1 gene negative. 
 Since several bacteriophage are present in E. coli O157:H7 strains, DNA was 
extracted from plaques and Stx2 PCR assays were carried out to identify and quantify 
plaques associated with Stx2-encoding bacteriophage (Perna et al., 2001).  Plaques 
containing the bacteriophage were treated with DNAse to ensure that the amplified 
product was not from chromosomal prophage DNA.  Replicate PCR results from 40 
ciprofloxacin induced plaques of EDL933 revealed that 37/40 plaques (92.5%) were Stx2 
positive. When the large spots from EC970520 were tested, 3/5 (60.0%) and 3/7 (42.8%) 
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Table 4.3.2.  PCR detection of A) VT2 and B) VT1 amplified products for Stx phage 
detected in lineage-specific E. coli O157:H7 strains after induction with ciprofloxacin, 
mitomycin C or UV light and DNAse treatment of the supernatant.   
(+): presence of expected band size. (-): no band. All results were replicated and shown in 
table. 
 
A) VT2 
Strain Lineage Ciprofloxacin Mitomycin C UV light 
F1299 I -, - -, - -, - 
EDL933 I +, + +, + +, + 
63154 I +, + +, + +, + 
58212 I +, + +, + +, + 
F1095 I +, + +, + +, + 
Sakai  I +, + +, + +, + 
59243 I/II -, - +, + +, + 
71074 I/II -, - +, + +, - 
LRH13 II -, - -, - -, - 
R1797 II +, - -, - -, - 
L568 II -, - -, - -, - 
F1081 II -, - -, - -, - 
FRIK 1999 II -, - -, - -, - 
R834 II +, + +, + -, - 
EC970520 II -, - -, - -, - 
12491 II +, - -, - -, - 
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B) VT1 
Strain Lineage Ciprofloxacin Mitomycin C UV light 
F1299 I +, + +, + -, + 
EDL933 I -, + +, + -, - 
63154 I +,+ +, + -, - 
58212 I +,+ +, + -, - 
F1095 I +,+ +, + -, - 
Sakai  I -, - +, + -, - 
59243 I/II -, - -, - -, - 
71074 I/II -, - -, - -, - 
LRH13 II -, - -,- -, - 
R1797 II -, - -,- -, - 
L568 II -, - -,- -, - 
F1081 II -, - -,- -, - 
FRIK 1999 II -, - -,+ -, - 
R834 II -, - -,- -, - 
EC970520 II -, - -,- -, - 
12491 II -, - -,- -, - 
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were Stx2 positive.  In all cases E. coli K12 strains tested negative for the Stx2 
bacteriophage.  
 
4.3.4.  Assessment of Stx production  
 An E. coli Stx-specific ELISA was performed to determine the relative toxin 
production in lineages I, I/II and II strains before and after induction.  After ciprofloxacin 
treatment, toxin production increased in all lineage I, I/II and lineage II strains (Figure 
4.3.9.).  The average ratio of induced Stx production (ciprofloxacin induction: no 
treatment) was similar for both lineages; i.e. the ratio was 4.2 for lineage I and 4.7 for 
lineage II strains.  However average toxin production for lineage I strains was higher in 
both untreated (0.437) and in ciprofloxacin induced cultures (1.13) than the average 
observed for lineage II strains in untreated (0.058) and in ciprofloxacin induced cultures 
(0.293).  Exceptions to this observation were seen for the lineage I strain F1299 which 
did not produce increased amounts of toxin after induction and for E. coli O157:H7 strain 
Sakai which did not show an increase in toxin production following induction equal to 
that of other lineage I and I/II strains.  Lineage II strain LRH13 exhibited higher levels of 
toxin production relative to other lineage II strains after ciprofloxacin treatment.  E. coli 
K12 did not produce any Stx in either the induced or uninduced cultures.  
 
4.3.5.  Stx-encoding bacteriophage and toxin release following infection of E. coli 
LE392 
 In order to determine if induced bacteriophage from E. coli O157:H7 strains were 
able to produce Stx in other E. coli, LE392 was used as a recipient. Culture supernatants 
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fro
 133
m E. coli O157:H7 strain EDL933 were inoculated into broth cultures of E. coli 
LE392.  Stx production was measured by ELISA assays.  There was significant toxin 
production, however, there was no difference in toxin production in supernatants between 
the ciprofloxacin-induced cultures and those that were untreated (Figure 4.3.10.).  No 
toxin production was observed in induced and uninduced E .coli O157:H7 EC970520 or 
control E. coli K12 culture supernatants.  
 
 
 
 
 
00.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
63
15
4 I
ED
L-9
33
 I
SA
KA
I I
F1
09
5 I
F1
29
9 I
58
21
2 I
59
24
3 I
/II
71
07
4 I
/II
FR
IK
 19
99
 II
R8
34
 II
R1
79
7 I
I
12
49
1 I
I
EC
97
05
20
 II
LR
H1
3 I
I
F1
08
1 I
I
L5
68
 II
K1
2
Lineage-specific strain
S
t
x
 
p
r
o
d
u
c
t
i
o
n
 
(
4
5
0
n
m
)
No treatment
Ciprofloxacin
 
Figure 4.3.9. ELISA Stx production for lineage I, I/II and lineage II E. coli O157:H7 strains treated with ciprofloxacin verses no 
treatment.  
Standard deviations are shown by error bars. The strains are 63154, EDL933, Sakai, F1095, F1299, 58212, 59243, 71074, FRIK 1999, 
R834, R1797, 12491, EC970520, LRH13, F1081, L568, and K12. 
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Figure 4.3.10.  ELISA Stx production after transfer of supernatant induced EDL933, EC970520 and E. coli K12 to an E. coli LE392 
recipient strain before and after ciprofloxacin induction.  
Errors bars represent standard deviations. 
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4.4. Discussion 
4.4.1. Phage release due to exposure to inducers  
 Exposure of E. coli cells to agents that damage or interfere with DNA replication 
can lead to induction of the lytic cycle resulting in phage release and toxin production. 
Cellular lysis of E. coli associated with phage release has been monitored by other works 
by measuring cellular optical density at 600 nm after exposure to inducers (Muniesa et 
al., 2003).  In this study, the OD600 of cultures induced with ciprofloxacin, mitomycin C 
and UV light were measured and compared to non-induced cultures to determine the 
relative effectiveness of these inducers on phage release from E. coli O157:H7.  It has 
also been determined that phage induction typically results in an initial increase in OD 
followed by a decrease, as phage are produced and bacterial lysis occurs (Gamage, 2004).  
Muniesa et al. (2003) have shown that in some E. coli O157 strains these lower OD600 
values resulting from bacterial cell lysis correspond to higher levels of phage release.  
The results of this study suggest that ciprofloxacin treatment resulted in the highest levels 
of phage release; decreases in OD600 over time were greatest for ciprofloxacin, followed 
by mitomycin C (Figure 4.3.6.).  UV light was not a strong inducer of bacteriophage 
production as the OD600 was closer to the non-induced treatments than the other inducers 
3 hr post treatment.  Each of the methods triggers phage induction in a slightly different 
manner; UV light and the mutagen, mitomycin C, directly damage DNA while the 
quinolone antibiotic, ciprofloxacin inhibits DNA gyrase (Lejeune et. al, 2004; Schmidt 
et. al, 1999; Gamage, 2004).  It is possible that inhibition of DNA gyrase induces the 
SOS response and subsequent phage release more efficiently than DNA damage-
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mediated induction effects of UV or mitomycin C.  For this reason, ciprofloxacin also 
was used in most of our experiments. 
It was observed that the OD600 from both lineages responded in a similar fashion 
before and after induction; there was a significant decrease in the OD600 following 
exposure to each of the inducers (Figure 4.3.3.; 4.3.4.; 4.3.5.).  Muniesa et al., (2003) has 
concluded that induced cultures with a similar absorbance likely contain similar amounts 
of bacteriophage.  However, previous studies have shown that the amount of extracellular 
toxin released by infected cells does not always correspond to the decrease in bacterial 
growth observed; i.e., some bacterial strains may produce different amounts of toxin 
(Grif et al., 1998).   
The  results of this study also showed that E. coli K12 cultures decreased in OD600 
after treatment with inducers, but not as much as the E. coli O157:H7 strains examined.  
This suggests that some of the decrease in cellular density observed in our study might be 
attributed to bacterial death caused by the inducer and not just from phage lysis.  In the 
present study E. coli O157:H7 strains Sakai and F1299 occasionally grew to higher cell 
densities suggesting that the phages in these strains may be less inducible.  This 
observation concurs with studies by Makino et al. (1999) who reported that the Stx-
encoding prophage in E. coli O157:H7 strain Sakai was not inducible. 
  The importance of linking bacteriophage release to the induction process is 
critical as the risk of toxemia may be enhanced after exposure to agents such as 
ciprofloxacin and mitomycin C when they are used as therapeutics.  These toxins may be 
expressed after induction and could result in more severe disease such as HUS.  
Treatment of STEC patients with antibiotics is therefore controversial as many of these 
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agents inhibit DNA synthesis in the infected bacteria leading to induction of the phage 
lytic cycle, an increase in bacteriophage release and toxin production.  Mitomycin C is 
used as a chemotherapeutic agent, but also is a potent bacteriophage inducer which is 
often associated with HUS.  It has been reported that between 2 and 10% of mitomycin 
C-treated patients come down with HUS (Wu et al., 1997).  In addition, UV light which 
is currently used as a source for disinfection of bacterial pathogens when aseptically 
filling liquid foods such as milk, beer and fruit juices, in the ripening of cheese and dry 
sausages, and in water treatment may be of concern.  Phage released from E. coli 
O157:H7 strains have been shown to infect and produce Stx toxin in non-pathogenic E. 
coli strains and this source of toxin may contribute to illness associated with E. coli 
O157:H7 (Gamage, 2004). In addition, to the possibility of increased phage release, these 
phage are more UV resistant than bacterial cells and therefore may survive bactericidal 
food processing procedures (Meng and Doyle, 2001).  Techniques which allow proper 
monitoring of phage release need to be developed and will be helpful in identifying those 
strains of E. coli with pathogenic potential to cause disease in humans. 
  
4.4.2.  Induction and release of bacteriophage 
 Since Stx genes may only be expressed in the lytic cycle, phage release by 
different strains of E. coli O157:H7 was assessed in this study by their ability to form 
plaques.  Lineage I and I/II strains of E. coli O157:H7 were able to produce plaques after 
induction but most lineage II strains were not. This suggests that phage in lineage I and 
I/II strains are much more readily able to enter the lytic cycle and produce viable phage 
particles that are able to infect other bacterial strains after their induction than lineage II 
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strains.  However, these experiments also left the possibility that the lineage II strains 
produce a different type of phage that does not form plaques on the E. coli test strains 
used in this study.  This may be evidenced by the different plaque morphologies observed 
for lineage I and I/II and lineage II strains in this study (Figure 4.3.7.; Figure 4.3.8.).  The 
ability of lineage II E. coli O157:H7 to produce large zones of clearing on E. coli K12  
lawns may be a result of the production of relatively few phage particles since these 
zones disappeared when the culture supernatants were diluted.  In some cases, the 
frequency of plaque formation might also be attributed to the presence of Stx1 phage in 
addition to Stx2 phage in the bacteria; e.g., E. coli O157:H7 strains 71074 and 59243 lack 
Stx1 and did not always produce plaques. In addition, E. coli O157:H7 strain R834 may 
be more inducible than other lineage II strains as it was able to produce a small number 
of plaques on E. coli DH5α while other lineage II strains could not.  It also is interesting 
to note that E. coli O157:H7 strain R834 although from lineage II was isolated from a 
human with clinical disease and this strain may be more pathogenic than other lineage II 
strains. 
 Some plaque formation was observed in the absence of a chemical inducer and 
may be attributed to spontaneous induction. Spontaneous activation of lytic phage occurs 
once in every 104 cell divisions and can be due to sporadic DNA damage such as stalled 
replication forks or decreased repressor (Calendar, 2006).  However, spontaneous 
induction of plaques was only observed in lineage I and I/II strains.  The small undefined 
plaques produced in response to UV light and mitomycin C treatments could result from 
lower levels of phage release. 
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Bacterial strains frequently contain defective or cryptic prophages in addition to 
complete ones (Calendar, 2006).  Deletions, mutations and insertions within prophage 
genomes over time contribute to the presence of these defective phages.  Lack of plaque 
formation may indicate an inability of the phage to produce lytic infection.  In Chapter 
Two of the thesis, the presence of IS elements in the E. coli O157:H7 strain EC970520 
were noted; these elements may contribute to production of a defective Stx2c lytic phage.  
Moreover, this defect may be present in all lineage II bacteria.   
 
4.4.3.  Presence of Stx2 bacteriophage  
 Sequencing of E. coli O157:H7 strains has revealed the presence of several 
prophages and phage-related elements within the genome.  However, the extent to which 
these prophages are capable of producing viable phage is unknown.  Many of these 
prophages appear to be defective and incapable of entering the lytic cycle.  In contrast, 
most Stx2 producing bacteriophage have been  shown to be capable of entering the lytic 
cycle and subsequently being released as infective phage particles (Ohnishi et al., 2002).  
In this study, PCR of DNAse-treated culture supernatants and DNA extraction was used 
to show that most lineage I and I/II E. coli O157:H7 strains are able to produce Stx2 
phage and that most lineage II strains are not (Table 4.3.2.A).  The ability for E. coli 
O157 strains to produce viable Stx2 producing phage may contribute to the virulence of 
lineage I and I/II E. coli O157:H7 strains since phage release from these bacteria has been 
associated with higher levels of toxin production and more severe disease (Muniesa et al., 
2003; Ziebell et al., 2008).  An exception to this was the lineage II strain, R834, which 
was positive for the Stx2 phage and produced plaques when plated onto E. coli K12.  
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However, this strain’s Stx2 phage does not seem to be as sensitive to induction as those 
found in lineage I strains since it did not produce plaques consistently and did not 
produce high levels of toxin after induction similar to lineage I and I/II strains.  The 
lineage I strain F1299 did not produce Stx2 phage, however, it did produce plaques; this 
likely is due to the presence of Stx1-encoding phage in the bacteria (Table 4.3.2.B).  The 
toxin levels in F1299 were also low, similar to lineage II strains.  This may make this 
bovine strain less virulent than other lineage I strains.  
 Use of PCR to examine culture supernatants from induced bacteria for the Stx1 
gene revealed that most lineage I strains were positive for Stx1 but not lineage II strains. 
The lineage I/II strains 71074 and 59243 were as expected, PCR negative for Stx1 phage 
lysogens.  UV light was unable to induce production of any Stx1 carrying phage. 
However, this may be due to the lower inducibility of the UV method. Optical density 
testing revealed very little cell lysis with the UV method.  This also suggests that Stx2 
producing phage may be more sensitive to UV induction than Stx1 producing phage.  As 
severe disease has been linked to strains producing Stx2; this may be due to their ability 
to readily release phage and produce more phage-encoded Stx2 than those strains 
containing only Stx1 (Gamage, 2004).  Similarly, the lack of phage induction in most 
lineage II strains and an accompanying lower toxin production may explain their 
infrequent association with human disease relative to lineage I strains. 
 Nitrocellulose membrane transfers were used to demonstrate that plaques 
contained Stx2. Most of the plaques in EDL933 were Stx2 positive (92.5%) but only a 
subset of the cleared zones found in the lineage II strain EC970520 contained Stx2 
(60.0%, 42.8%).  The presence of Stx2 in the EC970520 may be due to low rates or 
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occasional phage release, or chromosomal leakage.  It is also possible that E. coli K12 
could aid in producing functional Stx2 phage in EC970520 resulting in a different 
morphology of plaque.  E. coli K12 contains remnant phage DNA and may be able to 
rescue mutations in related bacteriophage either by recombining with them to produce 
functional genes (Blattner et al., 1997) or by complementing gene deficiencies within the 
related strains. 
 
4.4.4.  Relative toxin production in lineage I and II E. coli O157:H7 
 Toxin production was monitored by an ELISA to determine if the quantity of 
toxin released was related to the ability of lineage-specific strains to make viable Stx2 
gene carrying phage.  Lineage I, I/II and lineage II strains produced toxin following 
treatment with ciprofloxacin.  Lineage I and I/II strains produce larger amounts of toxin 
than lineage II strains.  The lineage I strain, F1299 did not produce very much toxin 
before or after induction with ciprofloxacin; and toxin production is likely only 
attributable to Stx1 (Table 4.3.2.B).  This also demonstrates that strains which cannot 
produce viable Stx2 phage do not produce as much Stx, even if they are capable of 
producing viable Stx1 phage.  It can also be noted that Stx2-producing phage strains 
71074 and 59243 which were missing Stx1, were still able to produce high toxin levels 
(Figure 4.3.9.).  The Sakai strain produced slightly less toxin than other lineage I and I/II 
strains and it is possible that this may be due to its lack of plaque-forming ability 
(Makino et al., 1999) (Figure 4.3.9.).  This strain may be capable of releasing Stx2 but 
not releasing Stx2-encoding phage like other lineage I and I/II strains.  Lineage II strains 
produced very little toxin with the exception of LRH13 which produced similar levels of 
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toxin to the lineage I and I/II strains (Figure 4.3.9.).  The reason why this strain is able to 
produce high levels of toxin is unknown.  However, it is interesting to note that this 
lineage II strain was isolated from a human source.  However, in contrast another human 
lineage II strain R834 did not produce high levels of toxin even though Stx2 producing 
phage were induced from this strain (Figure 4.3.9.).  It should be noted that plaques were 
not consistently produced with R834 on bacteriophage-free strains and were uninducible 
with UV light (Table 4.3.1.; Table 4.3.2.).  
 
4.4.5.  Bacteriophage viability and toxin production   
The ability of bacteria containing bacteriophage to produce viable phage, lyse the 
recipient strain LE392 and produce toxin was verified by ELISA.  EDL933 filtered 
supernatants were able to transfer the ability to produce toxin to LE392; but filtered 
supernatants from lineage II EC970520 were not (Figure 4.3.10.).  Future experiments 
with strains including F1299, Sakai, and R834 may aid us in understanding why these 
strains appear to differ from other strains of the same lineage and determine if these 
strains are producing viable Stx-encoding bacteriophage. The ability of lineage I strains 
to produce viable phage that are capable of converting strains that are otherwise non-
pathogenic into toxin-producing strains capable of cellular lysis allows toxin production 
to be increased or amplified 1000-fold (Gamage et al., 2004)  and could also contribute to 
the evolution of pathogenic organisms from non pathogens. It has been proposed that 
bacteriophages are part of a mobile common gene pool which can enable the creation of 
new phage with new properties at high frequencies (Hendrix et al., 1999). The co-
evolution of both virus and host can result in generation of mutants that also contribute to 
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the diversity of newly emerging pathogens by changing their fitness and host range 
(Weitz et al., 2008).  The mobility of inducible phage can cause recombination between 
genomes and generate diversity both within species and with other members of the 
intestinal flora creating the possibility for expansion of the bacterial host range of Stx2-
encoding bacteriophage.  The ability of lineage I strains to produce viable Stx2 phage that 
can infect other strains may contribute to the evolution of more highly pathogenic species 
capable of causing more severe human infections.  
 
4.5.  Conclusions 
Little is known about genotypic differences between Stx2-encoding phages from 
different E. coli O157:H7 lineages and to what extent they contribute to phenotypic 
differences between the lineages.  In this study, 
 
1) Ciprofloxacin treatment was shown to result in the greatest decrease in cell 
density over time. The effect of mitomycin C treatment was intermediate and UV 
light treatment was the lowest in terms of cell density.  Most lineage I and I/II 
strains were capable of plaque production while most lineage II bacteria were not 
or produced few phage with a different plaque morphology.  Lineage I and I/II 
strains were capable of producing Stx2 phages whereas lineage II strains produce 
none or low amounts of Stx2 phage.  Spontaneous phage induction was shown to 
occur in lineage I and I/II strains.  Stx2 phage appear to be more sensitive to UV 
induction than Stx1 producing phage. 
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3) Lineage I and I/II strains produce higher levels of toxins than lineage II strains.  
Strains that cannot produce viable Stx2 phages appear to produce less toxin, and 
strains without Stx1 but with Stx2 produce high toxin levels.  Some lineage II 
human strains produce more Stx2 than others and this may make them more 
virulent than other lineage II strains.  The ability to produce viable Stx2-encoding 
phage and by so doing increase toxin expression and dissemination of phage may 
be important in the evolution of highly pathogenic E. coli O157:H7 strains. 
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CHAPTER FIVE 
5.  Implications and Future Studies 
 The Stx2 phage genomes within E. coli O157:H7 are highly heterogeneous and 
this level of heterogeneity suggests that many recombination events have occurred 
resulting in the formation of new strains with varying pathogenic potentials.  The 
EC970520 Stx2 phage was selected for sequencing because microarray and PCR studies 
suggested that lineage II Stx2 phages are distinct from those found in E. coli 057:H7 
lineage I strains.  The Stx2 phage in EC970520, like the majority of other lineage II 
strains, contains the Stx2c variant.  Lineage II strains consist mainly of bovine isolates 
whereas lineage I strains consist of both human and bovine isolates.  While the Stx2c 
variant has been shown to be produced by strains associated with human disease, strains 
which produce this toxin variant may not be as virulent as strains which produce Stx2, 
such as the outbreak associated lineage I strain EDL933.  This decreased virulence may 
be associated with the toxin type (Stx2c versus Stx2) or simply by the amount of Stx2 
produced.  Since toxin production in these phages appears to be closely linked to 
induction of the Stx2 phages into the lytic cycle, it is possible that genetic differences 
between Stx2 phage such as the presence of an IS element in the lineage II strains may 
inhibit the activation of crucial lytic genes.  Several lineage-specific genes such as those 
for the Q anti-terminator protein upstream of the Stx2 genes in the phage sequence may 
be vital for Stx2 expression.  Integration of Stx2 phages occurs in the sbcB region in 
lineage II strains whereas integration of this phage in lineage I strains occurs in the wrbA 
region.  This difference in integration sites is likely associated with a difference in 
genetic mechanisms which allow these phage to integrate in a site-specific manner.  
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Differences in the ability of Stx2 phage present in each lineage to enter the lytic cycle and 
integrate into specific regions of the genome may contribute to the bacteria’s virulence 
for humans and biased host distribution.  Based on the results of this study, lineage I 
strains exhibit much higher inducer-mediated and spontaneous rates of phage release than 
lineage II strains.  Triggering of the lytic cycle is clearly associated with increased Stx2 
production.  Following lysis, the phage released are also capable of infecting commensal 
E. coli to increase toxin production further.  The phage may also integrate into the 
genomes of these other E. coli strains and allow a new STEC strain to emerge. The 
characterization of Stx-producing phage in human and bovine isolates will aid in 
identifying these phage in other bacterial strains and help us to determine how these 
phage are evolving and creating new potential pathogens. These data are also useful for 
genotyping strains and understand phenotypic differences observed among E. coli 
O157:H7 and STEC isolates from other seropathotypes.  
 A multiplex Bioplex assay was developed and it was able to specifically identify 
E. coli O157:H7 and the types of Stx(s) found within each strain.  The Bioplex assays 
may be more specific than simple PCR for some loci.  This assay format may be useful 
for detection of E. coli O157:H7 contamination in food and water samples.  Several 
probes for the Bioplex assay were designed based on genetic sequences from Stx2 phage 
from EC970520 and EDL933.  These probes were used to detect variation in the Stx2 
phage present in human and bovine E. coli O157:H7 strains.  The EC970520 Stx2 phage 
genes were lineage II-specific but only a subset of EDL933 Stx2 phage genes were 
lineage I-specific.  The presence of several Stx2 phage gene combinations within a 
collection of lineage I strains confirms the heterogeneity of these phage and their highly 
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recombinogenic nature that allows the production of new phage variants.  When 
characterizing these Stx2 phage genes in a collection of STEC strains from a variety of 
serotypes and seropathotypes, Stx2c phage genes from lineage II strain EC970520 were 
found to be more widely distributed throughout these strains than those from the Stx2 
phage from lineage I strain EDL933.  Certain EDL933 Stx2 phage genes appear to be 
markers for a subset of the most virulent strains from seropathotype A.  These Stx2 
probes are also helpful in differentiation among STEC strains and may be helpful for 
“molecular risk assessment” and epidemiological typing of strains to identify sources of 
infection.  
 We wished to determine if genotypic differences in Stx2 phage in E. coli 
O157:H7 strains was associated with their ability to produce viable phage and toxin.  
Ciprofloxacin treatment resulted in the greatest decrease in E. coli O157:H7 cell density 
over time followed by Mitomycin C and UV treatments.  This decrease in cell density 
was associated with plaque formation and Stx2 production by most lineage I E. coli 
O157:H7 strains.  Therefore treating human STEC infections with antibiotics such as 
ciprofloxacin or disinfection of food by UV light may trigger toxin production and phage 
release.  In contrast, lineage II E. coli O157:H7 strains produce fewer plaques of distinct 
morphology from lineage I strains following treatment with these inducers.  It is possible 
that the IS element found in lineage II EC970520 may also contribute to defective Stx2 
phage production in other lineage II strains.  Lineage I strains were also capable of 
spontaneous Stx2 phage release.  The greater association of lineage I strains with human 
illness may be directly related to higher toxin production by both induced and non-
induced cultures compared with those of most lineage II strains.  Interestingly, one 
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lineage II strain with relatively high levels of induced and non-induced toxin production 
was isolated from a human with clinical disease.  In addition, strains which possessed the 
Stx2 phage but lacked the Stx1 phage appeared to produce as high a level of toxin as 
strains which produced both Stx1 and Stx2.   
The ability of Stx2 phage to produce viable Stx2 phage capable of producing 
plaques and therefore able to leave their hosts and integrate into the genomes of other 
bacteria is important in the evolution of new pathogenic bacteria.  Detection of these 
phage in bacterial species and identification of their genetic components could aid in 
understanding how these strains have emerged, to trace sources of exposure in outbreaks 
of disease and how to prevent and treat disease associated with them. It is evident from 
this study that Stx phages are critical components in the evolution of these important  
pathogenic microorganisms. 
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